Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,A1BG,Alpha-1B-glycoprotein,1608,152,2.08 [0.86-5.05],0.1041354669120107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AAMDC,Mth938 domain-containing protein,1562,150,1.37 [1.03-1.81],0.031170499057901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AARSD1,Alanyl-tRNA editing protein Aarsd1,1849,189,1.26 [1.02-1.57],0.0347540651708793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABCA2,ATP-binding cassette sub-family A member 2,1541,149,1.41 [0.94-2.13],0.0995241658589547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABHD14B,Protein ABHD14B,1824,185,1.16 [0.94-1.44],0.1751737349902761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABL1,Tyrosine-protein kinase ABL1,1849,189,1.30 [1.09-1.54],0.0033441741895923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABO,Histo-blood group ABO system transferase,1606,152,1.04 [0.94-1.16],0.4175138163250979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ABRAXAS2,BRISC complex subunit Abraxas 2,1541,149,1.15 [0.91-1.45],0.2343659396155216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",1798,185,1.01 [0.88-1.17],0.8675606224621286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1574,146,1.08 [0.86-1.37],0.5103806526825858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",1596,150,1.01 [0.85-1.21],0.8772917420430363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACAN,Aggrecan core protein,1829,187,1.07 [0.71-1.64],0.7378962647214679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE,Angiotensin-converting enzyme,1606,152,1.21 [0.69-2.13],0.5021030870874382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACE2,Angiotensin-converting enzyme 2,1814,185,0.96 [0.78-1.17],0.6544460745452656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACHE,Acetylcholinesterase,1570,146,1.06 [0.69-1.64],0.7926567086133405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOT13,Acyl-coenzyme A thioesterase 13,1581,150,1.04 [0.91-1.19],0.5576520436873607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,1850,189,1.09 [0.84-1.40],0.5211112531686339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,1548,150,1.04 [0.74-1.46],0.8324236244275043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP5,Tartrate-resistant acid phosphatase type 5,1859,190,1.51 [1.00-2.27],0.0492049603849823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACP6,Lysophosphatidic acid phosphatase type 6,1862,190,1.10 [0.90-1.35],0.3622142055265809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRBP,Acrosin-binding protein,1593,150,1.09 [0.76-1.56],0.6439052733727355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACRV1,Acrosomal protein SP-10,1548,150,1.01 [0.64-1.58],0.9692550526757328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACSL1,Long-chain-fatty-acid--CoA ligase 1,1541,149,1.19 [0.80-1.77],0.3974922558806499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTA2,"Actin, aortic smooth muscle",1814,185,1.72 [1.44-2.07],3.9074651903816705e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN2,Alpha-actinin-2,1541,149,1.13 [0.86-1.47],0.3762957035485064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACTN4,Alpha-actinin-4,1801,185,1.58 [1.18-2.12],0.0021136074106591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1829,185,3.28 [2.21-4.87],3.539137290224895e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY1,Aminoacylase-1,1850,189,0.88 [0.74-1.05],0.1706032210148158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,1541,149,1.06 [0.83-1.37],0.6346547230007211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ACYP1,Acylphosphatase-1,1565,146,1.20 [0.96-1.51],0.1156620859375407
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA,Adenosine deaminase,1864,187,1.49 [1.06-2.09],0.0223994140705922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADA2,Adenosine deaminase 2,1842,186,1.79 [1.38-2.33],1.3846194073329816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1548,150,1.62 [1.11-2.35],0.0116842047084977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,1814,185,1.38 [0.91-2.09],0.128086541484921
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1832,185,1.33 [0.94-1.87],0.103567743646991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,1864,187,1.63 [1.11-2.40],0.0132007346761347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,1860,188,1.24 [0.79-1.93],0.3499693238270716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1581,150,2.22 [1.46-3.37],0.0001777259601944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1548,150,1.24 [0.75-2.05],0.3973695344234502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,1869,190,1.09 [0.66-1.81],0.7357932561269258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,1849,189,1.09 [0.83-1.42],0.5374006678482297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,1814,185,1.20 [0.81-1.78],0.3516046555917202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,1548,150,1.17 [0.77-1.78],0.4617177109006045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,1855,187,0.79 [0.60-1.03],0.0771837464641015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL2,ADAMTS-like protein 2,1604,153,1.42 [1.01-2.00],0.0430536949773512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL4,ADAMTS-like protein 4,1562,150,1.08 [0.57-2.03],0.8126386061302975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADAMTSL5,ADAMTS-like protein 5,1596,150,1.32 [0.90-1.93],0.1617194164620564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,1798,185,1.18 [0.90-1.56],0.233621648649805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADD1,Alpha-adducin,1570,146,1.11 [0.89-1.38],0.3518601717853246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRB3,Adhesion G protein-coupled receptor B3,1829,185,2.07 [1.54-2.79],1.5872960435170496e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRD1,Adhesion G-protein coupled receptor D1,1570,146,1.52 [1.06-2.20],0.0243092793541875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE1,Adhesion G protein-coupled receptor E1,1581,150,1.18 [0.91-1.53],0.2071145251031163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE2,Adhesion G protein-coupled receptor E2,1853,187,2.45 [1.67-3.61],5.543738875372528e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRE5,Adhesion G protein-coupled receptor E5,1862,190,2.24 [1.61-3.11],1.4381634337634872e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRF5,Adhesion G protein-coupled receptor F5,1596,150,1.35 [0.79-2.31],0.2788779472375395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG1,Adhesion G-protein coupled receptor G1,1849,189,1.28 [1.14-1.43],2.202972361573341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRG2,Adhesion G-protein coupled receptor G2,1850,189,0.51 [0.33-0.79],0.0026827991475622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADGRV1,Adhesion G-protein coupled receptor V1,1537,150,0.81 [0.62-1.05],0.1081330775919467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH1B,All-trans-retinol dehydrogenase,1570,146,0.83 [0.68-1.00],0.045330952317623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,1814,185,0.81 [0.70-0.94],0.0048351257929703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADIPOQ,Adiponectin,1608,152,1.02 [0.84-1.24],0.8408046040268331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADM,Pro-adrenomedullin,1867,190,1.54 [0.97-2.46],0.0688314553929023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ADRA2A,Alpha-2A adrenergic receptor,1541,149,1.16 [0.95-1.42],0.1377714431007371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFAP1,Actin filament-associated protein 1,1570,146,1.01 [0.83-1.23],0.8934919373267155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFM,Afamin,1608,152,0.53 [0.27-1.07],0.0769683370267079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AFP,Alpha-fetoprotein,1824,184,0.69 [0.56-0.85],0.0004611564464367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGBL2,Cytosolic carboxypeptidase 2,1537,150,1.13 [0.96-1.33],0.1539423745981964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGER,Advanced glycosylation end product-specific receptor,1840,186,1.07 [0.80-1.43],0.6613277749629911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR2,Anterior gradient protein 2 homolog,1777,183,1.35 [1.20-1.52],1.0583051368245286e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGR3,Anterior gradient protein 3,1796,185,1.34 [1.08-1.67],0.0083235005729597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRN,Agrin,1853,187,1.84 [1.39-2.43],2.103101866543855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGRP,Agouti-related protein,1864,187,1.33 [1.05-1.68],0.0160840289965494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGT,Angiotensinogen,1606,152,1.16 [0.60-2.22],0.6631611552404645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AGXT,Serine--pyruvate aminotransferase,1850,189,0.91 [0.78-1.06],0.2290660025807263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHCY,Adenosylhomocysteinase,1850,189,1.08 [0.90-1.31],0.3996847291786917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK,Neuroblast differentiation-associated protein AHNAK,1562,150,1.42 [0.87-2.33],0.165956816727348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHNAK2,Protein AHNAK2,1562,150,1.51 [0.98-2.35],0.0644714914672381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,1593,150,1.02 [0.81-1.28],0.8885180109642791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSG,Alpha-2-HS-glycoprotein,1606,152,0.87 [0.50-1.53],0.6333946560661875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AHSP,Alpha-hemoglobin-stabilizing protein,1853,188,1.08 [0.94-1.24],0.2612474802845003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIDA,"Axin interactor, dorsalization-associated protein",1557,147,1.08 [0.90-1.29],0.4290625454457046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1,Allograft inflammatory factor 1,1798,185,1.15 [0.90-1.47],0.2677695416543061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIF1L,Allograft inflammatory factor 1-like,1562,150,1.03 [0.79-1.35],0.827596313785768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",1847,189,1.02 [0.91-1.15],0.6847013219249993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK1,Adenylate kinase isoenzyme 1,1850,189,1.08 [0.90-1.31],0.4135134249655501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AK2,"Adenylate kinase 2, mitochondrial",1592,150,1.13 [0.97-1.31],0.1173090228433086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKAP12,A-kinase anchor protein 12,1570,146,1.70 [1.01-2.87],0.0444275875225019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B1,Aldo-keto reductase family 1 member B1,1798,185,1.10 [0.93-1.31],0.2630183815526909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1B10,Aldo-keto reductase family 1 member B10,1557,147,1.01 [0.83-1.22],0.9570791456923996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR1C4,Aldo-keto reductase family 1 member C4,1814,185,0.99 [0.79-1.24],0.9316833999101284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,1548,150,1.04 [0.85-1.27],0.7159712435989867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT1S1,Proline-rich AKT1 substrate 1,1788,185,1.15 [0.95-1.40],0.1462120897623599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT2,RAC-beta serine/threonine-protein kinase,1601,151,1.03 [0.91-1.17],0.6196554726296168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AKT3,RAC-gamma serine/threonine-protein kinase,1787,182,1.16 [0.92-1.47],0.2065415585262671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALCAM,CD166 antigen,1869,190,1.64 [0.93-2.88],0.0879001391455186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH1A1,Retinal dehydrogenase 1,1855,188,0.96 [0.79-1.16],0.6536269475342436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",1593,150,0.81 [0.57-1.16],0.2571439872243145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",1834,186,1.03 [0.89-1.20],0.6523133975851307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",1601,151,1.02 [0.73-1.42],0.9150572871816726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALMS1,Alstrom syndrome protein 1,1574,146,0.99 [0.67-1.44],0.9380819782450402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPI,Intestinal-type alkaline phosphatase,1548,150,1.16 [1.02-1.31],0.0188540685043982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ALPP,"Alkaline phosphatase, placental type",1849,189,1.10 [0.98-1.23],0.1130855559530224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBN,Ameloblastin,1801,185,1.27 [0.82-1.96],0.2858249605044746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMBP,Protein AMBP,1864,189,3.27 [1.86-5.74],3.744510461710176e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,1604,153,0.82 [0.44-1.51],0.5179297842543646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMFR,E3 ubiquitin-protein ligase AMFR,1788,185,1.16 [0.96-1.41],0.1323821825798546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO1,Amphoterin-induced protein 1,1557,147,1.12 [0.86-1.45],0.4035681481162083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMIGO2,Amphoterin-induced protein 2,1849,189,1.82 [1.07-3.11],0.0272316134187229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMN,Protein amnionless,1801,185,0.98 [0.76-1.27],0.886792456121678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOT,Angiomotin,1570,146,0.99 [0.68-1.43],0.9551988977740694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMOTL2,Angiomotin-like protein 2,1586,148,1.07 [0.78-1.46],0.669511640677579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMPD3,AMP deaminase 3,1592,150,1.09 [0.89-1.34],0.4080275196299108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,1499,145,0.88 [0.64-1.21],0.4289987649550528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2A,Pancreatic alpha-amylase,1758,181,0.85 [0.66-1.09],0.2020612829390524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AMY2B,Alpha-amylase 2B,1706,177,0.80 [0.62-1.04],0.0954585879392057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANG,Angiogenin,1851,187,1.97 [1.42-2.74],4.436389289577039e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT1,Angiopoietin-1,1839,185,0.94 [0.81-1.10],0.4685896751062408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPT2,Angiopoietin-2,1867,190,1.31 [0.94-1.82],0.1136284136467974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL1,Angiopoietin-related protein 1,1820,185,1.18 [0.77-1.80],0.452422943897509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL2,Angiopoietin-related protein 2,1849,186,1.15 [0.86-1.55],0.3411487095914244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL3,Angiopoietin-related protein 3,1856,187,0.80 [0.58-1.11],0.1822679301205554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL4,Angiopoietin-related protein 4,1848,187,1.99 [1.52-2.62],6.57773998379e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANGPTL7,Angiopoietin-related protein 7,1867,190,1.33 [1.00-1.76],0.0525161416493045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANK2,Ankyrin-2,1541,149,0.88 [0.69-1.11],0.2727197125504177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,1548,150,1.12 [0.92-1.35],0.2494214579124552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRA2,Ankyrin repeat family A protein 2,1538,145,0.95 [0.70-1.27],0.7166168558297001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANKRD54,Ankyrin repeat domain-containing protein 54,1798,185,1.10 [0.91-1.33],0.3357471784595784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,1562,150,1.01 [0.70-1.48],0.9422579397730334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANPEP,Aminopeptidase N,1855,188,0.91 [0.59-1.40],0.677488934282154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA1,Annexin A1,1565,145,0.94 [0.65-1.37],0.7432821727947192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA10,Annexin A10,1788,185,1.17 [1.03-1.34],0.0197738560884034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA11,Annexin A11,1839,187,1.01 [0.82-1.23],0.9359620145688696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA2,Annexin A2,1545,147,1.26 [1.01-1.57],0.0402463154212463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA3,Annexin A3,1860,188,1.06 [0.89-1.28],0.4990586370672707
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA4,Annexin A4,1841,187,1.05 [0.87-1.25],0.6265433700589329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ANXA5,Annexin A5,1782,183,1.71 [1.14-2.57],0.0098618996991515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC1,Amiloride-sensitive amine oxidase [copper-containing],1801,185,1.03 [0.84-1.27],0.7802630414156994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AOC3,Membrane primary amine oxidase,1858,188,2.52 [1.71-3.71],3.185612789519371e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP1G2,AP-1 complex subunit gamma-like 2,1593,150,1.11 [0.92-1.33],0.2639258687158149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP2B1,AP-2 complex subunit beta,1557,147,1.28 [0.94-1.72],0.1135503596784152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3B1,AP-3 complex subunit beta-1,1581,150,1.21 [1.00-1.48],0.054077097447359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AP3S2,AP-3 complex subunit sigma-2,1592,150,1.14 [0.84-1.54],0.4018071985250654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1849,189,1.25 [0.96-1.62],0.1000534821113196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APCS,Serum amyloid P-component,1593,152,0.68 [0.44-1.03],0.0670893750471304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,1859,189,1.08 [0.87-1.34],0.4952088357851513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APLP1,Amyloid-like protein 1,1850,189,0.87 [0.68-1.12],0.2862023108429349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA1,Apolipoprotein A-I,1608,152,0.63 [0.34-1.15],0.1343698254137036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA2,Apolipoprotein A-II,1606,152,1.48 [1.11-1.97],0.0074765021727888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOA4,Apolipoprotein A-IV,1608,152,2.33 [1.69-3.21],2.059088273725285e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOB,Apolipoprotein B-100,1606,152,1.12 [0.57-2.23],0.7399886950388517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOBR,Apolipoprotein B receptor,1562,150,0.76 [0.52-1.10],0.1502251935512822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOC1,Apolipoprotein C-I,1604,152,0.58 [0.38-0.89],0.0133635710958928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOD,Apolipoprotein D,1538,144,0.70 [0.46-1.08],0.1102461866126469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOE,Apolipoprotein E,1608,152,0.83 [0.62-1.10],0.1970498233282362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOF,Apolipoprotein F,1606,152,0.84 [0.59-1.21],0.3599690235381005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOH,Beta-2-glycoprotein 1,1855,188,1.47 [1.05-2.07],0.0244347852420732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOL1,Apolipoprotein L1,1606,152,0.84 [0.66-1.08],0.1747787463687819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APOM,Apolipoprotein M,1857,188,0.73 [0.48-1.10],0.1296438113870485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APP,Amyloid-beta precursor protein,1852,188,1.04 [0.86-1.26],0.6808143703206687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APPL2,DCC-interacting protein 13-beta,1570,146,1.01 [0.87-1.16],0.917426808580328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,APRT,Adenine phosphoribosyltransferase,1831,185,1.56 [1.17-2.08],0.002582782656915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARAF,Serine/threonine-protein kinase A-Raf,1574,146,1.01 [0.80-1.28],0.9412818911378964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AREG,Amphiregulin,1849,189,1.76 [1.41-2.19],7.187001533649504e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARF6,ADP-ribosylation factor 6,1581,150,1.07 [0.93-1.24],0.346689586618483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARFIP1,Arfaptin-1,1601,151,1.09 [0.88-1.35],0.4374145604131688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG1,Arginase-1,1848,188,1.05 [0.84-1.32],0.6419960046986555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARG2,"Arginase-2, mitochondrial",1593,150,1.15 [0.82-1.61],0.4286591177696619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP1,Rho GTPase-activating protein 1,1798,185,1.05 [0.79-1.40],0.717320614033839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP25,Rho GTPase-activating protein 25,1798,185,1.17 [0.94-1.45],0.1642231131178987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP30,Rho GTPase-activating protein 30,1574,146,1.20 [0.81-1.78],0.3624895015935511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP45,Rho GTPase-activating protein 45,1570,146,1.01 [0.84-1.23],0.8903476041992998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGAP5,Rho GTPase-activating protein 5,1538,145,1.05 [0.86-1.28],0.6351709432354247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF1,Rho guanine nucleotide exchange factor 1,1592,150,1.10 [0.92-1.31],0.2934655607307465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF10,Rho guanine nucleotide exchange factor 10,1601,151,1.05 [0.89-1.24],0.5397263051407646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF12,Rho guanine nucleotide exchange factor 12,1840,187,1.04 [0.92-1.18],0.4963784818359777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARHGEF5,Rho guanine nucleotide exchange factor 5,1537,150,1.28 [1.06-1.55],0.0089856007256836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID3A,AT-rich interactive domain-containing protein 3A,1537,150,1.11 [0.75-1.66],0.6059135968682305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARID4B,AT-rich interactive domain-containing protein 4B,1788,185,1.16 [0.87-1.53],0.3104338307250926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL13B,ADP-ribosylation factor-like protein 13B,1541,149,1.05 [0.85-1.30],0.6608100088583938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,1541,149,1.00 [0.69-1.45],0.9981161058590732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARMCX2,Armadillo repeat-containing X-linked protein 2,1537,150,0.85 [0.63-1.14],0.2814409997694773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,1801,185,0.99 [0.69-1.42],0.9593728327528288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,1541,149,0.73 [0.52-1.04],0.08477169870279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSA,Arylsulfatase A,1855,188,1.08 [0.83-1.39],0.5737409771662383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARSB,Arylsulfatase B,1849,189,0.97 [0.77-1.22],0.8044175033669733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART3,Ecto-ADP-ribosyltransferase 3,1858,188,1.60 [1.16-2.20],0.0041711084309365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ART5,Ecto-ADP-ribosyltransferase 5,1537,150,1.04 [0.81-1.34],0.7557530651000353
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ARTN,Artemin,1801,185,0.94 [0.70-1.26],0.6581065397660757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH1,Acid ceramidase,1594,152,1.03 [0.75-1.43],0.8382270382910604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASAH2,Neutral ceramidase,1832,185,1.00 [0.78-1.27],0.9955785487878318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR1,Asialoglycoprotein receptor 1,1832,185,1.92 [1.34-2.75],0.0004087589316597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASGR2,Asialoglycoprotein receptor 2,1606,152,2.55 [1.61-4.04],6.88645150914636e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPN,Asporin,1596,150,1.21 [0.72-2.02],0.4681968131633225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASPSCR1,Tether containing UBX domain for GLUT4,1601,151,1.12 [0.89-1.41],0.3188362545711279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASRGL1,Isoaspartyl peptidase/L-asparaginase,1562,150,1.06 [0.90-1.24],0.4948091758079636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ASS1,Argininosuccinate synthase,1541,149,0.82 [0.68-0.99],0.034883888068818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF2,Cyclic AMP-dependent transcription factor ATF-2,1788,185,1.05 [0.89-1.25],0.5392644908501653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATF4,Cyclic AMP-dependent transcription factor ATF-4,1538,145,1.01 [0.63-1.62],0.9632121841728892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG16L1,Autophagy-related protein 16-1,1581,150,1.10 [0.91-1.32],0.3304802601493283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATG4A,Cysteine protease ATG4A,1798,185,1.31 [1.08-1.61],0.0074908593574497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATOX1,Copper transport protein ATOX1,1855,187,1.25 [1.03-1.52],0.0228723110254294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,1541,149,1.17 [0.86-1.60],0.306669919398998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,1541,149,1.16 [0.85-1.58],0.336607654604667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,1541,149,1.37 [0.95-1.95],0.0885410714214319
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP1B4,Protein ATP1B4,1538,145,0.93 [0.61-1.39],0.7092212695444815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP2B4,Plasma membrane calcium-transporting ATPase 4,1541,149,1.09 [0.86-1.38],0.4760937162692571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5F1D,"ATP synthase subunit delta, mitochondrial",1541,149,1.25 [0.96-1.63],0.1033277651226621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5IF1,"ATPase inhibitor, mitochondrial",1853,187,1.01 [0.90-1.14],0.8593850021500734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP5PO,"ATP synthase subunit O, mitochondrial",1788,185,1.29 [0.99-1.68],0.0574224291837091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6AP2,Renin receptor,1798,185,1.15 [0.83-1.59],0.4028398539148385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1D,V-type proton ATPase subunit D,1849,189,1.56 [1.08-2.26],0.0185130619048021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1F,V-type proton ATPase subunit F,1784,185,1.23 [1.02-1.50],0.0334015667965457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G1,V-type proton ATPase subunit G 1,1562,150,1.11 [0.90-1.37],0.3461022324767911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATP6V1G2,V-type proton ATPase subunit G 2,1541,149,1.04 [0.88-1.23],0.6555854438369014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1581,150,2.02 [1.39-2.94],0.0002340425787662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATRN,"Attractin, Isoform 2",1608,152,1.25 [0.52-3.02],0.6216849382601398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN10,Ataxin-10,1788,185,1.06 [0.88-1.27],0.5417859711796775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2,Ataxin-2,1537,150,1.03 [0.89-1.19],0.6721368857071255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN2L,Ataxin-2-like protein,1601,151,1.13 [0.83-1.54],0.4546380227466811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ATXN3,Ataxin-3,1592,150,1.24 [0.98-1.57],0.0684508761277742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXIN1,Axin-1,1840,187,1.04 [0.91-1.20],0.5350724297747838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AXL,Tyrosine-protein kinase receptor UFO,1858,188,1.71 [1.11-2.64],0.0154633035332173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZI2,5-azacytidine-induced protein 2,1601,151,1.05 [0.80-1.38],0.7043779913104584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,AZU1,Azurocidin,1797,185,0.92 [0.78-1.09],0.3573517201112114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B2M,Beta-2-microglobulin,1608,152,2.52 [1.73-3.67],1.5338099809050768e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,1541,149,1.14 [0.50-2.59],0.7592752839580958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1562,150,2.89 [1.94-4.31],1.846518031152867e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",1853,187,2.37 [1.60-3.52],1.8660946925563325e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,B4GAT1,"Beta-1,4-glucuronyltransferase 1",1855,188,1.30 [0.77-2.19],0.3260779445620299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BABAM1,BRISC and BRCA1-A complex member 1,1548,150,1.06 [0.62-1.84],0.8220704381697109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BACH1,Transcription regulator protein BACH1,1840,187,0.94 [0.78-1.13],0.4976392318537269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG3,BAG family molecular chaperone regulator 3,1829,185,1.01 [0.74-1.37],0.9575845989738712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG4,BAG family molecular chaperone regulator 4,1548,150,1.08 [0.79-1.48],0.6391150144585235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAG6,Large proline-rich protein BAG6,1814,185,1.28 [0.90-1.82],0.1669804019150432
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1798,185,1.12 [0.94-1.33],0.2218795544087251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,1798,185,1.77 [1.22-2.56],0.0024825284302216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BANK1,B-cell scaffold protein with ankyrin repeats,1840,187,1.02 [0.90-1.16],0.7397111524473599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAP18,Chromatin complexes subunit BAP18,1592,150,0.99 [0.80-1.22],0.8993259666491419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BATF,Basic leucine zipper transcriptional factor ATF-like,1557,147,1.05 [0.88-1.26],0.5713928753499435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BAX,Apoptosis regulator BAX,1787,185,1.14 [0.98-1.32],0.0820278180831199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAM,Basal cell adhesion molecule,1855,188,1.52 [0.93-2.50],0.0961947968436669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAN,Brevican core protein,1832,185,0.58 [0.41-0.80],0.0011995545364531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",1596,150,1.22 [0.78-1.91],0.3768967828931246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",1537,150,1.12 [0.85-1.48],0.422654130405514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCHE,Cholinesterase,1583,151,1.07 [0.60-1.90],0.8147126664726053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2,Apoptosis regulator Bcl-2,1581,150,1.27 [1.01-1.60],0.044052689139547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L1,Bcl-2-like protein 1,1592,150,1.08 [0.92-1.26],0.3524015206823722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",1840,187,1.48 [1.06-2.05],0.02009189714846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL2L15,Bcl-2-like protein 15,1548,150,1.31 [1.04-1.65],0.0217788914106918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7A,B-cell CLL/lymphoma 7 protein family member A,1538,145,1.04 [0.81-1.34],0.7582073646647187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCL7B,B-cell CLL/lymphoma 7 protein family member B,1593,150,0.96 [0.65-1.40],0.8206418386136023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BCR,Breakpoint cluster region protein,1840,187,1.08 [0.93-1.24],0.2995552552608866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BDNF,Brain-derived neurotrophic factor,1604,153,0.97 [0.81-1.17],0.7708879701699103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BECN1,Beclin-1,1562,150,1.17 [0.91-1.50],0.2111231754516046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BEX3,Protein BEX3,1538,145,1.23 [1.00-1.50],0.0491084965131782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGLAP,Osteocalcin,1604,153,0.86 [0.74-0.99],0.036906924130179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BGN,Biglycan,1795,184,1.04 [0.94-1.16],0.4398536488664161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHLHE40,Class E basic helix-loop-helix protein 40,1537,150,1.06 [0.86-1.30],0.5741997771453499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,1541,149,1.08 [0.58-2.02],0.8050322947971882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BID,BH3-interacting domain death agonist,1840,187,1.10 [0.92-1.32],0.2750775609782613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIN2,Bridging integrator 2,1855,188,1.04 [0.90-1.20],0.5832726540398387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BIRC2,Baculoviral IAP repeat-containing protein 2,1798,185,1.25 [1.02-1.54],0.0281012133610708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLMH,Bleomycin hydrolase,1869,190,1.07 [0.72-1.58],0.750939621024136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLNK,B-cell linker protein,1548,150,0.87 [0.54-1.39],0.5555052400393394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,1537,150,1.13 [0.91-1.39],0.2722025989089294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,1592,150,1.17 [0.81-1.70],0.4032061381957952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BLVRB,Flavin reductase,1855,188,1.09 [0.91-1.30],0.3403553544215711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP10,Bone morphogenetic protein 10,1570,146,3.08 [1.80-5.25],3.647684124589877e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP4,Bone morphogenetic protein 4,1829,185,1.27 [0.99-1.64],0.0591434268674019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMP6,Bone morphogenetic protein 6,1811,185,1.19 [0.86-1.64],0.2884199290923301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BMPER,BMP-binding endothelial regulator protein,1570,146,2.97 [1.57-5.62],0.0008452766636611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,1596,150,1.45 [0.96-2.19],0.0811503440729088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,1548,150,1.33 [0.95-1.87],0.0984524906154592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOC,Brother of CDO,1814,185,2.21 [1.31-3.74],0.0030989545147171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA1,BolA-like protein 1,1537,150,1.50 [1.15-1.94],0.0023638517022354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BOLA2_BOLA2B,BolA-like protein 2,1562,150,1.23 [0.93-1.63],0.1387736124756914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFA2,BPI fold-containing family A member 2,1515,145,1.03 [0.90-1.18],0.645976356171727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB1,BPI fold-containing family B member 1,1833,185,1.14 [0.94-1.38],0.1935544041150685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BPIFB2,BPI fold-containing family B member 2,1593,149,1.02 [0.85-1.23],0.8145708590499979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRAP,BRCA1-associated protein,1562,149,1.10 [0.95-1.28],0.1954560438095144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD1,Bromodomain-containing protein 1,1574,146,1.09 [0.68-1.74],0.7235183668652474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD2,Bromodomain-containing protein 2,1537,150,1.40 [0.94-2.09],0.0941365109447157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRD3,Bromodomain-containing protein 3,1541,149,0.89 [0.63-1.26],0.5129118066521017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRDT,Bromodomain testis-specific protein,1541,149,1.40 [0.91-2.17],0.1283702060878279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRK1,Protein BRICK1,1788,185,1.64 [1.25-2.14],0.0003364659016794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRME1,Break repair meiotic recombinase recruitment factor 1,1537,150,1.29 [0.86-1.94],0.2136682574488992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BRSK2,Serine/threonine-protein kinase BRSK2,1601,151,0.89 [0.59-1.34],0.5768337271471551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSG,Basigin,1862,187,1.93 [1.12-3.31],0.0173119621574895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BSND,Barttin,1538,145,1.38 [0.92-2.07],0.122602149203456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,1863,188,1.03 [0.76-1.41],0.8389226949023265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BST2,Bone marrow stromal antigen 2,1863,188,0.94 [0.76-1.18],0.6058209085127034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTC,Probetacellulin,1798,185,1.04 [0.86-1.26],0.6496030013324439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTD,Biotinidase,1608,152,1.29 [0.62-2.70],0.4926890768706093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTLA,B- and T-lymphocyte attenuator,1538,145,1.00 [0.83-1.19],0.9731510787857696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN1A1,Butyrophilin subfamily 1 member A1,1590,150,1.25 [0.88-1.78],0.2090298295675095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN2A1,Butyrophilin subfamily 2 member A1,1853,187,2.84 [2.07-3.90],1.3175177268515978e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTN3A2,Butyrophilin subfamily 3 member A2,1840,187,1.78 [1.27-2.48],0.000774623558311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,BTNL10,Butyrophilin-like protein 10,1538,145,0.88 [0.58-1.34],0.543160543558431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C19orf12,Protein C19orf12,1788,185,0.99 [0.84-1.16],0.8595404421202958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1GALT1C1,C1GALT1-specific chaperone 1,1541,149,1.37 [0.87-2.18],0.1779640678543876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QA,Complement C1q subcomponent subunit A,1855,186,1.49 [0.90-2.46],0.1215449874091893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",1601,151,0.98 [0.79-1.21],0.8610255270227214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QL2,Complement C1q-like protein 2,1548,150,0.78 [0.55-1.10],0.1536025045576213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1858,188,1.51 [1.16-1.95],0.002158159642927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,1570,146,0.87 [0.57-1.32],0.5110478041819486
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1601,151,1.25 [0.86-1.83],0.2418352120097122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,1567,146,0.96 [0.71-1.30],0.7756010695388701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1R,Complement C1r subcomponent,1608,152,0.62 [0.24-1.59],0.3222072526816429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1RL,Complement C1r subcomponent-like protein,1606,152,2.99 [1.39-6.44],0.0051501999566312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C1S,Complement C1s subcomponent,1608,152,0.83 [0.44-1.56],0.5600114624210897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2,Complement C2,1857,188,2.65 [1.39-5.07],0.0032243524714641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2CD2L,Phospholipid transfer protein C2CD2L,1784,185,1.10 [0.82-1.49],0.5196061749246118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C2orf69,UPF0565 protein C2orf69,1557,147,1.14 [0.92-1.41],0.2449131830426668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C3,Complement C3,1516,142,1.12 [0.79-1.58],0.5366678199066367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C4BPB,C4b-binding protein beta chain,1855,187,1.14 [0.84-1.54],0.41784286099362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C5,Complement C5,1608,152,1.51 [0.60-3.79],0.3761976918743713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7,Complement component C7,1561,149,3.09 [2.11-4.51],5.687382105953471e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C7orf50,Uncharacterized protein C7orf50,1592,150,1.14 [0.56-2.32],0.7115797662831471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C8B,Complement component C8 beta chain,1608,152,0.53 [0.33-0.86],0.0097184114006105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9,Complement component C9,1606,152,1.01 [0.77-1.33],0.9236498605396176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,C9orf40,Uncharacterized protein C9orf40,1581,150,1.04 [0.87-1.25],0.6295965616312651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA1,Carbonic anhydrase 1,1816,182,1.08 [0.89-1.32],0.4393690614208084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA11,Carbonic anhydrase-related protein 11,1798,185,1.18 [0.90-1.55],0.2299880609458948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA12,Carbonic anhydrase 12,1849,189,2.52 [2.02-3.14],1.7927045157370882e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA13,Carbonic anhydrase 13,1827,184,1.04 [0.92-1.19],0.5283421517830209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA14,Carbonic anhydrase 14,1867,190,1.59 [1.16-2.16],0.0035828046354585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA2,Carbonic anhydrase 2,1852,188,1.18 [1.00-1.39],0.0544461254566207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA3,Carbonic anhydrase 3,1867,190,1.28 [1.06-1.54],0.0112852168067279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA4,Carbonic anhydrase 4,1869,190,1.63 [1.03-2.59],0.0381663298796846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",1814,185,0.99 [0.87-1.13],0.9132203255288268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA6,Carbonic anhydrase 6,1846,187,1.06 [0.87-1.29],0.5674366359018869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA7,Carbonic anhydrase 7,1574,146,0.98 [0.60-1.59],0.9225996998830236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA8,Carbonic anhydrase-related protein,1548,150,0.97 [0.50-1.87],0.9220520622773294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CA9,Carbonic anhydrase 9,1867,190,1.51 [1.22-1.86],0.0001340029245412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CABP2,Calcium-binding protein 2,1557,147,1.09 [0.86-1.39],0.4768348348839599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,1537,150,1.44 [0.96-2.16],0.0778312637432321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,1541,149,0.95 [0.72-1.25],0.7047290287641834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,1537,150,1.27 [1.02-1.59],0.0308252176063401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,1601,151,1.08 [0.90-1.29],0.4011565056510275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CACYBP,Calcyclin-binding protein,1566,146,1.02 [0.87-1.20],0.7819681485668677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CADPS,Calcium-dependent secretion activator 1,1557,147,1.09 [0.80-1.48],0.5954874945087376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB1,Calbindin,1849,189,1.41 [1.06-1.88],0.0195179243185549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALB2,Calretinin,1788,185,2.16 [1.50-3.12],3.4460700951632226e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCA,Calcitonin,1828,185,1.34 [1.12-1.61],0.0012904714369275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCB,Calcitonin gene-related peptide 2,1592,150,1.41 [1.12-1.78],0.0040960440616146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,1858,189,1.05 [0.92-1.19],0.4732034889673158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,1562,150,1.16 [0.95-1.42],0.1515641320439099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CALY,Neuron-specific vesicular protein calcyon,1541,149,0.71 [0.44-1.16],0.1748063462418927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,1798,185,1.32 [1.00-1.76],0.0539671268110958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,1557,147,0.93 [0.69-1.26],0.6540831262877198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,1601,151,1.04 [0.90-1.21],0.5655988466690041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CANT1,Soluble calcium-activated nucleotidase 1,1844,188,1.58 [0.89-2.82],0.118745935455584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPG,Macrophage-capping protein,1838,184,1.20 [0.97-1.48],0.0893983077600604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPN3,Calpain-3,1593,150,1.33 [0.88-2.02],0.1780627845572133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAPS,Calcyphosin,1592,150,1.00 [0.85-1.18],0.975625442087636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CARHSP1,Calcium-regulated heat-stable protein 1,1788,185,1.36 [1.09-1.70],0.0063568826747369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASC3,Protein CASC3,1557,147,1.35 [0.96-1.91],0.0842626419431862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP1,Caspase-1,1788,185,1.13 [0.96-1.33],0.15789550571198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP10,Caspase-10,1788,185,1.18 [0.98-1.41],0.0863875906127719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP2,Caspase-2,1840,187,1.07 [0.90-1.27],0.4569032927201358
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP3,Caspase-3,1869,190,1.11 [0.95-1.29],0.1760161571945726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP4,Caspase-4,1574,146,1.02 [0.93-1.11],0.7016292375384812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP7,Caspase-7,1592,150,1.10 [0.91-1.32],0.3388600829946568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP8,Caspase-8,1859,189,1.09 [0.90-1.33],0.3835749747981217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASP9,Caspase-9,1548,150,1.10 [0.86-1.39],0.4475934369324158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CASQ2,Calsequestrin-2,1541,149,0.79 [0.53-1.19],0.2612383107750725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CAT,Catalase,1579,151,1.11 [0.86-1.45],0.4224583788768223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLIF,Cobalamin binding intrinsic factor,1850,189,1.09 [0.94-1.26],0.2365434353769958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN1,Cerebellin-1,1537,150,1.04 [0.89-1.22],0.6314449313309827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBLN4,Cerebellin-4,1867,190,0.55 [0.38-0.81],0.0022411322958736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBS,Cystathionine beta-synthase,1562,150,0.75 [0.56-1.02],0.0647226309697323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CBX2,Chromobox protein homolog 2,1541,149,1.08 [0.73-1.60],0.6952642058170689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,1832,185,1.17 [0.99-1.39],0.0660692687710048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCAR2,Cell cycle and apoptosis regulator protein 2,1592,150,1.17 [0.91-1.49],0.2220336589219895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC134,Coiled-coil domain-containing protein 134,1593,150,1.31 [0.99-1.73],0.0589688755896335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC28A,Coiled-coil domain-containing protein 28A,1557,147,1.01 [0.59-1.72],0.97355512379401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC50,Coiled-coil domain-containing protein 50,1601,151,1.10 [0.92-1.33],0.2993913647725231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCDC80,Coiled-coil domain-containing protein 80,1850,189,1.31 [0.95-1.82],0.0971532048712285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,1562,150,0.94 [0.74-1.18],0.5909530148681206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL11,Eotaxin,1864,187,2.17 [1.57-3.00],2.730468313239147e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL13,C-C motif chemokine 13,1862,187,1.05 [0.87-1.26],0.6273078548407667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL14,C-C motif chemokine 14,1851,187,1.31 [0.96-1.80],0.0926939669070476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL15,C-C motif chemokine 15,1869,190,1.80 [1.42-2.27],1.097270616779026e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL16,C-C motif chemokine 16,1869,190,1.24 [1.01-1.53],0.0429667586680718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL17,C-C motif chemokine 17,1840,187,1.10 [0.95-1.26],0.2038146976882743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL18,C-C motif chemokine 18,1834,186,0.99 [0.82-1.20],0.939011915174502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL19,C-C motif chemokine 19,1863,188,0.97 [0.88-1.06],0.4910417334287899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL2,C-C motif chemokine 2,1829,185,1.17 [0.93-1.49],0.186545066365913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL20,C-C motif chemokine 20,1864,187,1.08 [0.95-1.22],0.2230176299564053
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL21,C-C motif chemokine 21,1853,187,1.21 [0.99-1.48],0.0637670439381505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL22,C-C motif chemokine 22,1828,186,1.02 [0.80-1.30],0.894768035517547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL23,C-C motif chemokine 23,1853,187,0.97 [0.74-1.28],0.8253688590593232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL24,C-C motif chemokine 24,1848,187,1.10 [0.94-1.28],0.2183770576476553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL25,C-C motif chemokine 25,1864,187,1.64 [1.25-2.15],0.0003696347929059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL26,C-C motif chemokine 26,1840,187,0.99 [0.86-1.13],0.836326954860187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL27,C-C motif chemokine 27,1850,189,1.07 [0.88-1.31],0.5080924483770617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL28,C-C motif chemokine 28,1829,185,1.12 [0.92-1.36],0.2769421491033688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL3,C-C motif chemokine 3,1840,187,1.07 [0.93-1.22],0.3361600560135243
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL4,C-C motif chemokine 4,1848,187,0.96 [0.79-1.15],0.652370323535028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL5,C-C motif chemokine 5,1858,188,0.96 [0.84-1.09],0.4978449718517322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL7,C-C motif chemokine 7,1840,187,1.28 [1.04-1.57],0.0203744298702713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCL8,C-C motif chemokine 8,1864,189,1.15 [0.94-1.42],0.1800808203834927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN1,CCN family member 1,1846,188,1.05 [0.88-1.25],0.5782278278872512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN2,CCN family member 2,1845,187,0.94 [0.74-1.18],0.5760143358362932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN3,CCN family member 3,1861,190,1.79 [1.33-2.41],0.0001262683490094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN4,CCN family member 4,1867,190,1.63 [1.23-2.17],0.0006522039776437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCN5,CCN family member 5,1855,188,1.57 [1.17-2.10],0.0027029558726255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCND2,G1/S-specific cyclin-D2,1574,146,0.97 [0.64-1.47],0.8872712283491152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCNE1,G1/S-specific cyclin-E1,1548,150,0.84 [0.65-1.09],0.1822629326290272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCS,Copper chaperone for superoxide dismutase,1832,185,1.12 [0.87-1.45],0.3831437804611125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CCT5,T-complex protein 1 subunit epsilon,1798,185,1.27 [0.97-1.65],0.078952174769871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD101,Immunoglobulin superfamily member 2,1581,150,1.20 [0.83-1.73],0.3274452003645982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD109,CD109 antigen,1855,188,2.36 [1.63-3.40],4.847636743917762e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD14,Monocyte differentiation antigen CD14,1826,186,1.74 [1.32-2.28],7.350172988167066e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD160,CD160 antigen,1864,187,1.75 [1.39-2.22],2.7561292879315285e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,1858,188,1.26 [0.96-1.65],0.1014868946202779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164,Sialomucin core protein 24,1855,188,1.46 [1.21-1.75],5.197743198578592e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD164L2,CD164 sialomucin-like 2 protein,1557,147,1.42 [1.03-1.96],0.0322932656237512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD177,CD177 antigen,1851,188,1.00 [0.90-1.10],0.9472074515067892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD1C,T-cell surface glycoprotein CD1c,1855,187,0.67 [0.41-1.10],0.1102858960589465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2,T-cell surface antigen CD2,1541,149,1.25 [0.91-1.72],0.1636523171079529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200,OX-2 membrane glycoprotein,1840,187,1.89 [1.25-2.86],0.0024090877057944
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD200R1,Cell surface glycoprotein CD200 receptor 1,1835,187,1.24 [0.84-1.83],0.2877247618813363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD207,C-type lectin domain family 4 member K,1825,188,2.06 [1.54-2.77],1.445951918374934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD209,CD209 antigen,1847,187,1.08 [0.77-1.51],0.6736592853921006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD22,B-cell receptor CD22,1864,187,0.97 [0.73-1.30],0.8562112940685886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD226,CD226 antigen,1548,150,1.08 [0.75-1.58],0.6725295240120693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD244,Natural killer cell receptor 2B4,1864,187,1.37 [0.89-2.11],0.1509136190241601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD248,Endosialin,1604,153,1.08 [0.76-1.56],0.6595018452945772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD27,CD27 antigen,1855,187,2.34 [1.86-2.95],3.527258851781341e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD274,Programmed cell death 1 ligand 1,1832,185,1.82 [1.30-2.56],0.0005299450421555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD276,CD276 antigen,1841,187,2.58 [1.95-3.41],4.11648205788589e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD28,T-cell-specific surface glycoprotein CD28,1798,185,1.78 [1.33-2.39],0.0001065858703603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD2AP,CD2-associated protein,1850,189,1.23 [1.02-1.49],0.0279302956101771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300A,CMRF35-like molecule 8,1570,146,1.88 [1.17-3.04],0.0093056609095836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300C,CMRF35-like molecule 6,1863,188,1.74 [1.25-2.43],0.0010048946645828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300E,CMRF35-like molecule 2,1859,189,1.73 [1.32-2.28],7.759084568395252e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LF,CMRF35-like molecule 1,1867,190,1.09 [0.90-1.30],0.3795248521199207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD300LG,CMRF35-like molecule 9,1855,188,1.51 [1.12-2.05],0.0076103410368331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD302,CD302 antigen,1849,189,2.47 [1.80-3.41],2.7188123362450174e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD33,Myeloid cell surface antigen CD33,1855,187,1.16 [0.97-1.38],0.0955013403260039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD34,Hematopoietic progenitor cell antigen CD34,1858,188,1.05 [0.64-1.72],0.8615186942350826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD36,Platelet glycoprotein 4,1548,150,1.13 [0.82-1.57],0.4532480463568314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1849,189,1.80 [1.27-2.56],0.0009692937907333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3D,T-cell surface glycoprotein CD3 delta chain,1537,150,1.32 [0.85-2.05],0.2202272727924599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3E,T-cell surface glycoprotein CD3 epsilon chain,1574,146,0.96 [0.57-1.63],0.8938597577316981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD3G,T-cell surface glycoprotein CD3 gamma chain,1548,150,0.89 [0.71-1.11],0.2872918466148064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD4,T-cell surface glycoprotein CD4,1835,186,1.40 [0.99-2.00],0.0601373039617103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40,Tumor necrosis factor receptor superfamily member 5,1843,187,1.35 [1.06-1.72],0.0137246577567391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD40LG,CD40 ligand,1864,187,1.02 [0.86-1.21],0.7875193056910622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD46,Membrane cofactor protein,1844,187,2.53 [1.69-3.77],5.864880561913027e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD48,CD48 antigen,1848,187,2.19 [1.47-3.27],0.0001168378978455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5,T-cell surface glycoprotein CD5,1864,189,2.38 [1.68-3.38],1.2630993973038414e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD55,Complement decay-accelerating factor,1781,182,2.42 [1.61-3.65],2.3808268025502816e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD58,Lymphocyte function-associated antigen 3,1838,185,1.19 [0.59-2.42],0.6237988322958938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD59,CD59 glycoprotein,1782,185,2.63 [1.76-3.93],2.676898944365581e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD5L,CD5 antigen-like,1601,152,1.02 [0.74-1.40],0.895935710018217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD6,T-cell differentiation antigen CD6,1862,187,0.80 [0.63-1.02],0.0762072795674228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD63,CD63 antigen,1829,185,1.10 [0.84-1.44],0.470175166993638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD69,Early activation antigen CD69,1842,189,1.03 [0.89-1.20],0.6562773674587379
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD7,T-cell antigen CD7,1543,149,1.42 [1.03-1.96],0.034813778016787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD70,CD70 antigen,1840,187,1.82 [1.33-2.48],0.0001569010265377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD72,B-cell differentiation antigen CD72,1570,146,1.25 [0.89-1.77],0.198061078608649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD74,HLA class II histocompatibility antigen gamma chain,1863,188,2.01 [1.45-2.80],3.00324658310299e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1864,187,1.72 [1.35-2.20],1.0606579352468262e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD80,T-lymphocyte activation antigen CD80,1596,150,1.62 [1.11-2.38],0.0134978346422803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD82,CD82 antigen,1574,146,0.76 [0.49-1.17],0.2114634537332292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD83,CD83 antigen,1840,187,1.88 [1.36-2.59],0.0001129752980129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD84,SLAM family member 5,1840,187,1.08 [0.71-1.64],0.7272301964713762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD86,T-lymphocyte activation antigen CD86,1581,150,1.04 [0.63-1.72],0.8875229073908422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,1863,188,1.12 [0.88-1.42],0.3423175767439183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD93,Complement component C1q receptor,1781,180,1.52 [1.04-2.22],0.0318159971656997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99,CD99 antigen,1855,188,2.39 [1.34-4.28],0.003238250027203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CD99L2,CD99 antigen-like protein 2,1855,188,1.84 [1.13-3.00],0.0147974436446566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDA,Cytidine deaminase,1595,150,0.82 [0.59-1.14],0.2470208206947911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDAN1,Codanin-1,1592,150,1.11 [0.52-2.40],0.7838161180454307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC123,Cell division cycle protein 123 homolog,1538,145,0.99 [0.79-1.25],0.9549066798409048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC25A,M-phase inducer phosphatase 1,1538,145,1.38 [0.93-2.04],0.108121409249902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC26,Anaphase-promoting complex subunit CDC26,1578,149,1.24 [1.00-1.55],0.0553130288485712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC27,Cell division cycle protein 27 homolog,1798,185,1.31 [1.07-1.59],0.0078797822873095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC37,Hsp90 co-chaperone Cdc37,1855,187,1.13 [0.97-1.32],0.1071854839984399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDC42BPB,Serine/threonine-protein kinase MRCK beta,1581,150,1.05 [0.90-1.22],0.52785231331387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDCP1,CUB domain-containing protein 1,1832,185,1.17 [0.93-1.46],0.1722802884898268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH1,Cadherin-1,1781,184,1.89 [1.53-2.33],2.163197226178246e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH15,Cadherin-15,1859,188,1.30 [1.07-1.59],0.0088473462843829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH17,Cadherin-17,1850,189,1.48 [1.27-1.73],5.4966471420337e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH2,Cadherin-2,1850,189,1.08 [0.79-1.49],0.627117641253224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH22,Cadherin-22,1574,146,1.34 [0.82-2.18],0.2470778741440141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH23,Cadherin-23,1592,150,2.34 [1.42-3.86],0.0009116656189469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH3,Cadherin-3,1863,188,1.56 [1.14-2.14],0.0054809670542985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH4,Cadherin-4,1537,150,1.18 [0.93-1.49],0.1735475360981291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH5,Cadherin-5,1869,190,1.00 [0.68-1.48],0.9950829062406789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDH6,Cadherin-6,1850,189,1.20 [0.90-1.61],0.2158950420608687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR1,Cadherin-related family member 1,1788,185,0.91 [0.66-1.26],0.565456890281421
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR2,Cadherin-related family member 2,1849,189,0.78 [0.67-0.91],0.001204694757899
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDHR5,Cadherin-related family member 5,1850,189,0.80 [0.59-1.09],0.1576141384734135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK1,Cyclin-dependent kinase 1,1538,145,1.49 [0.99-2.24],0.0559567009847058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,1601,151,0.98 [0.75-1.28],0.8968205378776821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKL5,Cyclin-dependent kinase-like 5,1537,150,1.23 [0.99-1.53],0.0604110664765385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN1A,Cyclin-dependent kinase inhibitor 1,1849,189,1.12 [0.99-1.26],0.0639515726143918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,1849,189,1.07 [0.93-1.23],0.357747861708712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDNF,Cerebral dopamine neurotrophic factor,1849,189,1.89 [1.34-2.66],0.0002634300364564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1845,187,1.88 [1.17-3.01],0.0088932092043728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CDSN,Corneodesmosin,1855,187,1.32 [1.01-1.73],0.0439056479682237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,1849,186,0.82 [0.57-1.19],0.3030944056430338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,1581,150,1.02 [0.84-1.25],0.8344507921803922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1574,146,1.01 [0.81-1.25],0.9540947296213056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,1581,150,1.11 [0.75-1.63],0.6016751399429363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,1574,146,1.48 [1.12-1.96],0.0061495708784653
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,1840,187,1.18 [1.03-1.36],0.0162567133012058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,1798,185,0.92 [0.70-1.22],0.5711913751461876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,1776,182,1.35 [1.13-1.63],0.0011832426038934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,1604,153,1.03 [0.70-1.53],0.8644845262147274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,1814,185,1.04 [0.80-1.35],0.7901011464950561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPA,CCAAT/enhancer-binding protein alpha,1548,150,1.24 [0.88-1.76],0.2220720426154032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEBPB,CCAAT/enhancer-binding protein beta,1814,185,0.81 [0.56-1.16],0.2472022873105869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA2A,Chymotrypsin-like elastase family member 2A,1604,153,0.90 [0.72-1.12],0.3289431604772506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELA3A,Chymotrypsin-like elastase family member 3A,1867,190,0.85 [0.70-1.03],0.105634804276336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1570,146,1.18 [0.70-1.99],0.5245269828742107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEMIP2,Cell surface hyaluronidase,1548,150,0.85 [0.52-1.38],0.5035661516885788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEND1,Cell cycle exit and neuronal differentiation protein 1,1537,150,1.12 [0.88-1.42],0.3760553585003328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPF,Centromere protein F,1574,146,1.14 [0.89-1.47],0.2970316631816914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CENPJ,Centromere protein J,1574,146,1.26 [1.05-1.51],0.0131741113476468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP112,Centrosomal protein of 112 kDa,1541,149,0.96 [0.68-1.36],0.816267359555437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP152,Centrosomal protein of 152 kDa,1538,145,0.86 [0.58-1.26],0.4313356417926265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP164,Centrosomal protein of 164 kDa,1801,185,1.16 [1.00-1.34],0.0559294238754635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP170,Centrosomal protein of 170 kDa,1562,150,1.12 [0.91-1.38],0.299516073291189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP20,Centrosomal protein 20,1798,185,1.21 [1.03-1.42],0.0223005039370304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP290,Centrosomal protein of 290 kDa,1574,146,1.01 [0.76-1.35],0.9239375189671302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP350,Centrosome-associated protein 350,1538,145,1.31 [0.81-2.11],0.2688617866873185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP43,Centrosomal protein 43,1801,182,1.24 [1.02-1.50],0.0290369108726345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CEP85,Centrosomal protein of 85 kDa,1798,185,1.14 [0.94-1.39],0.1837658560351137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CERT,Ceramide transfer protein,1788,185,1.12 [0.90-1.39],0.3031920873810008
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES1,Liver carboxylesterase 1,1847,188,0.88 [0.78-1.00],0.0564945655765846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES2,Cocaine esterase,1849,189,1.35 [1.09-1.67],0.0052134097502623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CES3,Carboxylesterase 3,1849,189,1.02 [0.86-1.22],0.7880210150651517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN2,Centrin-2,1788,185,1.19 [0.98-1.45],0.0770410515713265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CETN3,Centrin-3,1581,150,1.08 [0.88-1.32],0.4903308104301263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFB,Complement factor B,1575,148,0.97 [0.60-1.57],0.8907656102206325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFC1,Cryptic protein,1798,185,1.33 [1.04-1.70],0.0215622012181536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFD,Complement factor D,1608,152,2.25 [1.20-4.21],0.011517110748199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFH,Complement factor H,1496,140,0.89 [0.44-1.80],0.7385994965899263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR2,Complement factor H-related protein 2,1595,150,1.05 [0.81-1.38],0.7011933170614715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR4,Complement factor H-related protein 4,1603,151,1.13 [0.91-1.40],0.266686512595069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFHR5,Complement factor H-related protein 5,1585,150,1.12 [0.77-1.62],0.5541396458915593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFI,Complement factor I,1608,152,0.91 [0.44-1.88],0.7990194132472779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CFP,Properdin,1608,152,0.55 [0.27-1.12],0.0991037896609287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGA,Glycoprotein hormones alpha chain,1855,188,1.23 [1.03-1.47],0.0193738252349214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,1606,152,1.18 [0.95-1.47],0.1250770299025483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGN,Cingulin,1557,147,1.01 [0.70-1.48],0.9381292311607888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1850,189,1.91 [1.50-2.44],1.973496215999661e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,1798,185,1.23 [1.03-1.47],0.0224545404828386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHAD,Chondroadherin,1570,146,0.63 [0.48-0.82],0.0005534369010127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1592,150,2.19 [1.63-2.94],1.7933672420068528e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHCHD6,MICOS complex subunit MIC25,1593,150,1.35 [0.84-2.17],0.2224012960457497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHEK2,Serine/threonine-protein kinase Chk2,1814,185,1.19 [0.81-1.75],0.3748919736008952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGA,Chromogranin-A,1604,153,1.19 [1.07-1.33],0.0019499591706677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHGB,Secretogranin-1,1856,188,1.53 [1.18-1.98],0.0012398794862798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHI3L1,Chitinase-3-like protein 1,1804,185,1.30 [1.12-1.50],0.0004451825151704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHIT1,Chitotriosidase-1,1851,190,1.04 [0.96-1.13],0.366060288876184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHL1,Neural cell adhesion molecule L1-like protein,1855,187,1.02 [0.68-1.53],0.9392052332613036
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHM,Rab proteins geranylgeranyltransferase component A 1,1557,147,1.21 [0.94-1.55],0.1379053239200909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP1A,Charged multivesicular body protein 1a,1832,185,1.09 [0.92-1.29],0.3048698120108215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHMP6,Charged multivesicular body protein 6,1596,150,0.96 [0.73-1.27],0.7942376007575218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHP1,Calcineurin B homologous protein 1,1537,150,0.99 [0.79-1.24],0.925367717144412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL1,Chordin-like protein 1,1848,187,1.78 [1.23-2.58],0.0023439254333714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRDL2,Chordin-like protein 2,1850,189,0.88 [0.70-1.11],0.2832581892458307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CHRM1,Muscarinic acetylcholine receptor M1,1557,147,1.51 [1.12-2.03],0.0062725938966896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIAPIN1,Anamorsin,1855,187,1.29 [1.05-1.58],0.0150756308509256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CILP,Cartilage intermediate layer protein 1,1604,153,1.61 [1.24-2.08],0.0003540606799734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CINP,Cyclin-dependent kinase 2-interacting protein,1574,146,1.13 [0.84-1.52],0.4279053276924844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIRBP,Cold-inducible RNA-binding protein,1581,150,1.08 [0.91-1.27],0.3927019913631603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CIT,Citron Rho-interacting kinase,1557,147,1.45 [1.07-1.95],0.0149814540603147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKAP4,Cytoskeleton-associated protein 4,1858,187,2.50 [1.80-3.48],5.788372194411058e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKB,Creatine kinase B-type,1604,153,1.61 [1.31-1.98],6.749094568838328e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",1836,185,1.38 [1.12-1.68],0.0020260868012284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLASP1,CLIP-associating protein 1,1538,145,0.99 [0.78-1.25],0.9263402778209606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLC,Galectin-10,1847,189,1.14 [0.94-1.38],0.1910894760204569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC10A,C-type lectin domain family 10 member A,1832,185,1.32 [0.92-1.89],0.1270139215152645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC11A,C-type lectin domain family 11 member A,1851,188,0.83 [0.64-1.08],0.1640541071923781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC12A,C-type lectin domain family 12 member A,1548,150,1.09 [0.51-2.32],0.818826351983615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC14A,C-type lectin domain family 14 member A,1855,188,2.26 [1.59-3.23],6.38242013604431e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1A,C-type lectin domain family 1 member A,1814,185,2.15 [1.56-2.94],2.1113105828474608e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC1B,C-type lectin domain family 1 member B,1863,188,1.05 [0.92-1.19],0.5066714593637349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC2L,C-type lectin domain family 2 member L,1557,147,1.29 [0.99-1.68],0.0584381626625511
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC3B,Tetranectin,1564,145,0.31 [0.16-0.60],0.000607504477428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4A,C-type lectin domain family 4 member A,1840,187,0.87 [0.62-1.24],0.4570959130106079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4C,C-type lectin domain family 4 member C,1840,187,0.71 [0.55-0.92],0.0099621316940287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4D,C-type lectin domain family 4 member D,1840,187,1.11 [0.92-1.34],0.2591722076255807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4G,C-type lectin domain family 4 member G,1840,187,1.10 [0.75-1.60],0.6345639453420057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC4M,C-type lectin domain family 4 member M,1602,153,0.81 [0.59-1.12],0.2053012486917595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC5A,C-type lectin domain family 5 member A,1846,189,2.22 [1.49-3.33],9.902859080780372e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC6A,C-type lectin domain family 6 member A,1798,185,1.16 [0.88-1.52],0.2833347438037674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLEC7A,C-type lectin domain family 7 member A,1864,187,1.47 [1.14-1.91],0.0033524204221019
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLGN,Calmegin,1557,147,1.35 [0.96-1.89],0.0852517937795043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIC5,Chloride intracellular channel protein 5,1557,147,1.20 [0.83-1.73],0.336081326728485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLINT1,Clathrin interactor 1,1538,145,0.87 [0.57-1.32],0.5184983834105075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLIP2,CAP-Gly domain-containing linker protein 2,1840,187,1.04 [0.93-1.17],0.5096401156629523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLMP,CXADR-like membrane protein,1867,190,2.17 [1.27-3.69],0.004463021270024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLNS1A,Methylosome subunit pICln,1557,147,1.34 [0.86-2.07],0.1967122937736275
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",1828,185,1.14 [0.99-1.30],0.0620762739606245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLPS,Colipase,1853,188,1.00 [0.85-1.17],0.9765259245227924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSPN,Claspin,1784,185,0.77 [0.50-1.18],0.2318073709874306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN1,Calsyntenin-1,1788,185,1.00 [0.78-1.28],0.9874792017149958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN2,Calsyntenin-2,1864,187,1.05 [0.78-1.42],0.7388396029052606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLSTN3,Calsyntenin-3,1592,150,1.19 [0.73-1.95],0.4833226807227594
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLTA,Clathrin light chain A,1814,185,1.31 [1.01-1.69],0.041006346657813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLU,Clusterin,1608,152,1.18 [0.70-2.00],0.5261263031570284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CLUL1,Clusterin-like protein 1,1846,188,0.81 [0.61-1.06],0.1219425304597929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMC1,COX assembly mitochondrial protein homolog,1596,150,1.06 [0.89-1.26],0.5040370850804191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CMIP,C-Maf-inducing protein,1593,150,1.05 [0.87-1.26],0.6111325213818837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNDP1,Beta-Ala-His dipeptidase,1858,188,1.00 [0.77-1.30],0.9803804363059544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNGB3,Cyclic nucleotide-gated cation channel beta-3,1537,150,1.10 [0.83-1.46],0.5154195967736994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",1556,149,1.10 [0.91-1.34],0.3307852214653538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY2,Protein canopy homolog 2,1814,185,1.03 [0.83-1.27],0.8082779099120078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNPY4,Protein canopy homolog 4,1849,189,1.15 [0.97-1.37],0.1063131800498848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNST,Consortin,1850,189,1.04 [0.92-1.17],0.5027907247739705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTF,Ciliary neurotrophic factor,1537,150,1.18 [0.72-1.92],0.5120705641920527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN1,Contactin-1,1869,190,1.16 [0.76-1.77],0.4940301470867485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN2,Contactin-2,1867,190,1.23 [0.94-1.60],0.1360344487777937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN3,Contactin-3,1855,188,1.16 [0.81-1.66],0.4212332292390809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN4,Contactin-4,1855,188,1.89 [1.13-3.15],0.0145106275577381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTN5,Contactin-5,1847,188,0.63 [0.45-0.87],0.0054664203818992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP2,Contactin-associated protein-like 2,1840,187,1.06 [0.79-1.43],0.6794076213194439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CNTNAP4,Contactin-associated protein-like 4,1557,147,1.07 [0.92-1.25],0.3803393047260583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COCH,Cochlin,1596,150,1.00 [0.72-1.37],0.97641413244348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL15A1,Collagen alpha-1(XV) chain,1604,153,0.92 [0.55-1.54],0.7462046652274787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL18A1,Collagen alpha-1(XVIII) chain,1852,190,3.13 [1.96-5.01],1.7265127673834022e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL1A1,Collagen alpha-1(I) chain,1869,190,0.76 [0.46-1.26],0.2937580964820231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL24A1,Collagen alpha-1(XXIV) chain,1581,150,1.02 [0.79-1.33],0.858592132796009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL28A1,Collagen alpha-1(XXVIII) chain,1557,147,1.07 [0.88-1.28],0.5067381231320478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL2A1,Collagen alpha-1(II) chain,1562,150,1.02 [0.85-1.23],0.8486516737112773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL3A1,Collagen alpha-1(III) chain,1604,153,1.15 [0.63-2.10],0.6598548359298018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A1,Collagen alpha-1(IV) chain,1850,189,1.77 [1.37-2.29],1.538164996683263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL4A4,Collagen alpha-4(IV) chain,1570,146,1.26 [0.92-1.72],0.1512988691001874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL5A1,Collagen alpha-1(V) chain,1570,146,1.15 [0.83-1.59],0.3930786140468842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL6A3,Collagen alpha-3(VI) chain,1869,190,2.14 [1.62-2.81],6.146627496515005e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A1,Collagen alpha-1(IX) chain,1840,187,1.09 [0.86-1.37],0.4886435766628764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COL9A2,Collagen alpha-2(IX) chain,1574,146,1.13 [0.84-1.51],0.4203604299052085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COLEC12,Collectin-12,1841,187,2.83 [1.93-4.16],1.1167141230854437e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD1,COMM domain-containing protein 1,1562,150,1.09 [0.84-1.41],0.5309375404307908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMMD9,COMM domain-containing protein 9,1593,150,1.22 [0.84-1.79],0.2964587598732056
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMP,Cartilage oligomeric matrix protein,1828,185,0.80 [0.55-1.15],0.2208103722880385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COMT,Catechol O-methyltransferase,1797,184,1.08 [0.92-1.27],0.3361064657156321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPB2,Coatomer subunit beta',1541,149,1.22 [0.87-1.71],0.2561539343356872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COPE,Coatomer subunit epsilon,1788,185,1.10 [0.88-1.38],0.3962791169218296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",1562,150,0.92 [0.64-1.34],0.6786014789559367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO1A,Coronin-1A,1810,185,1.05 [0.91-1.22],0.4909612165523879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CORO6,Coronin-6,1537,150,1.49 [1.10-2.00],0.0088406240401608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",1849,189,1.15 [0.96-1.37],0.132678113411083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,COX6B1,Cytochrome c oxidase subunit 6B1,1596,150,1.36 [0.88-2.10],0.1657957135660381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA1,Carboxypeptidase A1,1869,190,0.82 [0.69-0.99],0.0346132446461769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA2,Carboxypeptidase A2,1858,188,1.39 [1.18-1.63],6.758153271326546e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPA4,Carboxypeptidase A4,1528,142,0.82 [0.57-1.17],0.272210779485562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB1,Carboxypeptidase B,1869,190,0.86 [0.70-1.05],0.1456144841096236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPB2,Carboxypeptidase B2,1604,152,0.81 [0.42-1.56],0.5317410167509402
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPE,Carboxypeptidase E,1851,189,0.72 [0.53-0.96],0.0266169309964133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPLX2,Complexin-2,1538,145,0.88 [0.51-1.49],0.6293907957982723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPM,Carboxypeptidase M,1853,186,1.07 [0.77-1.50],0.6911753165404672
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",1548,150,0.77 [0.43-1.36],0.3659714692441428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPPED1,Serine/threonine-protein phosphatase CPPED1,1863,188,1.25 [1.03-1.51],0.0218607687892321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPQ,Carboxypeptidase Q,1603,153,0.89 [0.64-1.23],0.4882841610445714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPTP,Ceramide-1-phosphate transfer protein,1541,149,1.10 [0.76-1.59],0.6188575987583057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPVL,Probable serine carboxypeptidase CPVL,1865,190,1.12 [0.80-1.56],0.524477311967821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM1,Probable carboxypeptidase X1,1855,187,0.98 [0.82-1.18],0.8418585515517341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CPXM2,Inactive carboxypeptidase-like protein X2,1596,150,1.93 [1.13-3.31],0.0164016960476081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR1,Complement receptor type 1,1603,151,1.14 [0.76-1.71],0.5221269503963559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CR2,Complement receptor type 2,1858,188,1.24 [0.95-1.61],0.1127581045863615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,1798,185,1.10 [0.95-1.27],0.2215613364822071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRADD,Death domain-containing protein CRADD,1828,185,1.17 [0.98-1.40],0.0738018335556932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREB3,Cyclic AMP-responsive element-binding protein 3,1538,145,0.85 [0.61-1.19],0.3537552345382295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREBZF,CREB/ATF bZIP transcription factor,1538,145,1.10 [0.59-2.05],0.7625317760029713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CREG1,Protein CREG1,1829,185,0.52 [0.37-0.73],0.0001478839200253
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD1,Protein disulfide isomerase CRELD1,1570,146,1.59 [1.11-2.29],0.0122413395592704
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRELD2,Protein disulfide isomerase CRELD2,1848,187,1.27 [1.01-1.59],0.0403786691808066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRH,Corticoliberin,1794,184,1.01 [0.87-1.17],0.927345791213371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHBP,Corticotropin-releasing factor-binding protein,1841,187,1.59 [1.03-2.45],0.0355784774857048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRHR1,Corticotropin-releasing factor receptor 1,1814,185,0.99 [0.81-1.22],0.9454120503376426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIM1,Cysteine-rich motor neuron 1 protein,1853,187,1.45 [0.82-2.55],0.1998432769907309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRIP2,Cysteine-rich protein 2,1832,185,1.79 [1.33-2.42],0.0001457527864194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP2,Cysteine-rich secretory protein 2,1867,190,0.82 [0.68-0.98],0.03045611928012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRISP3,Cysteine-rich secretory protein 3,1587,149,0.35 [0.20-0.62],0.000304241227296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRKL,Crk-like protein,1845,185,1.09 [0.96-1.23],0.1998373304587559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRLF1,Cytokine receptor-like factor 1,1853,187,1.16 [0.71-1.90],0.5520662307752413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRNN,Cornulin,1806,182,1.06 [0.89-1.27],0.4992995704737687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAC1,Cartilage acidic protein 1,1869,190,0.70 [0.46-1.05],0.0834798851333426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAM,Cytotoxic and regulatory T-cell molecule,1832,185,1.30 [1.02-1.67],0.0334123944684969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRTAP,Cartilage-associated protein,1557,147,1.30 [0.98-1.73],0.0667004600036365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRX,Cone-rod homeobox protein,1814,185,1.02 [0.89-1.16],0.7902027736177026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB1,Beta-crystallin B1,1596,150,1.24 [0.98-1.57],0.07729960973297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYBB2,Beta-crystallin B2,1592,150,1.17 [1.02-1.34],0.0210653734909818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYGD,Gamma-crystallin D,1592,150,1.05 [0.90-1.22],0.5287158961603875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYM,Ketimine reductase mu-crystallin,1537,150,1.06 [0.87-1.29],0.590068719279078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CRYZL1,Quinone oxidoreductase-like protein 1,1562,150,1.04 [0.88-1.24],0.6329691163555418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSDE1,Cold shock domain-containing protein E1,1541,149,1.14 [1.00-1.29],0.0512216951955766
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1,Macrophage colony-stimulating factor 1,1853,187,2.22 [1.50-3.31],7.90385771589807e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,1606,152,1.43 [0.99-2.06],0.0540055724312259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2,Granulocyte-macrophage colony-stimulating factor,1541,149,1.03 [0.66-1.61],0.8857670803022859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,1832,185,1.02 [0.82-1.28],0.8629952222163806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF2RB,Cytokine receptor common subunit beta,1548,150,1.29 [0.90-1.85],0.1609299508090674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3,Granulocyte colony-stimulating factor,1801,185,0.83 [0.63-1.09],0.1707401572270693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSF3R,Granulocyte colony-stimulating factor receptor,1548,150,0.83 [0.52-1.32],0.4302978238822705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSH1,Chorionic somatomammotropin hormone 1,1606,152,1.27 [0.74-2.18],0.3802005592647238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK1D,Casein kinase I isoform delta,1548,150,1.07 [0.83-1.36],0.6060429934402785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSNK2A1,Casein kinase II subunit alpha,1601,151,1.06 [0.75-1.49],0.7375221480754213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG4,Chondroitin sulfate proteoglycan 4,1604,153,1.74 [1.12-2.68],0.013014320850308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSPG5,Chondroitin sulfate proteoglycan 5,1537,150,1.00 [0.72-1.38],0.9891500503474174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSRP3,Cysteine and glycine-rich protein 3,1541,149,1.07 [0.92-1.25],0.3656011208918251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST1,Cystatin-SN,1406,128,1.00 [0.84-1.18],0.9561125260338824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST3,Cystatin-C,1851,188,2.21 [1.56-3.14],7.703916399483538e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST5,Cystatin-D,1816,184,1.29 [1.04-1.61],0.0218648136353628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST6,Cystatin-M,1800,188,0.84 [0.66-1.09],0.1863046672976808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CST7,Cystatin-F,1848,187,1.10 [0.97-1.24],0.1315485023693631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CSTB,Cystatin-B,1822,188,1.75 [1.32-2.32],9.127070262722032e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTAG1A_CTAG1B,Cancer/testis antigen 1,1569,146,0.96 [0.70-1.31],0.775447623558057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTBS,Di-N-acetylchitobiase,1575,149,1.19 [0.69-2.05],0.5243338110980662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTF1,Cardiotrophin-1,1814,185,1.06 [0.91-1.23],0.4753526081616612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTHRC1,Collagen triple helix repeat-containing protein 1,1604,153,1.96 [1.25-3.06],0.0033458486279598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTLA4,Cytotoxic T-lymphocyte protein 4,1604,153,0.56 [0.33-0.94],0.0297634993668951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTNNA1,Catenin alpha-1,1537,150,1.53 [1.07-2.18],0.0183306511394192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRB1,Chymotrypsinogen B,1855,188,0.87 [0.72-1.06],0.1610080236014982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRC,Chymotrypsin-C,1841,187,0.78 [0.66-0.92],0.0040205383006383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTRL,Chymotrypsin-like protease CTRL-1,1592,150,0.88 [0.71-1.08],0.2165312350831725
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSB,Cathepsin B,1849,190,1.05 [0.82-1.35],0.6713135556278138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSC,Dipeptidyl peptidase 1,1846,184,1.15 [0.86-1.54],0.3465737385624169
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSD,Cathepsin D,1737,179,1.04 [0.78-1.39],0.7893645810965526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSE,Cathepsin E,1570,146,1.52 [1.16-1.98],0.0022179568087663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSF,Cathepsin F,1855,187,1.20 [0.89-1.62],0.2383293802906249
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSH,Pro-cathepsin H,1812,185,0.97 [0.81-1.16],0.7388101141345255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSL,Cathepsin L1,1850,189,1.93 [1.17-3.19],0.0101910899128354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSO,Cathepsin O,1864,187,1.58 [1.07-2.33],0.0207837057152168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSS,Cathepsin S,1438,143,2.78 [1.42-5.42],0.0028023828088883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSV,Cathepsin L2,1863,190,0.70 [0.53-0.92],0.0104274843726531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CTSZ,Cathepsin Z,1853,188,1.94 [1.35-2.79],0.0003784264071562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,1557,147,1.27 [0.95-1.71],0.1078710517272156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CWC15,Spliceosome-associated protein CWC15 homolog,1574,150,1.13 [0.90-1.43],0.2910869009978967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CX3CL1,Fractalkine,1832,185,2.05 [1.50-2.81],7.765454604927073e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXADR,Coxsackievirus and adenovirus receptor,1840,187,1.28 [1.01-1.62],0.0381907044817819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL1,Growth-regulated alpha protein,1846,187,1.04 [0.92-1.18],0.5140342773944144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL10,C-X-C motif chemokine 10,1853,187,1.12 [0.94-1.35],0.2096349153110758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL11,C-X-C motif chemokine 11,1863,188,1.02 [0.88-1.20],0.7688409670973048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL12,Stromal cell-derived factor 1,1801,185,1.07 [0.79-1.45],0.6755470001790522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL13,C-X-C motif chemokine 13,1863,188,1.07 [0.88-1.30],0.4905206221584257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL14,C-X-C motif chemokine 14,1801,185,1.02 [0.81-1.27],0.8875653704388099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL16,C-X-C motif chemokine 16,1866,190,1.76 [1.09-2.84],0.0198912811732284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL17,C-X-C motif chemokine 17,1864,187,0.87 [0.64-1.19],0.3792842732706643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL3,C-X-C motif chemokine 3,1843,187,1.05 [0.92-1.21],0.4734902402843647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL5,C-X-C motif chemokine 5,1846,189,0.99 [0.89-1.10],0.860875160038075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL6,C-X-C motif chemokine 6,1864,187,1.14 [0.97-1.33],0.1201300995248897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL8,Interleukin-8,1832,185,1.23 [1.05-1.44],0.012438025887192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CXCL9,C-X-C motif chemokine 9,1853,187,1.36 [1.16-1.59],0.0001562388624002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5A,Cytochrome b5,1538,145,0.85 [0.66-1.09],0.2000465484567943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYB5R2,NADH-cytochrome b5 reductase 2,1565,150,1.08 [0.83-1.40],0.5746135300297006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",1541,149,1.10 [0.94-1.29],0.2297341719075346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTH3,Cytohesin-3,1538,145,0.92 [0.74-1.16],0.5008978132724662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,CYTL1,Cytokine-like protein 1,1604,153,0.44 [0.24-0.82],0.0099365354371012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAAM1,Disheveled-associated activator of morphogenesis 1,1570,146,1.03 [0.86-1.25],0.7276967939838572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAB2,Disabled homolog 2,1867,190,1.06 [0.95-1.20],0.2921892371107847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAG1,Dystroglycan,1853,187,1.44 [1.09-1.90],0.0101492236029686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAND5,DAN domain family member 5,1548,150,1.05 [0.82-1.35],0.6995404198164177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPK2,Death-associated protein kinase 2,1548,150,1.12 [0.87-1.46],0.3841548750978851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,1840,187,1.02 [0.91-1.14],0.7055884794194018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DARS1,"Aspartate--tRNA ligase, cytoplasmic",1828,185,1.10 [0.92-1.32],0.3092585354522318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBH,Dopamine beta-hydroxylase,1605,152,0.94 [0.82-1.08],0.364251737504799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBI,Acyl-CoA-binding protein,1843,187,1.23 [1.04-1.46],0.0171880498592304
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBN1,Drebrin,1548,150,1.11 [0.82-1.51],0.501482195459714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DBNL,Drebrin-like protein,1853,187,1.09 [0.94-1.25],0.2397201532205184
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1855,187,2.50 [1.82-3.43],1.4530533193060997e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCC,Netrin receptor DCC,1557,147,1.83 [0.99-3.41],0.0550060609437416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCDC2C,Doublecortin domain-containing protein 2C,1538,145,1.16 [0.91-1.48],0.2264215337374596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCLRE1C,Protein artemis,1538,145,0.78 [0.45-1.36],0.39005570984959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCN,Decorin,1814,185,3.41 [2.14-5.44],2.618123023322966e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTD,Deoxycytidylate deaminase,1570,146,1.03 [0.87-1.21],0.7539569859824096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN1,Dynactin subunit 1,1867,190,1.01 [0.82-1.23],0.9583459863784596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN2,Dynactin subunit 2,1849,189,1.02 [0.89-1.17],0.7436379226192043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTN6,Dynactin subunit 6,1788,185,1.16 [1.00-1.34],0.0498356497630205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCTPP1,dCTP pyrophosphatase 1,1850,189,1.22 [0.82-1.84],0.3287330180003763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D1,DCN1-like protein 1,1537,150,1.06 [0.87-1.29],0.5863102887543111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCUN1D2,DCN1-like protein 2,1538,145,1.15 [0.98-1.34],0.0984136189672259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DCXR,L-xylulose reductase,1855,187,0.75 [0.59-0.95],0.0172750342808828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDA1,DET1- and DDB1-associated protein 1,1541,149,0.89 [0.60-1.32],0.5705184466875772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1849,189,1.50 [1.15-1.97],0.0031351994551965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDC,Aromatic-L-amino-acid decarboxylase,1850,189,1.03 [0.81-1.30],0.8357679378727916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDHD2,Phospholipase DDHD2,1601,151,1.04 [0.82-1.31],0.7624373089201251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDI2,Protein DDI1 homolog 2,1570,146,1.05 [0.87-1.26],0.6159157251803267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDR1,Epithelial discoidin domain-containing receptor 1,1863,188,1.38 [0.83-2.32],0.2159609704621283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDT,D-dopachrome decarboxylase,1604,153,1.17 [0.84-1.63],0.3562855311991398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX1,ATP-dependent RNA helicase DDX1,1581,150,1.07 [0.82-1.40],0.6291039896875152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX25,ATP-dependent RNA helicase DDX25,1557,147,1.52 [1.20-1.93],0.000546345559035
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX39A,ATP-dependent RNA helicase DDX39A,1548,150,0.68 [0.33-1.43],0.3117810413034063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX4,Probable ATP-dependent RNA helicase DDX4,1548,150,0.76 [0.53-1.07],0.1180059528748645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX53,Probable ATP-dependent RNA helicase DDX53,1557,147,0.77 [0.49-1.22],0.2654469051367821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DDX58,Antiviral innate immune response receptor RIG-I,1798,185,1.02 [0.83-1.26],0.8586196561232383
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",1840,187,1.03 [0.90-1.18],0.6940969726108066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFA1_DEFA1B,Neutrophil defensin 1,1801,186,1.18 [0.95-1.46],0.1311064635188773
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB103A_DEFB103B,Beta-defensin 103,1542,149,1.36 [1.07-1.73],0.0116753392319818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB104A_DEFB104B,Beta-defensin 104,1537,150,1.01 [0.77-1.32],0.9561927762172862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB116,Beta-defensin 116,1537,150,1.09 [0.91-1.30],0.3485616713359261
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB118,Beta-defensin 118,1537,150,0.88 [0.65-1.19],0.4157767915990067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DEFB4A_DEFB4B,Beta-defensin 4A,1837,189,1.05 [0.97-1.14],0.2466426484684298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENND2B,DENN domain-containing protein 2B,1541,149,1.05 [0.77-1.45],0.7557730823471104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DENR,Density-regulated protein,1548,150,1.20 [0.91-1.57],0.1978953684438344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DFFA,DNA fragmentation factor subunit alpha,1864,187,1.22 [1.01-1.47],0.0395375124208328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGCR6,Protein DGCR6,1537,150,1.10 [0.80-1.51],0.552279887326439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKA,Diacylglycerol kinase alpha,1548,150,1.21 [0.92-1.60],0.1743961614344857
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DGKZ,Diacylglycerol kinase zeta,1801,185,1.01 [0.69-1.48],0.951817474586692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHODH,Dihydroorotate dehydrogenase,1541,149,1.21 [0.96-1.53],0.1124292412909615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHPS,Deoxyhypusine synthase,1593,150,1.14 [0.80-1.63],0.4591879610890135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,1592,150,1.11 [0.82-1.49],0.5016766560467557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIABLO,"Diablo homolog, mitochondrial",1846,189,1.03 [0.91-1.16],0.6571377443424077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK1C,Divergent protein kinase domain 1C,1557,147,0.91 [0.63-1.32],0.6249452180137887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DIPK2B,Divergent protein kinase domain 2B,1570,146,1.13 [0.67-1.92],0.6486152543831997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK1,Dickkopf-related protein 1,1863,188,1.00 [0.81-1.24],0.9864497986530492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK3,Dickkopf-related protein 3,1869,190,1.03 [0.68-1.54],0.9005851674593369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKK4,Dickkopf-related protein 4,1831,185,1.98 [1.58-2.49],3.099546092232487e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DKKL1,Dickkopf-like protein 1,1849,189,0.96 [0.84-1.11],0.6023999242569806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLG4,Disks large homolog 4,1592,150,1.11 [0.89-1.38],0.3406898837977113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLGAP5,Disks large-associated protein 5,1601,151,0.90 [0.65-1.23],0.4943155062076715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLK1,Protein delta homolog 1,1869,190,1.06 [0.85-1.32],0.6321856184404278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL1,Delta-like protein 1,1855,187,2.71 [1.94-3.78],5.170080997875317e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DLL4,Delta-like protein 4,1562,150,1.06 [0.90-1.24],0.5021478561160007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMD,Dystrophin,1562,150,1.26 [0.97-1.64],0.0799322643422809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DMP1,Dentin matrix acidic phosphoprotein 1,1562,150,0.73 [0.59-0.91],0.0046555212453937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA1,DnaJ homolog subfamily A member 1,1538,145,0.88 [0.60-1.30],0.5211953002287049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA2,DnaJ homolog subfamily A member 2,1860,187,1.09 [0.93-1.28],0.3107242334719664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJA4,DnaJ homolog subfamily A member 4,1592,150,1.11 [0.91-1.36],0.291024882597415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB1,DnaJ homolog subfamily B member 1,1849,189,1.19 [1.03-1.37],0.021128048969181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB14,DnaJ homolog subfamily B member 14,1581,150,1.11 [0.89-1.39],0.3642435082268617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB2,DnaJ homolog subfamily B member 2,1570,146,1.20 [0.92-1.56],0.1705401866999046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB6,DnaJ homolog subfamily B member 6,1557,145,1.05 [0.87-1.27],0.589312347575961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJB8,DnaJ homolog subfamily B member 8,1814,185,1.08 [0.87-1.34],0.4977531986230692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC21,DnaJ homolog subfamily C member 21,1592,150,1.48 [1.00-2.19],0.0521082591586799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC6,Putative tyrosine-protein phosphatase auxilin,1562,150,1.17 [0.98-1.40],0.0757975361035085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNAJC9,DnaJ homolog subfamily C member 9,1581,150,1.23 [1.01-1.50],0.0377791502934227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,1838,187,1.04 [0.64-1.67],0.879089979205047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNLZ,DNL-type zinc finger protein,1537,150,1.15 [0.97-1.37],0.1113247918805341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM1,Dynamin-1,1581,150,1.05 [0.92-1.21],0.4655254992449171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNM3,Dynamin-3,1601,151,1.30 [1.00-1.69],0.0526832927077959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNMBP,Dynamin-binding protein,1832,185,1.20 [0.98-1.47],0.072702499883401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPEP,Aspartyl aminopeptidase,1592,150,1.06 [0.81-1.38],0.6900833427692485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,1850,185,1.19 [0.94-1.50],0.1512932909914514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOC2B,Double C2-like domain-containing protein beta,1557,147,0.82 [0.50-1.32],0.4099874100240752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOCK9,Dedicator of cytokinesis protein 9,1537,150,1.02 [0.89-1.17],0.7442802744806547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK1,Docking protein 1,1592,150,1.05 [0.94-1.18],0.3996469731896117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DOK2,Docking protein 2,1850,189,1.05 [0.95-1.17],0.3335685188743085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP1,Dipeptidase 1,1828,185,0.91 [0.72-1.15],0.4181941835551284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPEP2,Dipeptidase 2,1849,189,1.31 [0.86-1.99],0.2154402741066122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP10,Inactive dipeptidyl peptidase 10,1840,187,1.13 [0.82-1.54],0.4581090249307111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP4,Dipeptidyl peptidase 4,1829,184,0.92 [0.62-1.38],0.6910633944304148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1849,189,2.04 [1.46-2.85],3.222140049891238e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPP7,Dipeptidyl peptidase 2,1838,188,0.98 [0.78-1.21],0.8242966689663795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPT,Dermatopontin,1869,190,1.87 [1.13-3.09],0.0144912563115299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DPY30,Protein dpy-30 homolog,1859,189,1.33 [1.09-1.61],0.0041007496985015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRAXIN,Draxin,1832,185,1.30 [0.97-1.75],0.0821177027633135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DRG2,Developmentally-regulated GTP-binding protein 2,1849,189,1.20 [0.96-1.49],0.1117878434504332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSC2,Desmocollin-2,1834,185,2.08 [1.68-2.58],1.3356076666789282e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSCAM,Down syndrome cell adhesion molecule,1601,151,1.00 [0.66-1.51],0.996551797767948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG2,Desmoglein-2,1855,188,2.12 [1.43-3.13],0.0001693099111012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG3,Desmoglein-3,1860,188,0.99 [0.68-1.43],0.9375460234890216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DSG4,Desmoglein-4,1841,189,0.61 [0.47-0.78],6.937724174085532e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTD1,D-aminoacyl-tRNA deacylase 1,1570,146,1.04 [0.87-1.25],0.6642967724930007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTNB,Dystrobrevin beta,1590,149,1.57 [1.13-2.18],0.0074899156928655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX2,Probable E3 ubiquitin-protein ligase DTX2,1557,147,0.84 [0.64-1.11],0.2268899266781695
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,1849,189,2.84 [1.74-4.62],2.8870421883840698e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DTYMK,Thymidylate kinase,1596,150,1.21 [0.98-1.51],0.0803771914771321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUOX2,Dual oxidase 2,1814,185,0.92 [0.76-1.11],0.381676859722924
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP13,Dual specificity protein phosphatase 13 isoform A,1593,150,0.96 [0.67-1.38],0.8315763325633168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP29,Dual specificity phosphatase 29,1557,147,0.95 [0.74-1.21],0.6774973492220352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUSP3,Dual specificity protein phosphatase 3,1788,185,1.16 [1.02-1.32],0.0250725079718192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",1581,150,1.11 [0.96-1.28],0.171659979875095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DXO,Decapping and exoribonuclease protein,1592,150,1.33 [0.95-1.85],0.096947757728452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,1593,150,1.21 [0.87-1.69],0.2499449253231724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT1,Dynein light chain Tctex-type 1,1557,147,1.07 [0.89-1.29],0.4738870060920207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,DYNLT3,Dynein light chain Tctex-type 3,1593,150,1.34 [0.96-1.87],0.0805659807931794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,1832,185,1.09 [0.95-1.25],0.2311455553550292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EBI3_IL27,Interleukin-27,1862,190,1.96 [1.34-2.88],0.0005920070081482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECE1,Endothelin-converting enzyme 1,1788,185,0.82 [0.57-1.18],0.284136188467201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",1596,150,0.91 [0.75-1.10],0.319195553281682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECHS1,"Enoyl-CoA hydratase, mitochondrial",1562,150,0.97 [0.83-1.14],0.744358525611587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECI2,Enoyl-CoA delta isomerase 2,1541,149,1.07 [0.84-1.35],0.5827034089752692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECM1,Extracellular matrix protein 1,1559,146,1.00 [0.64-1.57],0.9958246333717016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ECSCR,Endothelial cell-specific chemotaxis regulator,1537,150,1.16 [0.85-1.59],0.349271761881724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1867,190,2.24 [1.79-2.80],2.2326183686128188e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDAR,Tumor necrosis factor receptor superfamily member EDAR,1840,187,1.03 [0.89-1.19],0.6794730585708779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDDM3B,Epididymal secretory protein E3-beta,1593,150,0.65 [0.43-0.97],0.0349832149639829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,1541,149,1.47 [1.01-2.13],0.0429210709051929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDF1,Endothelial differentiation-related factor 1,1601,151,1.06 [0.84-1.33],0.6295347940317645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,1814,185,1.35 [0.93-1.95],0.1131752236106961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDN1,Endothelin-1,1562,150,1.68 [1.02-2.76],0.0427645312887465
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EDNRB,Endothelin receptor type B,1548,150,1.08 [0.75-1.55],0.6839032020392022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EEF1D,Elongation factor 1-delta,1596,150,1.08 [0.91-1.27],0.3892729826758722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1581,150,2.06 [1.31-3.25],0.0017881375374756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFCAB2,Dynein regulatory complex protein 8,1574,146,1.21 [0.80-1.82],0.3663185991806158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1855,188,1.80 [1.26-2.57],0.0012777436778507
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFHD1,EF-hand domain-containing protein D1,1601,151,1.41 [1.00-1.98],0.0527865383983777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA1,Ephrin-A1,1854,188,2.77 [1.98-3.87],3.0260133841798542e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNA4,Ephrin-A4,1829,185,3.53 [2.61-4.78],3.2195345494492647e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EFNB2,Ephrin-B2,1557,147,1.31 [1.06-1.61],0.0112795078093276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGF,Pro-epidermal growth factor,1837,186,1.01 [0.89-1.15],0.8377865080830914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFL7,Epidermal growth factor-like protein 7,1798,185,1.15 [0.83-1.59],0.4059517209897502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFLAM,Pikachurin,1581,150,1.37 [0.84-2.23],0.2013544764728503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGFR,Epidermal growth factor receptor,1869,190,0.68 [0.34-1.35],0.2710328644063122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EGLN1,Egl nine homolog 1,1840,187,1.17 [0.97-1.41],0.0963017150113678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHBP1,EH domain-binding protein 1,1596,150,1.08 [0.87-1.33],0.4886224714365595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EHD3,EH domain-containing protein 3,1562,150,1.03 [0.90-1.18],0.6520786868889301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",1592,150,1.29 [1.05-1.60],0.0178043833178451
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",1573,149,1.07 [0.93-1.22],0.3574769605322887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,1541,149,1.01 [0.80-1.28],0.9135073378915116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,1562,150,1.42 [0.99-2.02],0.054647984010103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4B,Eukaryotic translation initiation factor 4B,1832,185,1.12 [0.90-1.40],0.3076270573949521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4E,Eukaryotic translation initiation factor 4E,1548,150,1.09 [0.91-1.30],0.3389757278981834
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,1850,189,1.34 [1.12-1.59],0.001303232002664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,1864,187,1.09 [0.95-1.24],0.2344790937170195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,1601,151,1.07 [0.85-1.33],0.5787838117586428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5,Eukaryotic translation initiation factor 5,1541,149,1.09 [0.76-1.55],0.646610831171998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EIF5A,Eukaryotic translation initiation factor 5A-1,1801,185,0.79 [0.49-1.28],0.3421301539986185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAC1,Zinc phosphodiesterase ELAC protein 1,1601,151,1.04 [0.86-1.25],0.677676888767464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELAVL4,ELAV-like protein 4,1537,150,0.87 [0.71-1.07],0.1960353784337029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELN,Elastin,1596,150,1.36 [0.94-1.97],0.1050085069462638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOA,Elongin-A,1849,189,1.06 [0.84-1.34],0.6228469180297831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ELOB,Elongin-B,1541,149,1.22 [0.92-1.62],0.1736877606141525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENAH,Protein enabled homolog,1801,185,1.40 [1.08-1.82],0.0113491287181121
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENDOU,Poly(U)-specific endoribonuclease,1469,140,0.92 [0.67-1.26],0.6099046200210727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENG,Endoglin,1869,190,1.22 [0.62-2.38],0.5649749252020541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO1,Alpha-enolase,1846,186,1.08 [0.91-1.28],0.3987068292298333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO2,Gamma-enolase,1863,188,1.13 [0.93-1.37],0.2217913597562039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENO3,Beta-enolase,1562,150,0.88 [0.68-1.13],0.3151356949656729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOPH1,Enolase-phosphatase E1,1593,150,0.95 [0.69-1.30],0.7322061227110959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,1541,149,1.27 [0.82-1.97],0.2819563506881172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPEP,Glutamyl aminopeptidase,1541,149,1.19 [0.87-1.61],0.2747068560316557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,1869,190,0.86 [0.58-1.26],0.4417779895505925
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,1853,187,0.88 [0.65-1.20],0.4320177761552172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,1562,150,1.38 [0.92-2.07],0.1196062225255409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,1777,179,0.92 [0.80-1.07],0.2928056195542229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENSA,Alpha-endosulfine,1593,150,1.13 [0.88-1.47],0.3380886669705349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,1798,185,1.02 [0.78-1.32],0.9084234926551102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,1814,185,0.80 [0.43-1.46],0.4657845880005318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1814,185,1.51 [0.88-2.58],0.1314387967778934
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ENTR1,Endosome-associated-trafficking regulator 1,1562,150,1.05 [0.83-1.33],0.6769770403076878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EP300,Histone acetyltransferase p300,1548,150,1.27 [0.79-2.04],0.31603845771861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPB41L5,Band 4.1-like protein 5,1557,147,1.18 [0.94-1.47],0.1558915443521884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPCAM,Epithelial cell adhesion molecule,1843,187,0.98 [0.86-1.13],0.7863269741204146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPGN,Epigen,1593,150,0.93 [0.65-1.33],0.6957418965648334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA1,Ephrin type-A receptor 1,1850,185,1.50 [1.06-2.14],0.0238482489754752
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA10,Ephrin type-A receptor 10,1788,185,1.04 [0.85-1.28],0.6928934000020232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA2,Ephrin type-A receptor 2,1787,181,2.72 [2.11-3.51],1.154962480232553e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHA4,Ephrin type-A receptor 4,1570,146,1.75 [1.03-2.98],0.0398838538333294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB4,Ephrin type-B receptor 4,1869,190,2.93 [2.03-4.24],1.1882638160355228e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHB6,Ephrin type-B receptor 6,1828,185,1.81 [1.27-2.57],0.0010287886076703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPHX2,Bifunctional epoxide hydrolase 2,1814,185,1.01 [0.82-1.24],0.9541111683232244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPN1,Epsin-1,1574,146,0.93 [0.62-1.40],0.7348892690813933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPO,Erythropoietin,1840,187,1.25 [1.08-1.44],0.0025095441681398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPPK1,Epiplakin,1562,150,1.12 [0.93-1.35],0.2446583195903375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,1864,189,1.76 [1.25-2.47],0.0010707081986039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB2,Receptor tyrosine-protein kinase erbB-2,1855,187,0.55 [0.35-0.89],0.0136260422650165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,1837,185,1.37 [0.71-2.64],0.3468683677677023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,1855,187,1.54 [1.02-2.32],0.0414653103149835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERBIN,Erbin,1849,189,1.07 [0.94-1.21],0.3069280934269534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERC2,ERC protein 2,1557,147,1.07 [0.86-1.32],0.5505859788757734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERCC1,DNA excision repair protein ERCC-1,1538,145,1.01 [0.62-1.66],0.9632299678091468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EREG,Proepiregulin,1828,185,1.01 [0.86-1.19],0.8970903973829428
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERI1,3'-5' exoribonuclease 1,1574,146,1.02 [0.63-1.65],0.942686179152087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERMAP,Erythroid membrane-associated protein,1548,150,1.74 [1.23-2.48],0.0019660135978827
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,1593,150,0.96 [0.65-1.41],0.8268368753530225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP29,Endoplasmic reticulum resident protein 29,1570,146,1.04 [0.91-1.19],0.559529862690813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERP44,Endoplasmic reticulum resident protein 44,1846,188,0.83 [0.51-1.35],0.4508295539333081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,1541,149,0.99 [0.70-1.39],0.9401647313885778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESAM,Endothelial cell-selective adhesion molecule,1869,190,1.88 [1.32-2.68],0.0005128893933587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESM1,Endothelial cell-specific molecule 1,1841,187,1.15 [0.81-1.63],0.4419989589158041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESPL1,Separin,1538,145,1.28 [1.01-1.61],0.0380885688353782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESR1,Estrogen receptor,1548,150,0.76 [0.52-1.11],0.1600714543197225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ESYT2,Extended synaptotagmin-2,1592,150,1.13 [0.94-1.37],0.1816162008369025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI2B,Protein EVI2B,1538,145,1.18 [0.84-1.66],0.3529855238970216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVI5,Ecotropic viral integration site 5 protein homolog,1548,150,1.09 [0.92-1.30],0.3115521639188736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EVPL,Envoplakin,1574,146,1.24 [0.79-1.94],0.35698992775131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXOSC10,Exosome component 10,1541,149,0.79 [0.58-1.09],0.1503547997468217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EXTL1,Exostosin-like 1,1541,149,1.08 [0.78-1.49],0.6348858329747784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,EZR,Ezrin,1863,188,1.05 [0.62-1.79],0.8521385920854171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F10,Coagulation factor X,1606,152,0.67 [0.39-1.12],0.1279609117646446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11,Coagulation factor XI,1586,150,1.19 [0.69-2.06],0.5259890960926312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F11R,Junctional adhesion molecule A,1855,188,1.25 [1.00-1.57],0.053530506555876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F12,Coagulation factor XII,1608,152,0.89 [0.62-1.28],0.5331164247615634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F13B,Coagulation factor XIII B chain,1601,152,1.06 [0.60-1.86],0.8501678497702099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2,Prothrombin,1608,152,1.33 [0.50-3.54],0.571451141154091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F2R,Proteinase-activated receptor 1,1848,187,1.48 [1.18-1.84],0.0005848913618869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F3,Tissue factor,1854,188,1.58 [1.07-2.33],0.0221604336549472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F7,Coagulation factor VII,1856,188,0.98 [0.66-1.44],0.9109645520382492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,F9,Coagulation factor IX,1857,188,0.90 [0.45-1.79],0.757509136422632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP1,"Fatty acid-binding protein, liver",1841,187,1.22 [1.08-1.38],0.0012442836170527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP2,"Fatty acid-binding protein, intestinal",1850,189,1.15 [0.99-1.34],0.0744186400492408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP3,"Fatty acid-binding protein, heart",1596,150,1.80 [1.43-2.28],7.434719570931075e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP4,"Fatty acid-binding protein, adipocyte",1869,190,1.69 [1.42-2.03],7.968831864787425e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP5,Fatty acid-binding protein 5,1860,187,1.45 [1.22-1.72],2.560246906179633e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP6,Gastrotropin,1810,184,1.20 [0.97-1.48],0.0855039667808569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FABP9,Fatty acid-binding protein 9,1840,187,0.88 [0.69-1.10],0.2621657569481392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FADD,FAS-associated death domain protein,1850,189,1.10 [0.93-1.31],0.2686133398362049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM13A,Protein FAM13A,1581,150,1.21 [0.96-1.52],0.1034698189950526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171A2,Protein FAM171A2,1601,151,1.01 [0.92-1.11],0.8440605767957396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM171B,Protein FAM171B,1593,150,1.23 [0.73-2.07],0.4423603083841201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM172A,Cotranscriptional regulator FAM172A,1562,150,1.07 [0.83-1.37],0.6142371712967948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM20A,Pseudokinase FAM20A,1596,150,0.95 [0.54-1.67],0.8678724483548061
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3B,Protein FAM3B,1849,189,2.20 [1.59-3.04],1.6978819907428474e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3C,Protein FAM3C,1850,189,2.99 [2.16-4.13],4.55401497972102e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAM3D,Protein FAM3D,1581,150,1.69 [1.41-2.03],1.9258009180024428e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAP,Prolyl endopeptidase FAP,1869,190,0.84 [0.56-1.28],0.4268936839167028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FARSA,Phenylalanine--tRNA ligase alpha subunit,1557,147,1.17 [0.94-1.46],0.154461697185679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FAS,Tumor necrosis factor receptor superfamily member 6,1864,190,1.47 [1.10-1.98],0.0097864373816126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FASLG,Tumor necrosis factor ligand superfamily member 6,1864,187,1.06 [0.75-1.49],0.7526587390535842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBLN2,Fibulin-2,1604,153,1.49 [1.01-2.22],0.0462292483074284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBN2,Fibrillin-2,1557,147,1.19 [0.90-1.58],0.21848419146384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FBP1,"Fructose-1,6-bisphosphatase 1",1850,189,0.82 [0.70-0.97],0.0190250178991349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,1596,150,1.14 [0.93-1.39],0.1967661682723742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCAR,Immunoglobulin alpha Fc receptor,1840,187,1.05 [0.80-1.36],0.7454883998679713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,1601,151,1.24 [0.62-2.50],0.5439415441400266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,1855,188,1.26 [0.98-1.63],0.0768957709008816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,1848,185,1.15 [0.91-1.44],0.2403809862586842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1798,185,0.85 [0.67-1.07],0.1724822441442126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,1855,188,0.90 [0.70-1.15],0.3945120417917104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN1,Ficolin-1,1605,152,1.02 [0.79-1.34],0.8589623775522561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCN2,Ficolin-2,1843,185,0.80 [0.59-1.08],0.1400960794655504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL1,Fc receptor-like protein 1,1850,189,0.96 [0.73-1.26],0.7837871806677812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL2,Fc receptor-like protein 2,1852,185,1.15 [0.91-1.47],0.2444923826609977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL3,Fc receptor-like protein 3,1801,185,1.03 [0.82-1.30],0.7976471925870422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL5,Fc receptor-like protein 5,1855,188,1.08 [0.87-1.35],0.4776653476623043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRL6,Fc receptor-like protein 6,1840,187,1.21 [1.01-1.46],0.042535528744729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FCRLB,Fc receptor-like B,1798,185,1.11 [0.91-1.35],0.2868718390947992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX1,"Adrenodoxin, mitochondrial",1541,149,1.22 [0.98-1.51],0.0724548248295647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FDX2,"Ferredoxin-2, mitochondrial",1541,149,1.15 [0.86-1.52],0.3441029143504357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FEN1,Flap endonuclease 1,1798,185,1.12 [0.95-1.32],0.1913373284979997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FES,Tyrosine-protein kinase Fes/Fps,1798,185,1.07 [0.82-1.39],0.6200803602660265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FETUB,Fetuin-B,1857,188,1.06 [0.74-1.53],0.7388326618989802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGA,Fibrinogen alpha chain,1557,146,1.21 [0.73-2.01],0.4556250475546142
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",1601,151,1.10 [0.91-1.32],0.3334409814140015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF12,Fibroblast growth factor 12,1548,150,1.05 [0.78-1.41],0.7638906872345655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF16,Fibroblast growth factor 16,1548,150,0.79 [0.56-1.13],0.1934767220411387
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF19,Fibroblast growth factor 19,1853,187,1.06 [0.91-1.24],0.4680222702412093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF2,Fibroblast growth factor 2,1840,187,1.10 [0.91-1.31],0.3278428608391858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF20,Fibroblast growth factor 20,1548,150,0.86 [0.57-1.32],0.4937098944106903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF21,Fibroblast growth factor 21,1862,190,1.07 [0.97-1.18],0.1652078042313296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF23,Fibroblast growth factor 23,1863,189,1.35 [1.15-1.59],0.0002451053320754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF3,Fibroblast growth factor 3,1548,150,1.80 [1.07-3.03],0.0255230299177284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF5,Fibroblast growth factor 5,1801,185,2.26 [1.59-3.20],4.811906493529308e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF6,Fibroblast growth factor 6,1548,150,1.10 [0.77-1.57],0.6042053593104743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF7,Fibroblast growth factor 7,1538,145,0.89 [0.70-1.13],0.3372142169044703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGF9,Fibroblast growth factor 9,1535,145,1.16 [0.84-1.59],0.3619754065178939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP1,Fibroblast growth factor-binding protein 1,1855,187,0.46 [0.31-0.67],5.536850399146312e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP2,Fibroblast growth factor-binding protein 2,1604,153,0.64 [0.47-0.86],0.0030230794884216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFBP3,Fibroblast growth factor-binding protein 3,1592,150,0.70 [0.46-1.07],0.1030348384622881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR2,Fibroblast growth factor receptor 2,1855,187,1.52 [0.94-2.47],0.0881611861765548
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGFR4,Fibroblast growth factor receptor 4,1570,146,0.88 [0.66-1.19],0.4146700933736762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGL1,Fibrinogen-like protein 1,1606,152,1.54 [1.22-1.94],0.0002478779670414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FGR,Tyrosine-protein kinase Fgr,1788,185,1.03 [0.84-1.25],0.8005821357832736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FH,"Fumarate hydratase, mitochondrial",1537,150,0.91 [0.74-1.12],0.3824680928597115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIP2A,FHF complex subunit HOOK interacting protein 2A,1541,149,0.90 [0.66-1.23],0.504477589887937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FHIT,Bis(5'-adenosyl)-triphosphatase,1788,185,1.07 [0.90-1.28],0.4457693392638748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FIS1,Mitochondrial fission 1 protein,1845,185,1.12 [0.95-1.32],0.1626741264713818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,1601,151,1.08 [0.92-1.27],0.3216548506097927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,1850,185,1.06 [0.95-1.18],0.3194758326669016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,1832,185,1.60 [1.17-2.19],0.0030210278460089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,1832,185,1.12 [0.97-1.30],0.1073659519513524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,1784,185,1.23 [0.98-1.54],0.073127463108605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FKBPL,FK506-binding protein-like,1581,150,1.16 [0.90-1.50],0.2619998023067688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLI1,Friend leukemia integration 1 transcription factor,1798,185,1.10 [0.98-1.23],0.1117927190282955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1832,185,1.61 [1.10-2.35],0.013713067522218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT1,Vascular endothelial growth factor receptor 1,1846,189,1.74 [1.06-2.84],0.0273607739109391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3,Receptor-type tyrosine-protein kinase FLT3,1798,185,1.16 [0.73-1.82],0.5295193704296869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,1864,187,1.12 [0.76-1.65],0.5652018087658881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FLT4,Vascular endothelial growth factor receptor 3,1855,187,0.92 [0.63-1.36],0.6849097683190992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMNL1,Formin-like protein 1,1788,185,1.08 [0.92-1.27],0.3581147420571431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FMR1,Synaptic functional regulator FMR1,1798,185,1.09 [0.75-1.57],0.6617330662248186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FN1,Fibronectin,1608,152,0.45 [0.26-0.80],0.0062307402064475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNDC1,Fibronectin type III domain-containing protein 1,1592,150,0.91 [0.66-1.24],0.544436618012715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,1593,150,1.05 [0.67-1.64],0.842239363640642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLH1,Glutamate carboxypeptidase 2,1548,150,0.89 [0.73-1.09],0.2457807363398501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR1,Folate receptor alpha,1845,185,1.99 [1.35-2.93],0.0004572873709155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR2,Folate receptor beta,1863,188,1.21 [0.82-1.80],0.3384806279311406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOLR3,Folate receptor gamma,1846,186,1.05 [0.99-1.12],0.087889803065248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOS,Proto-oncogene c-Fos,1535,145,1.14 [0.72-1.81],0.5789180749515795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOSB,Protein fosB,1788,185,0.89 [0.61-1.30],0.5415937983913026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXJ3,Forkhead box protein J3,1548,150,1.15 [0.82-1.61],0.4308790202712727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO1,Forkhead box protein O1,1840,187,1.11 [0.95-1.30],0.1724922881667837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FOXO3,Forkhead box protein O3,1798,185,1.12 [0.98-1.28],0.0998614954326052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD4B,FERM domain-containing protein 4B,1541,149,1.09 [0.88-1.36],0.4271930290939049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRMD7,FERM domain-containing protein 7,1557,147,1.13 [0.75-1.71],0.5491062708571541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FRZB,Secreted frizzled-related protein 3,1826,185,0.77 [0.48-1.21],0.2569606148442968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSHB,Follitropin subunit beta,1562,150,1.28 [1.00-1.63],0.0467193548385411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FST,Follistatin,1848,187,0.93 [0.71-1.22],0.5908834677842549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL1,Follistatin-related protein 1,1562,150,3.20 [1.81-5.68],6.561409657988443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FSTL3,Follistatin-related protein 3,1841,185,1.81 [1.32-2.49],0.0002140890178533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FTCD,Formimidoyltransferase-cyclodeaminase,1589,149,0.88 [0.75-1.02],0.0988935454608795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUCA1,Tissue alpha-L-fucosidase,1863,190,1.08 [0.92-1.27],0.3648112202114821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUOM,Fucose mutarotase,1570,146,0.85 [0.68-1.07],0.163690921659863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FURIN,Furin,1855,187,0.60 [0.42-0.87],0.0063572054458964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUS,RNA-binding protein FUS,1794,184,1.69 [1.21-2.34],0.0018499987398939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",1569,145,0.98 [0.77-1.26],0.8958337230427456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1863,188,1.39 [1.08-1.80],0.0111785710886132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FUT8,"Alpha-(1,6)-fucosyltransferase",1832,185,1.04 [0.84-1.30],0.7106706514332297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXN,"Frataxin, mitochondrial",1867,190,1.12 [0.94-1.33],0.1946869682644116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FXYD5,FXYD domain-containing ion transport regulator 5,1801,185,1.18 [0.99-1.42],0.0668098512206978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FYB1,FYN-binding protein 1,1853,188,1.04 [0.90-1.19],0.6176183971259424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD10,Frizzled-10,1557,147,1.08 [0.85-1.36],0.5228228880601562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,FZD8,Frizzled-8,1537,150,0.97 [0.68-1.40],0.8899028817571512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAP,Gamma-aminobutyric acid receptor-associated protein,1593,150,0.85 [0.61-1.18],0.325533590292859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,1574,146,1.19 [0.98-1.44],0.0760271309453103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,1537,150,0.82 [0.63-1.08],0.1579119038762775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD1,Glutamate decarboxylase 1,1538,145,0.83 [0.43-1.58],0.56913295908324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAD2,Glutamate decarboxylase 2,1548,150,0.94 [0.64-1.39],0.7589702613829961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,1574,146,1.13 [0.83-1.56],0.4327765680798202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,1562,150,1.20 [0.91-1.60],0.1951095784431477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAGE2A,G antigen 2A,1538,145,0.98 [0.78-1.24],0.8920721159531346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAL,Galanin peptides,1853,187,0.75 [0.61-0.92],0.0061978079168875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1849,189,1.66 [1.07-2.58],0.0234145780636133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,1867,190,0.77 [0.48-1.23],0.2705868230601191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,1801,185,1.63 [1.24-2.14],0.0004215179141307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,1596,150,1.19 [0.71-1.97],0.5094681054661665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GALNT7,N-acetylgalactosaminyltransferase 7,1849,189,1.32 [0.73-2.39],0.350848481139959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAMT,Guanidinoacetate N-methyltransferase,1541,149,0.82 [0.50-1.33],0.4102695331837435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,1527,141,1.37 [0.78-2.42],0.2741947094585488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GART,Trifunctional purine biosynthetic protein adenosine-3,1601,151,1.04 [0.62-1.77],0.874036211588998
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS2,Growth arrest-specific protein 2,1574,146,0.84 [0.59-1.18],0.3058936703948791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAS6,Growth arrest-specific protein 6,1858,189,0.98 [0.61-1.56],0.918862381152738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GASK1A,Golgi-associated kinase 1A,1541,149,0.74 [0.52-1.05],0.0890263208316923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GAST,Gastrin,1592,150,1.05 [0.96-1.15],0.266551917420335
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,1538,145,1.07 [0.57-2.00],0.8365954914721417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",1562,150,1.14 [0.94-1.39],0.1740127788900959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBA,Lysosomal acid glucosylceramidase,1557,147,1.17 [0.90-1.51],0.2497050974524983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP1,Guanylate-binding protein 1,1590,150,1.06 [0.84-1.33],0.6354216141806781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP2,Guanylate-binding protein 2,1801,185,1.17 [0.94-1.47],0.1637581848368207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP4,Guanylate-binding protein 4,1788,185,1.12 [0.87-1.45],0.3743937947341327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GBP6,Guanylate-binding protein 6,1541,149,1.07 [0.78-1.47],0.663088317530189
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GC,Vitamin D-binding protein,1608,152,0.96 [0.53-1.74],0.9009442075687843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCC1,GRIP and coiled-coil domain-containing protein 1,1592,150,1.04 [0.90-1.20],0.6270900774176237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCG,Pro-glucagon,1798,185,1.30 [1.18-1.43],1.90768632519666e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,1533,145,1.27 [0.96-1.67],0.0920477249749366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCLM,Glutamate--cysteine ligase regulatory subunit,1541,149,0.99 [0.71-1.38],0.9647674610022277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",1849,189,1.51 [1.06-2.14],0.0223989537858012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF15,Growth/differentiation factor 15,1869,190,2.14 [1.80-2.54],4.24884763530034e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDF2,Growth/differentiation factor 2,1850,189,1.22 [0.87-1.71],0.2440958316060819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GDNF,Glial cell line-derived neurotrophic factor,1788,185,1.69 [1.28-2.22],0.0001751569300466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GET3,ATPase GET3,1596,150,0.92 [0.70-1.22],0.5752558912440782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFAP,Glial fibrillary acidic protein,1795,185,0.94 [0.71-1.24],0.6566324135800619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFER,FAD-linked sulfhydryl oxidase ALR,1798,185,1.17 [0.96-1.43],0.1206702052184633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,1798,185,1.04 [0.95-1.14],0.3850895102976412
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA1,GDNF family receptor alpha-1,1862,190,2.97 [2.08-4.25],2.491545463965382e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA2,GDNF family receptor alpha-2,1849,189,1.92 [1.04-3.55],0.0367503062022882
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRA3,GDNF family receptor alpha-3,1825,184,1.87 [1.23-2.83],0.0033562110477458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GFRAL,GDNF family receptor alpha-like,1545,148,1.06 [0.83-1.36],0.6252199660697201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGA1,ADP-ribosylation factor-binding protein GGA1,1788,185,0.99 [0.81-1.21],0.8928092837178623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGACT,Gamma-glutamylaminecyclotransferase,1596,150,1.09 [0.88-1.36],0.4344200906180565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGCT,Gamma-glutamylcyclotransferase,1595,150,1.17 [0.85-1.61],0.3413506660266915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGH,Gamma-glutamyl hydrolase,1819,185,0.56 [0.38-0.82],0.0031474679426351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT1,Glutathione hydrolase 1 proenzyme,1854,188,0.85 [0.66-1.08],0.1758403104144149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GGT5,Glutathione hydrolase 5 proenzyme,1832,185,2.26 [1.40-3.67],0.0009118075694537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH1,Somatotropin,1850,189,1.08 [1.00-1.16],0.0473759956412543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GH2,Growth hormone variant,1798,185,1.00 [0.92-1.08],0.9490033418462244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHR,Growth hormone receptor,1570,146,0.44 [0.26-0.73],0.0015965735762131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRHR,Growth hormone-releasing hormone receptor,1788,185,1.03 [0.81-1.31],0.7946189474045728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GHRL,Appetite-regulating hormone,1850,189,1.03 [0.88-1.20],0.7301471935390595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GID8,Glucose-induced degradation protein 8 homolog,1601,151,1.06 [0.67-1.68],0.7961596889011551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIGYF2,GRB10-interacting GYF protein 2,1601,151,1.24 [1.01-1.51],0.0395816234737918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP7,GTPase IMAP family member 7,1570,146,1.24 [0.74-2.06],0.4146696319919434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIMAP8,GTPase IMAP family member 8,1538,145,1.02 [0.75-1.40],0.8826480824562537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIP,Gastric inhibitory polypeptide,1562,150,1.39 [1.07-1.81],0.012908275818637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC2,PDZ domain-containing protein GIPC2,1592,150,1.84 [1.18-2.88],0.007105628199063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPC3,PDZ domain-containing protein GIPC3,1581,150,1.09 [0.93-1.28],0.3039997010959266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIPR,Gastric inhibitory polypeptide receptor,1548,150,1.25 [0.97-1.61],0.0901203287575469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GIT1,ARF GTPase-activating protein GIT1,1548,150,1.06 [0.90-1.25],0.4641682725759236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GJA8,Gap junction alpha-8 protein,1538,145,1.15 [0.91-1.46],0.2434889848718188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GKN1,Gastrokine-1,1748,178,1.21 [0.78-1.88],0.3891402431024633
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLA,Alpha-galactosidase A,1566,146,1.00 [0.66-1.50],0.9890323585661536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLB1,Beta-galactosidase,1832,185,1.01 [0.74-1.38],0.931918368751212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLI2,Zinc finger protein GLI2,1548,150,0.59 [0.33-1.08],0.0858914076515443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLO1,Lactoylglutathione lyase,1814,185,1.22 [0.98-1.52],0.0705307586405317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLOD4,Glyoxalase domain-containing protein 4,1840,185,1.55 [1.08-2.22],0.0182743780745355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLP1R,Glucagon-like peptide 1 receptor,1537,150,1.65 [1.26-2.17],0.0003043164329609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX,Glutaredoxin-1,1837,186,1.21 [0.97-1.50],0.0874860937632111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",1570,146,1.04 [0.87-1.24],0.6728581835524445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,1788,185,0.80 [0.59-1.10],0.1721955593933781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GLYR1,Putative oxidoreductase GLYR1,1593,150,0.80 [0.58-1.08],0.1440403889611813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GM2A,Ganglioside GM2 activator,1567,150,1.85 [1.38-2.48],3.664676984849425e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMFG,Glia maturation factor gamma,1596,150,1.08 [0.87-1.34],0.4941017306444463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR,GMP reductase 1,1864,187,1.32 [1.02-1.71],0.0345548562578385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GMPR2,GMP reductase 2,1570,146,1.11 [0.88-1.39],0.3930909845321274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNAS,Neuroendocrine secretory protein 55,1601,151,0.96 [0.81-1.14],0.6564734870875935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,1798,185,1.05 [0.86-1.29],0.6229428268781977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,1557,147,1.03 [0.78-1.36],0.8133178211614838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNLY,Granulysin,1855,188,1.24 [0.98-1.57],0.0724724881598901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA1,Glucosamine-6-phosphate isomerase 1,1562,150,1.06 [0.70-1.62],0.7693848271047687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,1570,146,0.90 [0.59-1.36],0.6147530531815979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLGA3,Golgin subfamily A member 3,1601,151,1.12 [0.92-1.37],0.2527467268257309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOLM2,Protein GOLM2,1863,188,1.17 [0.70-1.96],0.549492429342916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,1840,187,1.03 [0.91-1.18],0.6408658626350568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GORASP2,Golgi reassembly-stacking protein 2,1581,150,1.22 [0.88-1.68],0.2340835541585608
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GOT1,"Aspartate aminotransferase, cytoplasmic",1604,153,0.79 [0.57-1.11],0.1821062320216126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BA,Platelet glycoprotein Ib alpha chain,1846,185,0.95 [0.65-1.40],0.7978260548634438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP1BB,Platelet glycoprotein Ib beta chain,1541,149,1.08 [0.86-1.35],0.5182713153311675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,1790,185,1.11 [0.98-1.26],0.1047940676659312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP5,Platelet glycoprotein V,1570,146,1.04 [0.67-1.63],0.8512756894993054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GP6,Platelet glycoprotein VI,1853,188,1.10 [0.95-1.28],0.2210439358551416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPA33,Cell surface A33 antigen,1849,189,0.90 [0.82-0.99],0.0351020446145198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC1,Glypican-1,1867,190,1.68 [1.12-2.52],0.0129158447424433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPC5,Glypican-5,1832,185,0.89 [0.71-1.12],0.335240393010737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPD1,Glycerol-3-phosphate dehydrogenase,1593,150,1.02 [0.79-1.30],0.8921866513814537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPHA2,Glycoprotein hormone alpha-2,1581,150,1.00 [0.73-1.37],0.9947702835925726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPI,Glucose-6-phosphate isomerase,1606,152,1.04 [0.76-1.43],0.7868709395375986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,1581,150,1.20 [0.97-1.49],0.1004229250622172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPKOW,G-patch domain and KOW motifs-containing protein,1788,185,1.43 [1.00-2.04],0.0471379487654546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPNMB,Transmembrane glycoprotein NMB,1804,184,2.73 [1.78-4.18],4.292880701646539e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR101,Probable G-protein coupled receptor 101,1537,150,1.26 [1.01-1.57],0.0378440965327323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR158,Probable G-protein coupled receptor 158,1601,151,1.32 [0.93-1.86],0.1197750167664957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR15L,Protein GPR15L,1581,150,1.03 [0.81-1.32],0.8182707924608682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPR37,Prosaposin receptor GPR37,1814,185,1.68 [1.40-2.00],1.1835926340599865e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GPRC5C,G-protein coupled receptor family C group 5 member C,1593,150,0.92 [0.72-1.19],0.5358542217226818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRAP2,GRB2-related adapter protein 2,1850,189,1.06 [0.96-1.17],0.2671297046281585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,1596,150,1.17 [0.92-1.48],0.1939210514696463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIK2,"Glutamate receptor ionotropic, kainate 2",1601,151,1.01 [0.71-1.45],0.940336415911822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",1537,150,1.26 [0.99-1.60],0.0613839984557813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRK5,G protein-coupled receptor kinase 5,1814,185,0.97 [0.74-1.26],0.8077195169003302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRN,Progranulin,1848,188,3.98 [2.39-6.61],1.0234465535460369e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRP,Gastrin-releasing peptide,1562,150,0.85 [0.65-1.12],0.2483531638097164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",1849,189,1.04 [0.85-1.27],0.7332244643871833
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GRSF1,G-rich sequence factor 1,1529,144,1.17 [0.96-1.41],0.116058462168774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSAP,Gamma-secretase-activating protein,1798,185,1.06 [0.93-1.23],0.3816674335708793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSN,Gelsolin,1598,150,0.56 [0.26-1.19],0.1310006905341472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSR,"Glutathione reductase, mitochondrial",1600,151,0.83 [0.43-1.60],0.5846291220864706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA1,Glutathione S-transferase A1,1847,189,0.84 [0.73-0.97],0.0183065542210746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTA3,Glutathione S-transferase A3,1798,185,0.94 [0.81-1.09],0.4154841400604062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTM4,Glutathione S-transferase Mu 4,1541,149,1.05 [0.86-1.29],0.606197790538989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTP1,Glutathione S-transferase P,1780,184,1.02 [0.84-1.23],0.8675917389907175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GSTT2B,Glutathione S-transferase theta-2B,1592,150,0.95 [0.89-1.01],0.1172831510208593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,1574,146,1.15 [0.93-1.43],0.2026735414926004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GTPBP2,GTP-binding protein 2,1557,147,1.06 [0.87-1.28],0.5857993105432009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCA2A,Guanylin,1846,187,2.05 [1.55-2.71],3.89905702211276e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUCY2C,Heat-stable enterotoxin receptor,1574,146,0.96 [0.79-1.17],0.6921457588027642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUK1,Guanylate kinase,1541,149,0.92 [0.57-1.46],0.7123392897584058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GUSB,Beta-glucuronidase,1859,190,0.86 [0.72-1.03],0.1029859738489349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GYS1,"Glycogen [starch] synthase, muscle",1814,185,0.96 [0.83-1.11],0.5831722751715083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMA,Granzyme A,1864,187,1.09 [0.76-1.56],0.6385314614356669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMB,Granzyme B,1840,187,0.96 [0.77-1.18],0.6813123218979324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,GZMH,Granzyme H,1814,185,1.05 [0.88-1.26],0.605125807095581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,H2AP,Huntingtin-interacting protein M,1538,145,0.81 [0.53-1.23],0.3223952358611431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",1541,149,1.09 [0.87-1.35],0.45975670111442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",1859,189,1.12 [0.95-1.32],0.1738312932882318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAO1,Hydroxyacid oxidase 1,1867,190,0.93 [0.85-1.02],0.1346679119379656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HARS1,"Histidine--tRNA ligase, cytoplasmic",1855,188,1.14 [0.96-1.35],0.130127445656094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR1,Hepatitis A virus cellular receptor 1,1864,189,1.67 [1.44-1.93],5.136437664467865e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HAVCR2,Hepatitis A virus cellular receptor 2,1855,188,1.96 [1.42-2.70],4.1550769353973074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBEGF,Proheparin-binding EGF-like growth factor,1859,189,1.05 [0.88-1.25],0.6085130752269645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBQ1,Hemoglobin subunit theta-1,1867,190,1.00 [0.82-1.23],0.9763516017018308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HBZ,Hemoglobin subunit zeta,1596,150,0.89 [0.76-1.03],0.1250458006779391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCG22,Protein PBMUCL2,1541,149,1.03 [0.76-1.39],0.8505032720731871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HCLS1,Hematopoietic lineage cell-specific protein,1864,187,1.14 [0.90-1.45],0.2796893219616384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC8,Histone deacetylase 8,1548,150,0.91 [0.67-1.24],0.547299597073312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDAC9,Histone deacetylase 9,1537,150,1.02 [0.79-1.33],0.8749616131965217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDDC2,5'-deoxynucleotidase HDDC2,1581,150,1.26 [0.92-1.73],0.150717450991619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGF,Hepatoma-derived growth factor,1865,190,1.14 [1.00-1.30],0.0578673884812529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HDGFL2,Hepatoma-derived growth factor-related protein 2,1592,150,1.03 [0.81-1.31],0.8036347349828133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEBP1,Heme-binding protein 1,1814,185,1.12 [0.88-1.42],0.3655561639223669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEG1,Protein HEG homolog 1,1570,146,1.58 [0.92-2.69],0.0948910790063571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPACAM2,HEPACAM family member 2,1592,150,1.09 [0.76-1.58],0.6356866085457338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEPH,Hephaestin,1596,150,3.14 [1.83-5.37],3.1256366746584e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HEXIM1,Protein HEXIM1,1840,187,1.08 [0.92-1.27],0.3547556591101094
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGF,Hepatocyte growth factor,1864,187,1.09 [0.77-1.54],0.6162993080546044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGFAC,Hepatocyte growth factor activator,1595,152,1.71 [0.99-2.95],0.0532461122798579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,1798,185,1.12 [0.95-1.32],0.1931780243806938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HHEX,Hematopoietically-expressed homeobox protein HHEX,1592,150,1.13 [0.92-1.40],0.2487220722923324
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIF1A,Hypoxia-inducible factor 1-alpha,1548,150,0.98 [0.76-1.26],0.8672840282103007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1,Huntingtin-interacting protein 1,1541,149,1.07 [0.68-1.68],0.780134057434174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HIP1R,Huntingtin-interacting protein 1-related protein,1590,150,1.21 [0.95-1.55],0.1229439692155636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HJV,Hemojuvelin,1601,151,1.14 [0.87-1.50],0.3502835635252072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HK2,Hexokinase-2,1814,185,0.83 [0.51-1.33],0.4286808867014928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1601,151,1.89 [1.17-3.06],0.0091481619831377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",1836,186,1.25 [0.90-1.75],0.1811028550520398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1840,187,2.79 [1.97-3.96],8.543608472081856e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMBS,Porphobilinogen deaminase,1867,190,1.08 [0.82-1.41],0.5930250544086726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMCN2,Hemicentin-2,1566,146,1.15 [0.88-1.51],0.3140026133601599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",1562,150,1.14 [0.86-1.50],0.3537401529879136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",1541,149,1.26 [0.98-1.63],0.0759283335692441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMMR,Hyaluronan mediated motility receptor,1535,144,0.97 [0.70-1.35],0.8643105243632113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX1,Heme oxygenase 1,1837,187,0.79 [0.61-1.03],0.0836794077930896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HMOX2,Heme oxygenase 2,1788,185,1.29 [1.00-1.65],0.0459291648655222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNF1A,Hepatocyte nuclear factor 1-alpha,1557,147,0.99 [0.81-1.22],0.9269558200655964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNMT,Histamine N-methyltransferase,1824,185,1.14 [0.90-1.45],0.2827650273759543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,1810,185,1.14 [0.97-1.34],0.114881631226812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,1601,151,1.19 [0.88-1.60],0.2558027655119671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPCAL1,Hippocalcin-like protein 1,1864,187,1.07 [0.90-1.28],0.4341489334974518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPGDS,Hematopoietic prostaglandin D synthase,1798,185,1.12 [0.81-1.56],0.4880620384510044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HPSE,Heparanase,1585,150,1.01 [0.85-1.19],0.9443444629660512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRAS,GTPase Hras,1570,146,0.87 [0.71-1.06],0.1635969032356553
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,1562,150,1.46 [1.12-1.91],0.0055298172710727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HRG,Histidine-rich glycoprotein,1601,152,1.50 [0.95-2.37],0.0802820570893127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS1BP3,HCLS1-binding protein 3,1562,150,1.12 [0.94-1.34],0.2090013099926922
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,1849,189,1.31 [0.95-1.81],0.0971698110086341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,1867,190,1.02 [0.73-1.42],0.9061288266350948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,1548,150,1.25 [0.80-1.96],0.3353010173072039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSBP1,Heat shock factor-binding protein 1,1562,150,1.21 [1.03-1.44],0.0224937862095273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,1840,187,0.79 [0.58-1.06],0.1092990490385209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,1592,150,1.15 [0.91-1.44],0.2373028445820813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSD17B3,Testosterone 17-beta-dehydrogenase 3,1541,149,1.26 [0.99-1.61],0.0562135474701502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,1562,150,0.98 [0.71-1.35],0.89447206517568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSP90B1,Endoplasmin,1784,184,1.03 [0.84-1.25],0.7943682048655719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA1A,Heat shock 70 kDa protein 1A,1850,185,1.18 [0.99-1.40],0.0586932486606131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPA2,Heat shock-related 70 kDa protein 2,1593,150,1.47 [1.05-2.07],0.0255144045650956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB1,Heat shock protein beta-1,1819,184,1.01 [0.83-1.23],0.929335752134962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPB6,Heat shock protein beta-6,1867,190,1.68 [1.26-2.24],0.0004350316991171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1840,185,1.96 [1.36-2.83],0.0002945862144337
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1A,5-hydroxytryptamine receptor 1A,1537,150,1.05 [0.86-1.28],0.629581658236172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTR1B,5-hydroxytryptamine receptor 1B,1537,150,1.46 [1.07-2.01],0.0181751806182546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HTRA2,"Serine protease HTRA2, mitochondrial",1855,187,1.07 [0.87-1.32],0.5022195850228026
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYAL1,Hyaluronidase-1,1835,186,1.35 [0.80-2.28],0.2682384355512395
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,HYOU1,Hypoxia up-regulated protein 1,1869,190,1.97 [1.17-3.30],0.0106872848859458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICA1,Islet cell autoantigen 1,1801,185,1.10 [0.94-1.29],0.2535917936324217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM1,Intercellular adhesion molecule 1,1845,186,1.11 [0.74-1.67],0.5979758410320044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM2,Intercellular adhesion molecule 2,1869,190,1.53 [1.03-2.28],0.0349058440776845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM3,Intercellular adhesion molecule 3,1869,190,1.25 [0.79-1.97],0.3389850246757892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM4,Intercellular adhesion molecule 4,1840,187,0.99 [0.78-1.27],0.9534757169569268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICAM5,Intercellular adhesion molecule 5,1850,189,1.19 [0.91-1.57],0.2097995091911878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ICOSLG,ICOS ligand,1849,189,1.25 [0.67-2.34],0.4860455190795514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ID4,DNA-binding protein inhibitor ID-4,1574,146,1.03 [0.73-1.46],0.8703728748446926
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,1788,185,0.96 [0.73-1.27],0.7929293718271506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDO1,"Indoleamine 2,3-dioxygenase 1",1562,150,1.07 [0.84-1.36],0.5836524516623267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDS,Iduronate 2-sulfatase,1864,187,0.58 [0.15-2.29],0.4359366875858508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IDUA,Alpha-L-iduronidase,1867,190,1.15 [0.87-1.52],0.3202357785505782
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,1543,146,1.46 [0.99-2.15],0.0583014681587534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,1574,146,0.93 [0.68-1.27],0.6440601815638427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,1574,146,1.01 [0.68-1.49],0.9790429940533604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNAR1,Interferon alpha/beta receptor 1,1581,150,0.73 [0.39-1.37],0.3257349213384138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNG,Interferon gamma,1801,185,1.05 [0.93-1.18],0.4367536648326384
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR1,Interferon gamma receptor 1,1853,187,2.40 [1.41-4.09],0.0012825252750017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNGR2,Interferon gamma receptor 2,1832,185,0.97 [0.77-1.23],0.829724817459777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL1,Interferon lambda-1,1788,185,1.10 [0.84-1.43],0.4899251746915343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNL2,Interferon lambda-2,1537,150,1.12 [0.91-1.38],0.2825444798957075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNLR1,Interferon lambda receptor 1,1840,187,1.39 [0.98-1.98],0.0659635108366667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFNW1,Interferon omega-1,1541,149,1.13 [0.78-1.64],0.50763552303581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IFT20,Intraflagellar transport protein 20 homolog,1557,147,1.32 [0.95-1.85],0.1024638593526765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGBP1,Immunoglobulin-binding protein 1,1601,151,1.15 [0.90-1.47],0.2554319443180332
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,1537,150,1.29 [0.98-1.69],0.066415840295378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,1604,153,1.59 [0.92-2.73],0.0943370154333164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF1R,Insulin-like growth factor 1 receptor,1849,189,2.99 [1.70-5.24],0.0001321883979491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,1541,149,1.16 [0.83-1.61],0.3829327878026087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGF2R,Cation-independent mannose-6-phosphate receptor,1855,188,1.98 [1.16-3.38],0.0122747420378097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP1,Insulin-like growth factor-binding protein 1,1867,190,1.13 [1.02-1.26],0.0196406070090393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP2,Insulin-like growth factor-binding protein 2,1867,190,1.49 [1.26-1.76],2.874051865449776e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP3,Insulin-like growth factor-binding protein 3,1858,188,0.63 [0.46-0.85],0.0024023234504207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP4,Insulin-like growth factor-binding protein 4,1829,185,1.82 [1.49-2.23],8.459378333133776e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP6,Insulin-like growth factor-binding protein 6,1849,187,1.81 [1.31-2.50],0.0002973932677671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBP7,Insulin-like growth factor-binding protein 7,1869,190,1.34 [0.95-1.90],0.098108638949569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1850,189,1.24 [0.92-1.67],0.1574167129225365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGFL4,Insulin growth factor-like family member 4,1548,150,1.10 [0.92-1.31],0.3113177430152671
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGHMBP2,DNA-binding protein SMUBP-2,1541,149,1.36 [1.06-1.74],0.0156271063251544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLC2,Immunoglobulin lambda constant 2,1601,150,2.15 [1.34-3.45],0.00147175605691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGLON5,IgLON family member 5,1538,145,0.99 [0.84-1.18],0.9531108567785536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF21,Immunoglobulin superfamily member 21,1562,150,0.61 [0.39-0.97],0.0386086488167209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF3,Immunoglobulin superfamily member 3,1849,189,1.25 [0.94-1.65],0.1262716304496439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF8,Immunoglobulin superfamily member 8,1850,189,1.99 [1.35-2.93],0.000552683124943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IGSF9,Protein turtle homolog A,1596,150,0.94 [0.80-1.10],0.4652974100036864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKBKG,NF-kappa-B essential modulator,1840,187,1.04 [0.90-1.20],0.6383340423909287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IKZF2,Zinc finger protein Helios,1798,185,0.95 [0.81-1.11],0.516283134753294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10,Interleukin-10,1801,185,1.23 [1.10-1.37],0.0003769179377447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RA,Interleukin-10 receptor subunit alpha,1801,185,1.04 [0.83-1.29],0.747007155951286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL10RB,Interleukin-10 receptor subunit beta,1853,187,1.92 [1.34-2.75],0.0003529669227231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL11,Interleukin-11,1801,185,1.14 [0.95-1.36],0.1579603975336188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12A_IL12B,Interleukin-12,1849,189,1.30 [1.12-1.50],0.0004892656998456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12B,Interleukin-12 subunit beta,1864,187,1.44 [1.16-1.80],0.0011315565467398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB1,Interleukin-12 receptor subunit beta-1,1801,185,1.46 [1.05-2.03],0.0232037472861158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL12RB2,Interleukin-12 receptor subunit beta-2,1548,150,1.28 [0.89-1.86],0.1862393249805449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13,Interleukin-13,1801,185,0.96 [0.75-1.23],0.7621791603098831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA1,Interleukin-13 receptor subunit alpha-1,1830,185,1.27 [0.70-2.32],0.4361769850565722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL13RA2,Interleukin-13 receptor subunit alpha-2,1537,150,1.40 [0.79-2.49],0.2551635458454865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15,Interleukin-15,1840,187,1.49 [1.08-2.04],0.0136042781786342
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL15RA,Interleukin-15 receptor subunit alpha,1801,185,1.95 [1.37-2.76],0.0001994477740669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL16,Pro-interleukin-16,1864,187,1.30 [1.00-1.67],0.0476134005227086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17A,Interleukin-17A,1798,185,1.16 [0.89-1.50],0.2778797883569059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17C,Interleukin-17C,1801,185,1.41 [1.23-1.60],3.3964063490100055e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17D,Interleukin-17D,1801,185,1.15 [0.84-1.56],0.3854435484462567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17F,Interleukin-17F,1801,185,1.12 [0.97-1.30],0.1362745838962018
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RA,Interleukin-17 receptor A,1855,188,1.45 [1.10-1.91],0.0083103379660954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL17RB,Interleukin-17 receptor B,1817,185,1.33 [1.05-1.68],0.0161409174945764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18,Interleukin-18,1837,185,1.49 [1.15-1.93],0.0023142675051802
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18BP,Interleukin-18-binding protein,1858,188,2.12 [1.50-2.99],1.835955186905718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18R1,Interleukin-18 receptor 1,1864,187,1.49 [1.07-2.09],0.0192089055579392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL18RAP,Interleukin-18 receptor accessory protein,1815,185,0.96 [0.89-1.04],0.3350625322010051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL19,Interleukin-19,1808,183,1.29 [1.10-1.52],0.0020208156642761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1A,Interleukin-1 alpha,1801,185,0.98 [0.77-1.24],0.843014265593636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1B,Interleukin-1 beta,1793,183,1.13 [0.91-1.40],0.2706982050226731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R1,Interleukin-1 receptor type 1,1854,188,3.87 [2.49-6.02],1.7431723628387795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1R2,Interleukin-1 receptor type 2,1839,187,0.93 [0.53-1.64],0.8009718185626706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RAP,Interleukin-1 receptor accessory protein,1855,188,1.14 [0.85-1.52],0.3956139297773113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL1,Interleukin-1 receptor-like 1,1864,190,1.66 [1.28-2.16],0.0001306241380093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RL2,Interleukin-1 receptor-like 2,1801,185,0.96 [0.69-1.33],0.8054505852425947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL1RN,Interleukin-1 receptor antagonist protein,1842,185,1.20 [1.00-1.43],0.0515889575859321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2,Interleukin-2,1801,185,0.79 [0.52-1.21],0.2740657819381155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20,Interleukin-20,1801,185,0.92 [0.71-1.20],0.5486900203152988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RA,Interleukin-20 receptor subunit alpha,1801,185,1.11 [0.86-1.45],0.4203788990108767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL20RB,Interleukin-20 receptor subunit beta,1548,150,1.12 [0.77-1.62],0.5478655525615523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL21R,Interleukin-21 receptor,1548,150,0.87 [0.62-1.21],0.4097890534859091
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22,Interleukin-22,1593,150,1.29 [1.04-1.59],0.019598982883807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL22RA1,Interleukin-22 receptor subunit alpha-1,1801,185,1.29 [0.97-1.72],0.0849246371496005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL24,Interleukin-24,1801,185,1.13 [0.91-1.42],0.272753436316713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL25,Interleukin-25,1534,145,1.38 [0.89-2.14],0.1466641645030477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RA,Interleukin-2 receptor subunit alpha,1840,187,1.70 [1.28-2.25],0.0002055091119668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RB,Interleukin-2 receptor subunit beta,1801,185,1.11 [0.86-1.43],0.4358492352698779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL2RG,Cytokine receptor common subunit gamma,1593,150,1.02 [0.72-1.45],0.9040579312529768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3,Interleukin-3,1538,145,0.96 [0.74-1.25],0.7456967137736508
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31,Interleukin-31,1548,150,0.74 [0.53-1.04],0.0794881010098237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL31RA,Interleukin-31 receptor subunit alpha,1540,148,0.93 [0.62-1.40],0.7373542035254225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL32,Interleukin-32,1840,187,0.99 [0.77-1.27],0.9445883567841942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL33,Interleukin-33,1801,185,1.20 [0.86-1.69],0.2845824184227928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL34,Interleukin-34,1787,185,1.22 [0.84-1.77],0.3044511785594213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36A,Interleukin-36 alpha,1548,150,1.04 [0.83-1.30],0.7388269318771437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL36G,Interleukin-36 gamma,1547,150,1.01 [0.81-1.26],0.9213214021900124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL3RA,Interleukin-3 receptor subunit alpha,1801,185,1.09 [0.73-1.61],0.6822999387775373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4,Interleukin-4,1801,185,1.07 [0.93-1.23],0.3323586927083731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL4R,Interleukin-4 receptor subunit alpha,1840,187,1.40 [1.03-1.90],0.0305587145561964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5,Interleukin-5,1801,185,0.99 [0.90-1.08],0.7972520132269829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL5RA,Interleukin-5 receptor subunit alpha,1840,187,1.14 [0.92-1.41],0.2374226260005995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6,Interleukin-6,1849,189,0.98 [0.82-1.16],0.8048427134589081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6R,Interleukin-6 receptor subunit alpha,1842,185,1.57 [1.08-2.26],0.0171400651806876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL6ST,Interleukin-6 receptor subunit beta,1850,189,1.74 [0.88-3.46],0.1136972895908054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7,Interleukin-7,1840,187,1.01 [0.82-1.24],0.9053533669512434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL7R,Interleukin-7 receptor subunit alpha,1855,188,1.00 [0.78-1.28],0.9787378728688336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IL9,Interleukin-9,1574,146,1.33 [1.07-1.66],0.0110303625272832
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,1784,185,1.24 [1.01-1.51],0.0362223864340355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMMT,MICOS complex subunit MIC60,1593,150,1.43 [1.11-1.86],0.0064464722851829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPA1,Inositol monophosphatase 1,1832,185,1.08 [0.87-1.33],0.4939664133374281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPACT,Protein IMPACT,1592,150,1.17 [0.89-1.53],0.2687454192692229
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IMPG1,Interphotoreceptor matrix proteoglycan 1,1537,150,1.62 [1.09-2.42],0.0167768483205664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ING1,Inhibitor of growth protein 1,1784,185,1.27 [0.98-1.66],0.0746528070451712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBB,Inhibin beta B chain,1570,146,1.43 [1.11-1.84],0.0055298128538659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INHBC,Inhibin beta C chain,1855,188,0.92 [0.67-1.26],0.6149848899263595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP1,Inositol polyphosphate 1-phosphatase,1849,189,1.20 [0.96-1.51],0.1108042518643916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",1562,150,1.27 [0.97-1.66],0.0821224780230116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1601,151,1.77 [1.32-2.38],0.0001517196563087
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",1849,189,1.10 [0.96-1.25],0.1700721100233962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL3,Insulin-like 3,1592,150,0.79 [0.63-1.00],0.0522583160384855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL4,Early placenta insulin-like peptide,1593,150,1.31 [1.04-1.65],0.0200960120062444
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSL5,Insulin-like peptide INSL5,1581,150,1.14 [0.98-1.32],0.0860382437789352
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,INSR,Insulin receptor,1548,150,0.77 [0.31-1.91],0.5790765377543504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IPCEF1,Interactor protein for cytohesin exchange factors 1,1829,185,1.09 [0.94-1.27],0.2448443603535254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IQGAP2,Ras GTPase-activating-like protein IQGAP2,1849,189,1.19 [0.95-1.49],0.1309129161554063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",1814,185,1.03 [0.89-1.19],0.7054678839870264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK1,Interleukin-1 receptor-associated kinase 1,1801,185,1.23 [1.03-1.48],0.0250107964131201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IRAK4,Interleukin-1 receptor-associated kinase 4,1840,187,1.08 [0.95-1.22],0.255497954679139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,1759,181,1.14 [0.82-1.59],0.4446794100454918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM1,Isthmin-1,1840,187,0.93 [0.68-1.28],0.6574225692083415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ISM2,Isthmin-2,1604,153,0.93 [0.63-1.36],0.6939024092114299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IST1,IST1 homolog,1569,150,1.11 [0.95-1.30],0.2020993157103014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA11,Integrin alpha-11,1840,187,0.89 [0.63-1.26],0.507827232648228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA2,Integrin alpha-2,1570,146,1.21 [0.77-1.91],0.4003558330381757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA5,Integrin alpha-5,1855,188,1.04 [0.66-1.64],0.8729817389193327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGA6,Integrin alpha-6,1840,187,0.89 [0.70-1.14],0.3654460525433314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAL,Integrin alpha-L,1548,150,1.01 [0.72-1.42],0.9521390930441316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAM,Integrin alpha-M,1855,188,1.65 [1.14-2.40],0.0080675901754347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAV,Integrin alpha-V,1867,190,0.52 [0.25-1.06],0.0699120783650426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGAX,Integrin alpha-X,1574,146,1.26 [0.98-1.62],0.0715707069460489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1,Integrin beta-1,1849,188,1.04 [0.60-1.80],0.8935533019739447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP1,Integrin beta-1-binding protein 1,1798,185,0.99 [0.73-1.35],0.9685273026851728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB1BP2,Integrin beta-1-binding protein 2,1814,185,1.11 [0.98-1.25],0.089117168879483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB2,Integrin beta-2,1835,190,1.68 [1.13-2.50],0.0100410393842255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB5,Integrin beta-5,1855,187,1.20 [0.89-1.62],0.2264665474163085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB6,Integrin beta-6,1801,185,1.88 [1.23-2.88],0.0038083953602414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGB7,Integrin beta-7,1867,190,1.41 [1.09-1.83],0.0088787372910127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITGBL1,Integrin beta-like protein 1,1604,153,1.25 [0.94-1.65],0.1199671174193307
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,1608,152,1.53 [0.74-3.16],0.2461862835155017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1858,188,1.90 [1.36-2.65],0.0001566912694623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,1608,152,1.00 [0.58-1.72],0.9973608878446673
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,1593,150,0.92 [0.64-1.33],0.6583028686354258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITM2A,Integral membrane protein 2A,1840,187,1.06 [0.86-1.32],0.5837491965422458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPA,Inosine triphosphate pyrophosphatase,1541,149,1.01 [0.81-1.26],0.9481358899975424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",1562,150,1.12 [0.90-1.40],0.3175958581723485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",1537,150,0.95 [0.67-1.36],0.7826679345122982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",1788,185,1.14 [0.90-1.46],0.2831217702083562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,IZUMO1,Izumo sperm-egg fusion protein 1,1538,145,0.92 [0.65-1.30],0.6313650458335746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM2,Junctional adhesion molecule B,1863,188,2.72 [1.89-3.92],8.054276954368966e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JAM3,Junctional adhesion molecule C,1570,146,1.37 [1.04-1.80],0.0272978339449228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JCHAIN,Immunoglobulin J chain,1801,185,1.22 [0.98-1.50],0.0719056593841992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,1538,145,1.25 [0.96-1.63],0.0911077965322013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JPT2,Jupiter microtubule associated homolog 2,1581,150,1.17 [0.98-1.41],0.0874480452947607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,JUN,Transcription factor AP-1,1801,185,1.09 [0.86-1.38],0.4896227205309081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,1849,189,1.29 [0.97-1.73],0.082764603087419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KAZN,Kazrin,1581,150,1.09 [0.93-1.26],0.2916309952724699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNC4,Potassium voltage-gated channel subfamily C member 4,1537,150,0.96 [0.71-1.29],0.7845037737618803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNH2,Potassium voltage-gated channel subfamily H member 2,1557,147,1.03 [0.84-1.27],0.7628085277546792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCNIP4,Kv channel-interacting protein 4,1788,185,1.28 [1.05-1.57],0.0168246753173674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KCTD5,BTB/POZ domain-containing protein KCTD5,1562,145,1.12 [0.80-1.55],0.5091114416715139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDM3A,Lysine-specific demethylase 3A,1548,150,0.96 [0.79-1.16],0.6439533246748236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KDR,Vascular endothelial growth factor receptor 2,1855,187,0.95 [0.56-1.61],0.8353792105607877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KEL,Kell blood group glycoprotein,1788,185,0.97 [0.68-1.38],0.8602676979791954
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHDC3L,KH domain-containing protein 3,1538,145,1.28 [1.08-1.52],0.0044096796856952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KHK,Ketohexokinase,1562,150,0.87 [0.69-1.09],0.2132095972016636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA0319,Dyslexia-associated protein KIAA0319,1592,150,1.64 [1.05-2.55],0.0285695067030858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549,UPF0606 protein KIAA1549,1574,146,1.03 [0.85-1.26],0.761441612469423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA1549L,UPF0606 protein KIAA1549L,1574,146,0.94 [0.54-1.66],0.8429535667761325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIAA2013,Uncharacterized protein KIAA2013,1593,150,0.89 [0.63-1.26],0.5088148053280545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF1C,Kinesin-like protein KIF1C,1541,149,1.57 [1.10-2.23],0.0123462635602247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF20B,Kinesin-like protein KIF20B,1537,150,1.12 [0.93-1.34],0.2214662412610246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIF22,Kinesin-like protein KIF22,1541,149,1.06 [0.92-1.21],0.4395720363045848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIFBP,KIF-binding protein,1849,189,1.09 [0.93-1.28],0.2771594416560456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,1593,150,1.00 [0.85-1.18],0.9925286610205284
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,1798,185,1.05 [0.90-1.23],0.5333206717683572
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,1581,150,1.03 [0.94-1.12],0.5682978714226161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,1798,185,1.09 [0.99-1.20],0.088696357622519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,1538,145,0.98 [0.81-1.19],0.8715818900837113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL1,Kin of IRRE-like protein 1,1537,150,1.36 [1.05-1.77],0.0205630752621658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIRREL2,Kin of IRRE-like protein 2,1788,185,1.14 [0.85-1.53],0.3739580287604089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KIT,Mast/stem cell growth factor receptor Kit,1857,188,0.96 [0.64-1.43],0.8328182495887495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KITLG,Kit ligand,1850,189,1.44 [1.05-1.97],0.0219222772212419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLB,Beta-klotho,1788,185,1.34 [1.13-1.59],0.0008915525333128
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLF4,Krueppel-like factor 4,1537,150,1.32 [0.86-2.00],0.2002916099988646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLHL41,Kelch-like protein 41,1601,151,1.30 [0.96-1.75],0.08673880669628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK1,Kallikrein-1,1828,183,0.95 [0.86-1.06],0.376954334747729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK10,Kallikrein-10,1848,187,1.10 [0.80-1.50],0.5720375466473044
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK11,Kallikrein-11,1832,185,1.82 [1.33-2.48],0.0001672544241092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK12,Kallikrein-12,1798,185,1.05 [0.96-1.15],0.3241668484183466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK13,Kallikrein-13,1807,185,0.93 [0.72-1.20],0.5844646259692119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK14,Kallikrein-14,1867,190,1.05 [0.80-1.37],0.7400364772968471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK15,Kallikrein-15,1592,150,1.13 [0.83-1.54],0.4332372930899869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK3,Prostate-specific antigen,1604,153,0.79 [0.60-1.03],0.0812495222378143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK4,Kallikrein-4,1867,190,1.68 [1.44-1.97],8.179687350633803e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK6,Kallikrein-6,1852,186,1.10 [0.75-1.60],0.629296840713373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK7,Kallikrein-7,1524,144,0.49 [0.32-0.76],0.0012302653915826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLK8,Kallikrein-8,1782,176,1.20 [0.85-1.69],0.2902510345026098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLKB1,Plasma kallikrein,1571,149,0.69 [0.38-1.27],0.232959347536951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1864,187,2.12 [1.61-2.79],8.06047121204535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,1537,150,1.14 [0.90-1.44],0.2900044049876372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRD1,Natural killer cells antigen CD94,1864,187,1.66 [1.28-2.17],0.0001700243390627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,1548,150,1.14 [0.88-1.48],0.3139873345659777
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KLRK1,NKG2-D type II integral membrane protein,1592,150,1.55 [1.08-2.22],0.0162246455448327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT14,"Keratin, type I cytoskeletal 14",1730,178,1.09 [0.69-1.73],0.7021970939023485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT17,"Keratin, type I cytoskeletal 17",1541,149,1.21 [0.81-1.80],0.3438004923695719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT18,"Keratin, type I cytoskeletal 18",1849,189,1.03 [0.91-1.17],0.6278409131822488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT19,"Keratin, type I cytoskeletal 19",1834,186,1.50 [1.29-1.75],1.3646260553144882e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT5,"Keratin, type II cytoskeletal 5",1788,185,0.85 [0.65-1.12],0.2531522224779982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT6C,"Keratin, type II cytoskeletal 6C",1541,149,1.11 [0.78-1.58],0.5566781478761618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KRT8,"Keratin, type II cytoskeletal 8",1537,150,1.05 [0.94-1.18],0.3503401693126927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYAT1,Kynurenine--oxoglutarate transaminase 1,1847,189,1.14 [0.91-1.42],0.2470177583822227
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,KYNU,Kynureninase,1864,187,0.76 [0.59-0.97],0.0310150294480195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L1CAM,Neural cell adhesion molecule L1,1855,187,0.89 [0.59-1.35],0.58991328838887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,1596,150,1.08 [0.91-1.29],0.3654696807668424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACRT,Extracellular glycoprotein lacritin,1589,149,0.90 [0.65-1.25],0.5432393485413638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LACTB2,Endoribonuclease LACTB2,1850,189,1.15 [0.95-1.40],0.1554431159989292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAG3,Lymphocyte activation gene 3 protein,1849,189,1.64 [1.27-2.13],0.0001912164498002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1841,187,1.60 [1.30-1.96],7.698368467608e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,1832,185,0.99 [0.88-1.12],0.8662825598341584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA1,Laminin subunit alpha-1,1541,149,0.80 [0.56-1.15],0.2277799794690047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMA4,Laminin subunit alpha-4,1853,187,1.14 [0.79-1.64],0.4838512309467772
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMB1,Laminin subunit beta-1,1562,150,1.52 [0.92-2.52],0.1011551482603685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP1,Lysosome-associated membrane glycoprotein 1,1559,150,1.22 [0.71-2.09],0.4644036305010951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP2,Lysosome-associated membrane glycoprotein 2,1798,180,0.61 [0.30-1.23],0.167946701058168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMP3,Lysosome-associated membrane glycoprotein 3,1862,187,1.18 [0.93-1.50],0.1630902259563808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAMTOR5,Ragulator complex protein LAMTOR5,1593,150,0.77 [0.50-1.17],0.2221156151646147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAP3,Cytosol aminopeptidase,1801,185,0.95 [0.71-1.27],0.7133284768070183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LARP1,La-related protein 1,1593,150,0.97 [0.75-1.26],0.8141178606962205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT,Linker for activation of T-cells family member 1,1864,187,1.03 [0.87-1.23],0.705525153206468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAT2,Linker for activation of T-cells family member 2,1849,189,1.07 [0.97-1.18],0.1805115942597919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LATS1,Serine/threonine-protein kinase LATS1,1548,150,1.11 [0.92-1.34],0.2817560206196779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LAYN,Layilin,1828,185,2.68 [2.06-3.48],1.4527020763950284e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBP,Lipopolysaccharide-binding protein,1858,188,1.03 [0.83-1.28],0.7881557993140884
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LBR,Delta(14)-sterol reductase LBR,1863,188,1.21 [1.04-1.42],0.0156677098253245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCAT,Phosphatidylcholine-sterol acyltransferase,1606,152,1.17 [0.58-2.36],0.6635337828066779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN15,Lipocalin-15,1601,151,1.41 [1.17-1.69],0.0002695938328021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCN2,Neutrophil gelatinase-associated lipocalin,1800,186,1.35 [1.02-1.80],0.0388041759809644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LCP1,Plastin-2,1604,153,1.12 [0.81-1.53],0.4998311381202861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLR,Low-density lipoprotein receptor,1849,186,0.84 [0.65-1.07],0.1513599983804699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LDLRAP1,Low density lipoprotein receptor adapter protein 1,1601,151,1.08 [0.92-1.26],0.3381952217528276
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LECT2,Leukocyte cell-derived chemotaxin-2,1596,150,0.93 [0.74-1.17],0.5396809601452326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEFTY2,Left-right determination factor 2,1862,190,1.35 [1.06-1.72],0.014947084370115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEG1,Protein LEG1 homolog,1519,142,0.95 [0.76-1.19],0.677630761811902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LELP1,Late cornified envelope-like proline-rich protein 1,1537,150,0.97 [0.78-1.22],0.8208254932341644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEO1,RNA polymerase-associated protein LEO1,1601,151,1.16 [0.80-1.69],0.4283429176082155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEP,Leptin,1850,189,0.78 [0.63-0.96],0.0214677455304417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LEPR,Leptin receptor,1850,189,2.35 [1.62-3.41],6.603001346973903e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LETM1,Mitochondrial proton/calcium exchanger protein,1601,151,1.39 [1.07-1.80],0.0136744698910449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS1,Galectin-1,1850,189,1.90 [1.35-2.67],0.0002313791052942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3,Galectin-3,1847,188,1.87 [1.24-2.83],0.0028816885771973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS3BP,Galectin-3-binding protein,1608,152,1.03 [0.65-1.64],0.887439950746103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS4,Galectin-4,1841,187,1.87 [1.54-2.27],2.3391568465069415e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS7_LGALS7B,Galectin-7,1851,187,1.16 [0.87-1.55],0.3164058717721252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS8,Galectin-8,1863,188,1.17 [0.95-1.44],0.1485608250861034
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGALS9,Galectin-9,1843,187,1.68 [1.17-2.41],0.004771330440606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LGMN,Legumain,1853,187,1.39 [0.98-1.96],0.0658429757192597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHB,Lutropin subunit beta,1798,185,1.22 [1.05-1.41],0.00810944087207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,1847,185,1.21 [1.01-1.47],0.0434350466159676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIF,Leukemia inhibitory factor,1788,185,1.07 [0.81-1.40],0.6377539201323796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIFR,Leukemia inhibitory factor receptor,1840,187,3.07 [2.04-4.61],7.06670020323793e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,1855,188,0.99 [0.71-1.38],0.9740398579122992
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,1604,153,1.04 [0.93-1.17],0.4958857833227478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,1541,149,1.13 [0.88-1.45],0.3484511599260645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,1850,189,1.35 [0.91-2.00],0.1406665239678309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,1596,150,1.09 [0.89-1.33],0.3878796938682644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,1869,190,0.96 [0.62-1.48],0.839814182583309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,1862,190,1.06 [0.74-1.51],0.7454142851142587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,1801,185,1.33 [1.02-1.74],0.0330108867304516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,1869,190,0.97 [0.81-1.17],0.762277409641994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LIPF,Gastric triacylglycerol lipase,1562,150,0.89 [0.70-1.13],0.3305373479808506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB1,Lamin-B1,1577,150,0.93 [0.74-1.18],0.5659026639709106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMNB2,Lamin-B2,1592,150,1.82 [1.10-3.03],0.0206819762741912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD1,Leiomodin-1,1601,151,1.95 [1.35-2.81],0.0003285831462233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LMOD2,Leiomodin-2,1537,150,1.16 [0.92-1.47],0.2039853490120163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LONP1,"Lon protease homolog, mitochondrial",1562,150,1.14 [0.95-1.36],0.1525415928939083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPA,Apolipoprotein(a),1556,147,1.20 [1.09-1.32],0.0001424343122757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPCAT2,Lysophosphatidylcholine acyltransferase 2,1849,189,1.16 [0.94-1.44],0.1720801584814467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPL,Lipoprotein lipase,1850,189,0.89 [0.68-1.14],0.3533673134693181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPO,Lactoperoxidase,1787,181,1.40 [1.16-1.69],0.0004515413796972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LPP,Lipoma-preferred partner,1541,149,1.24 [0.98-1.56],0.0673451738097104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,1541,149,1.19 [0.94-1.50],0.1433470566647694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,1557,147,1.29 [0.99-1.68],0.0605795508482545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRG1,Leucine-rich alpha-2-glycoprotein,1608,152,1.69 [0.96-2.99],0.069581988656409
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1859,189,1.66 [1.16-2.38],0.0058546541909613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1542,148,1.44 [0.97-2.14],0.0722256890211973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,1849,189,0.94 [0.58-1.52],0.7962621491806012
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP11,Low-density lipoprotein receptor-related protein 11,1850,189,1.72 [1.28-2.31],0.0003347686500124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2,Low-density lipoprotein receptor-related protein 2,1557,147,1.51 [1.04-2.19],0.0293794137554146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRP2BP,LRP2-binding protein,1557,147,1.14 [0.97-1.33],0.1056528808350698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,1863,188,0.95 [0.76-1.20],0.6814640542967193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC25,Leucine-rich repeat-containing protein 25,1849,189,1.10 [0.80-1.53],0.5508351385298085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC37A2,Leucine-rich repeat-containing protein 37A2,1581,150,1.14 [0.80-1.64],0.4720602685181013
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC38,Leucine-rich repeat-containing protein 38,1557,147,1.28 [0.96-1.72],0.0969942916995854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRC59,Leucine-rich repeat-containing protein 59,1596,150,1.15 [0.85-1.56],0.3576865817603556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,1593,150,1.01 [0.74-1.38],0.9471591129014976
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRRN1,Leucine-rich repeat neuronal protein 1,1801,185,0.64 [0.47-0.88],0.0054606410221559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,1557,147,1.08 [0.74-1.57],0.692867049356592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,1601,151,0.99 [0.55-1.78],0.9743947591517296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM1,U6 snRNA-associated Sm-like protein LSm1,1798,185,1.14 [0.94-1.40],0.1911946217068115
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSM8,U6 snRNA-associated Sm-like protein LSm8,1574,146,0.96 [0.80-1.14],0.6131780711486267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LSP1,Lymphocyte-specific protein 1,1840,187,1.16 [0.85-1.60],0.3464126401598644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA,Lymphotoxin-alpha,1840,187,1.12 [0.81-1.54],0.4880075020030218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTA4H,Leukotriene A-4 hydrolase,1867,190,1.09 [0.88-1.35],0.4187618693517192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTB,Lymphotoxin-beta,1593,150,0.76 [0.46-1.24],0.2723398257047636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1869,190,1.85 [1.32-2.59],0.0003141169704911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,1798,185,1.20 [0.96-1.49],0.1015808746159543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1833,185,2.36 [1.72-3.24],1.226861600065393e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LTO1,Protein LTO1 homolog,1801,185,1.22 [0.90-1.64],0.1998281387374769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LUZP2,Leucine zipper protein 2,1593,150,1.13 [0.89-1.45],0.315739515034419
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LXN,Latexin,1818,184,1.00 [0.82-1.21],0.9977493915883684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY6D,Lymphocyte antigen 6D,1832,184,1.66 [1.29-2.14],7.018508211678682e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY75,Lymphocyte antigen 75,1840,187,1.18 [0.85-1.65],0.3211372688032712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY9,T-lymphocyte surface antigen Ly-9,1826,182,1.93 [1.30-2.86],0.0010851430965279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LY96,Lymphocyte antigen 96,1832,185,1.27 [0.90-1.80],0.1744815048556102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYAR,Cell growth-regulating nucleolar protein,1798,185,1.21 [0.95-1.55],0.1273576375069381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYN,Tyrosine-protein kinase Lyn,1849,189,1.04 [0.90-1.22],0.5836836895556872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD1,Ly6/PLAUR domain-containing protein 1,1788,185,0.95 [0.74-1.22],0.6845186450970546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD3,Ly6/PLAUR domain-containing protein 3,1831,186,1.29 [0.91-1.84],0.1532960720718796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPD8,Ly6/PLAUR domain-containing protein 8,1798,185,1.32 [1.06-1.65],0.0142385208106363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYPLA2,Acyl-protein thioesterase 2,1537,150,0.97 [0.84-1.12],0.6587263660849847
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,1557,147,1.04 [0.90-1.20],0.5772228430881688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,1608,152,1.94 [0.93-4.02],0.0754334804798521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LYZL2,Lysozyme-like protein 2,1538,145,1.03 [0.65-1.61],0.9094575592469426
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,LZTFL1,Leucine zipper transcription factor-like protein 1,1570,146,1.10 [0.88-1.37],0.4165369231977964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,M6PR,Cation-dependent mannose-6-phosphate receptor,1562,150,1.02 [0.71-1.48],0.9015574117222656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,1825,185,1.26 [1.03-1.54],0.0250663448983273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAEA,E3 ubiquitin-protein transferase MAEA,1798,185,0.98 [0.70-1.38],0.9038563523892404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAG,Myelin-associated glycoprotein,1557,147,0.60 [0.43-0.84],0.0026018426217279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGEA3,Melanoma-associated antigen 3,1574,146,0.88 [0.76-1.03],0.1052846907086679
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAGED1,Melanoma-associated antigen D1,1798,185,1.08 [0.83-1.41],0.5695637878556112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC2,MAM domain-containing protein 2,1596,150,2.10 [1.47-3.01],4.845069404825026e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAMDC4,Apical endosomal glycoprotein,1593,150,1.09 [0.84-1.42],0.5193974927133238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",1562,150,1.56 [0.85-2.89],0.1529229095833187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAN2B2,Epididymis-specific alpha-mannosidase,1596,150,0.90 [0.70-1.17],0.4394594990861006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",1538,145,0.97 [0.71-1.33],0.8508788145235571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANF,Mesencephalic astrocyte-derived neurotrophic factor,1853,187,1.04 [0.92-1.16],0.5482193531821768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC1,MANSC domain-containing protein 1,1855,187,1.59 [1.05-2.39],0.0276832725425463
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MANSC4,MANSC domain-containing protein 4,1541,149,1.01 [0.80-1.28],0.9109032248842308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,1537,150,1.07 [0.65-1.77],0.7845714338001981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,1541,149,1.06 [0.86-1.31],0.582586982796125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2,Microtubule-associated protein 2,1592,150,1.24 [0.91-1.68],0.1685949899567497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,1581,150,1.24 [0.99-1.57],0.065967835807945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,1840,187,1.06 [0.93-1.20],0.4081550239737525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,1798,185,1.01 [0.88-1.16],0.8539823741950163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,1828,185,1.09 [0.97-1.23],0.1460478100399688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK13,Mitogen-activated protein kinase 13,1538,145,0.96 [0.68-1.36],0.8221047275137897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPK9,Mitogen-activated protein kinase 9,1840,187,0.94 [0.70-1.27],0.6946550984114007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPKAPK2,MAP kinase-activated protein kinase 2,1574,146,1.05 [0.85-1.31],0.6292979998728667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPRE3,Microtubule-associated protein RP/EB family member 3,1538,145,1.03 [0.92-1.15],0.651855151517577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAPT,Microtubule-associated protein tau,1788,185,1.14 [0.89-1.46],0.3078360829866408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARCO,Macrophage receptor MARCO,1850,189,1.02 [0.64-1.61],0.9394791617190102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MARS1,"Methionine--tRNA ligase, cytoplasmic",1566,146,1.04 [0.87-1.26],0.6558505113129025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MASP1,Mannan-binding lectin serine protease 1,1828,185,0.67 [0.40-1.14],0.1395584300675652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN2,Matrilin-2,1845,187,1.04 [0.70-1.56],0.8418448259445923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MATN3,Matrilin-3,1829,185,0.91 [0.61-1.35],0.6389431786153743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAVS,Mitochondrial antiviral-signaling protein,1798,185,1.12 [0.97-1.29],0.1254794274267903
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MAX,Protein max,1788,185,1.02 [0.90-1.15],0.8014664120175531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MB,Myoglobin,1869,190,1.21 [0.96-1.52],0.109165224915843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MBL2,Mannose-binding protein C,1581,148,0.98 [0.85-1.13],0.7633135418867333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCAM,Cell surface glycoprotein MUC18,1858,188,1.60 [1.15-2.22],0.0050218482978829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",1601,151,1.06 [0.72-1.56],0.7591975014806317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCEMP1,Mast cell-expressed membrane protein 1,1548,150,1.02 [0.86-1.21],0.8492486562030692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCFD2,Multiple coagulation factor deficiency protein 2,1840,187,1.36 [1.02-1.83],0.0372126515703727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MCTS1,Malignant T-cell-amplified sequence 1,1581,150,0.59 [0.30-1.16],0.1268630964106581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,1832,185,1.16 [0.98-1.38],0.0917896790029043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDH1,"Malate dehydrogenase, cytoplasmic",1599,151,1.32 [0.93-1.88],0.1207610102521687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDK,Midkine,1852,187,1.58 [1.27-1.96],3.447023706652501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MDM1,Nuclear protein MDM1,1557,147,1.93 [1.19-3.11],0.0072988943954405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",1562,150,1.11 [0.94-1.31],0.2301972430464947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED18,Mediator of RNA polymerase II transcription subunit 18,1798,185,1.16 [0.98-1.38],0.0876717630956265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MED21,Mediator of RNA polymerase II transcription subunit 21,1541,149,1.26 [0.94-1.68],0.1231755208028392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,1841,187,1.25 [0.90-1.75],0.182111053856892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,1541,149,1.15 [0.71-1.87],0.5768848110833733
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEGF9,Multiple epidermal growth factor-like domains protein 9,1864,190,0.71 [0.40-1.28],0.2519707436774706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MELTF,Melanotransferrin,1596,150,1.32 [0.83-2.10],0.2361027374300065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MENT,Protein MENT,1570,146,1.10 [0.57-2.14],0.7711168691114627
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1A,Meprin A subunit alpha,1581,150,1.18 [0.97-1.44],0.0991191960390375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEP1B,Meprin A subunit beta,1850,189,0.90 [0.81-1.00],0.0475087249586391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MEPE,Matrix extracellular phosphoglycoprotein,1841,187,0.52 [0.35-0.77],0.0010939637578367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MERTK,Tyrosine-protein kinase Mer,1864,187,1.78 [1.15-2.76],0.0098667184145331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MESD,LRP chaperone MESD,1855,188,1.06 [0.96-1.18],0.2444544775974886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MET,Hepatocyte growth factor receptor,1848,186,1.22 [0.67-2.20],0.5157503195021245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1,Methionine aminopeptidase 1,1788,185,1.02 [0.66-1.59],0.9268548486591888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",1840,187,1.04 [0.89-1.23],0.6107665146859493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,METAP2,Methionine aminopeptidase 2,1862,190,1.32 [1.04-1.68],0.0225879931243855
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3,Microfibril-associated glycoprotein 3,1814,185,0.86 [0.66-1.14],0.3029829394383176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP3L,Microfibrillar-associated protein 3-like,1557,147,1.01 [0.81-1.27],0.9110131069541504
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP4,Microfibril-associated glycoprotein 4,1570,146,1.97 [1.27-3.05],0.0025568449358614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFAP5,Microfibrillar-associated protein 5,1869,190,1.31 [0.98-1.75],0.0644843096700938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MFGE8,Lactadherin,1855,188,1.52 [1.22-1.90],0.0001796298570621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGLL,Monoglyceride lipase,1848,187,1.03 [0.89-1.20],0.6888983521939573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MGMT,Methylated-DNA--protein-cysteine methyltransferase,1840,187,1.04 [0.94-1.17],0.4404598586842362
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIA,Melanoma-derived growth regulatory protein,1855,187,1.02 [0.73-1.42],0.9128711734706132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICALL2,MICAL-like protein 2,1557,147,1.22 [0.97-1.52],0.0838233374212285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,1840,187,1.11 [1.01-1.22],0.0231180834202853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MIF,Macrophage migration inhibitory factor,1852,188,1.15 [0.95-1.40],0.1496482549333678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MILR1,Allergin-1,1801,185,1.17 [0.92-1.49],0.2025354028743434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,1593,150,1.03 [0.89-1.20],0.6552666016761417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MINK1,Misshapen-like kinase 1,1592,150,1.04 [0.88-1.23],0.6538642942987054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MITD1,MIT domain-containing protein 1,1832,185,1.07 [0.93-1.23],0.3189900563296735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MKI67,Proliferation marker protein Ki-67,1548,150,1.07 [0.73-1.57],0.7234422051954825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLLT1,Protein ENL,1538,145,1.07 [0.87-1.33],0.521374704970027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MLN,Promotilin,1840,187,1.12 [0.97-1.29],0.1362545085307318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MME,Neprilysin,1849,189,0.90 [0.78-1.05],0.1690732168741223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP1,Interstitial collagenase,1780,179,1.23 [1.06-1.42],0.0070172738891247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP10,Stromelysin-2,1842,187,1.33 [1.09-1.63],0.0058202499330224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP12,Macrophage metalloelastase,1849,186,1.65 [1.33-2.05],6.310513816368151e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP13,Collagenase 3,1788,185,1.47 [1.00-2.15],0.0478679118420394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP15,Matrix metalloproteinase-15,1596,150,0.95 [0.66-1.38],0.7957291454446949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP3,Stromelysin-1,1855,188,1.42 [1.15-1.76],0.0012511916882073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP7,Matrilysin,1812,185,1.60 [1.23-2.07],0.0003852923114083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP8,Neutrophil collagenase,1860,188,1.10 [0.93-1.29],0.2761482044175377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMP9,Matrix metalloproteinase-9,1854,188,1.12 [0.91-1.38],0.2748190051717655
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",1541,149,1.22 [0.87-1.70],0.2509893800761745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MN1,Transcriptional activator MN1,1557,147,1.15 [0.91-1.45],0.2291243544703016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNAT1,CDK-activating kinase assembly factor MAT1,1574,146,0.91 [0.63-1.33],0.6316845949203909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MNDA,Myeloid cell nuclear differentiation antigen,1847,189,0.97 [0.86-1.10],0.6868590787077583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOCS2,Molybdopterin synthase catalytic subunit,1570,146,1.04 [0.82-1.32],0.7470238705135266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MOG,Myelin-oligodendrocyte glycoprotein,1867,190,1.11 [0.79-1.56],0.5352545643245705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORC3,MORC family CW-type zinc finger protein 3,1592,150,1.32 [0.87-2.00],0.1865343714388479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L1,Mortality factor 4-like protein 1,1574,146,0.98 [0.69-1.40],0.9139497999146576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORF4L2,Mortality factor 4-like protein 2,1538,145,1.20 [0.82-1.76],0.3424229641985743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MORN4,MORN repeat-containing protein 4,1538,145,0.98 [0.81-1.19],0.8470200391939533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPHOSPH8,M-phase phosphoprotein 8,1814,185,1.17 [0.99-1.39],0.0616839316254489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPI,Mannose-6-phosphate isomerase,1849,189,1.10 [0.95-1.28],0.2015387417650024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,1848,187,0.97 [0.82-1.15],0.7240616057521688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPO,Myeloperoxidase,1855,188,0.99 [0.75-1.31],0.9608238679032496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MPRIP,Myosin phosphatase Rho-interacting protein,1588,149,0.86 [0.60-1.22],0.3987007379776075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRC1,Macrophage mannose receptor 1,1606,152,1.74 [1.09-2.77],0.0200012613711049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRI1,Methylthioribose-1-phosphate isomerase,1557,147,1.10 [0.88-1.39],0.4034192682104102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL24,"39S ribosomal protein L24, mitochondrial",1541,149,0.98 [0.66-1.45],0.917798682080836
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL28,"39S ribosomal protein L28, mitochondrial",1601,151,1.06 [0.68-1.65],0.7944708003265382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL46,"39S ribosomal protein L46, mitochondrial",1788,185,1.24 [0.83-1.86],0.2976006224832845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL52,"39S ribosomal protein L52, mitochondrial",1535,144,1.88 [1.09-3.24],0.0240099959370534
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",1601,151,1.13 [0.94-1.36],0.1821039914176593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MRPS16,"28S ribosomal protein S16, mitochondrial",1548,150,0.85 [0.47-1.54],0.5889409512824969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLN,Mesothelin,1842,187,1.16 [0.94-1.41],0.1602450695604561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSLNL,Mesothelin-like protein,1557,147,1.21 [0.78-1.88],0.3943735241447048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSMB,Beta-microseminoprotein,1843,184,1.21 [1.01-1.44],0.0375906198327098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSR1,Macrophage scavenger receptor types I and II,1863,188,1.42 [1.08-1.87],0.0117642840010678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSRA,Mitochondrial peptide methionine sulfoxide reductase,1855,187,1.10 [0.92-1.32],0.3050937372076434
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MST1,Hepatocyte growth factor-like protein,1578,151,1.12 [0.84-1.49],0.4430321997047995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MSTN,Growth/differentiation factor 8,1814,185,0.76 [0.59-0.98],0.0351616356339248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTDH,Protein LYRIC,1548,150,1.15 [0.97-1.35],0.1044730201827829
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",1592,150,1.67 [1.01-2.76],0.0441694220210137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,1574,146,1.02 [0.89-1.18],0.7291446988601371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTIF3,"Translation initiation factor IF-3, mitochondrial",1581,150,1.07 [0.90-1.27],0.4609159609666758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTPN,Myotrophin,1814,185,0.66 [0.41-1.08],0.0970028924964564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTR,Methionine synthase,1541,149,1.08 [0.89-1.32],0.4426611502405339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS1,Protein MTSS 1,1581,150,1.07 [0.93-1.23],0.3264767513553025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTSS2,Protein MTSS 2,1593,150,1.06 [0.90-1.24],0.485360236323722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MTUS1,Microtubule-associated tumor suppressor 1,1574,146,0.80 [0.60-1.07],0.1301966678819323
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC13,Mucin-13,1788,185,1.80 [1.53-2.13],4.144304828739016e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC16,Mucin-16,1849,189,1.01 [0.94-1.08],0.7441816930081318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUC2,Mucin-2,1604,153,1.15 [0.98-1.34],0.0850036379478206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MUCL3,Mucin-like protein 3,1538,145,1.04 [0.73-1.48],0.8285319328670389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MVK,Mevalonate kinase,1801,185,1.09 [0.94-1.25],0.2529697200281824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MXRA8,Matrix remodeling-associated protein 8,1570,146,0.90 [0.55-1.48],0.6865521610379756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC1,"Myosin-binding protein C, slow-type",1596,150,1.32 [1.09-1.61],0.0054326073101647
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYBPC2,"Myosin-binding protein C, fast-type",1562,150,1.14 [0.96-1.34],0.1269552744790259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,1601,151,1.00 [0.79-1.27],0.982698339893595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYDGF,Myeloid-derived growth factor,1596,150,1.06 [0.91-1.24],0.4544886887605917
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH4,Myosin-4,1541,149,1.06 [0.76-1.48],0.7367710608748212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH7B,Myosin-7B,1538,145,0.96 [0.68-1.34],0.7949388248419911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYH9,Myosin-9,1604,153,1.03 [0.90-1.18],0.6814510056396688
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",1541,149,1.12 [0.80-1.55],0.5149529703055991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL3,Myosin light chain 3,1562,150,1.21 [0.98-1.49],0.073402775077871
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL4,Myosin light chain 4,1562,150,1.41 [1.11-1.79],0.0049575708942078
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYL6B,Myosin light chain 6B,1557,147,1.05 [0.88-1.24],0.5884738065933774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1557,147,1.52 [1.16-1.99],0.0023566412520308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO6,Unconventional myosin-VI,1601,151,1.19 [0.81-1.74],0.3701272976156475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYO9B,Unconventional myosin-IXb,1801,185,1.15 [0.95-1.38],0.1429015138382411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOC,Myocilin,1855,188,1.07 [0.81-1.40],0.6438831415637706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM1,Myomesin-1,1537,150,0.87 [0.60-1.25],0.4460738179501405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM2,Myomesin-2,1541,149,1.21 [0.88-1.65],0.2457319443482724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MYOM3,Myomesin-3,1570,146,1.20 [1.01-1.42],0.0334797367306055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZB1,Marginal zone B- and B1-cell-specific protein,1850,187,1.29 [1.02-1.64],0.0370778635753208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,MZT1,Mitotic-spindle organizing protein 1,1798,185,1.01 [0.78-1.31],0.91415735399318
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA10,N-alpha-acetyltransferase 10,1541,149,1.28 [0.96-1.72],0.0963554145154566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAA80,N-alpha-acetyltransferase 80,1557,147,1.10 [0.96-1.25],0.1632913523974516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAAA,N-acylethanolamine-hydrolyzing acid amidase,1825,185,0.91 [0.72-1.14],0.3966755831674654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NACC1,Nucleus accumbens-associated protein 1,1593,150,1.02 [0.78-1.35],0.8755085065761598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NADK,NAD kinase,1850,189,1.05 [0.84-1.30],0.6722169807586492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGA,Alpha-N-acetylgalactosaminidase,1543,149,0.86 [0.62-1.21],0.3956653064717023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGK,N-acetyl-D-glucosamine kinase,1556,149,0.87 [0.66-1.14],0.3011302842109894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1570,146,2.89 [1.48-5.65],0.0018777617988843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAMPT,Nicotinamide phosphoribosyltransferase,1798,185,1.11 [0.91-1.34],0.3116776045116126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAP1L4,Nucleosome assembly protein 1-like 4,1578,149,1.38 [0.95-2.01],0.0941274993063107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NAPRT,Nicotinate phosphoribosyltransferase,1592,150,1.53 [1.05-2.24],0.0285596296950443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NARS1,"Asparagine--tRNA ligase, cytoplasmic",1601,151,1.11 [0.80-1.54],0.5484021401748042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1855,187,2.41 [1.61-3.61],1.9511587835638283e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NBN,Nibrin,1801,185,1.06 [0.83-1.35],0.6336233921225349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM1,Neural cell adhesion molecule 1,1858,188,0.99 [0.65-1.50],0.963485455626604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAM2,Neural cell adhesion molecule 2,1855,188,1.05 [0.67-1.64],0.8436084813103542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCAN,Neurocan core protein,1863,188,0.55 [0.41-0.73],4.190255872992058e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCF2,Neutrophil cytosol factor 2,1837,187,1.02 [0.89-1.18],0.766672311685564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCK2,Cytoplasmic protein NCK2,1853,187,1.07 [0.95-1.21],0.2807184105818716
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCLN,Nicalin,1801,185,0.96 [0.73-1.28],0.7934432109627491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR1,Natural cytotoxicity triggering receptor 1,1839,186,2.00 [1.48-2.71],8.196924747637387e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1581,150,2.43 [1.62-3.65],1.861585064796476e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NCS1,Neuronal calcium sensor 1,1867,190,3.06 [2.06-4.56],3.514947685698314e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDRG1,Protein NDRG1,1788,185,1.08 [0.91-1.29],0.3734461198508864
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,1593,150,1.06 [0.85-1.32],0.6238719446319964
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,1545,150,1.41 [0.93-2.16],0.1087259521982436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,1581,150,1.07 [0.90-1.27],0.4741874699297294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",1798,185,1.22 [1.07-1.40],0.0042035264583029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEB,Nebulin,1541,149,0.98 [0.61-1.57],0.9189100544097382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECAP2,Adaptin ear-binding coat-associated protein 2,1541,149,1.17 [0.94-1.46],0.1670299729093844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN1,Nectin-1,1548,150,0.97 [0.57-1.65],0.906217758074787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN2,Nectin-2,1850,189,2.64 [1.93-3.62],1.4681818508575052e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NECTIN4,Nectin-4,1855,187,1.98 [1.56-2.50],1.1142527239711124e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,1548,150,1.26 [0.90-1.76],0.1711037830137759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEDD9,Enhancer of filamentation 1,1548,150,1.20 [0.75-1.92],0.4492520243279717
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEFL,Neurofilament light polypeptide,1782,184,2.40 [1.94-2.96],6.041587397758171e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEK7,Serine/threonine-protein kinase Nek7,1574,146,0.98 [0.79-1.23],0.8928565110254085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL1,Protein kinase C-binding protein NELL1,1855,187,0.60 [0.46-0.78],0.0001075868166057
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NELL2,Protein kinase C-binding protein NELL2,1853,187,1.33 [0.88-2.00],0.1758114626440153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NENF,Neudesin,1593,150,1.01 [0.88-1.17],0.8527432384192848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEO1,Neogenin,1601,151,1.67 [0.91-3.08],0.0989745264527469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NEXN,Nexilin,1606,152,1.06 [0.86-1.32],0.5738877014253997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFASC,Neurofascin,1864,187,2.61 [1.80-3.77],3.5855778225255066e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFAT5,Nuclear factor of activated T-cells 5,1548,150,1.06 [0.88-1.27],0.545458194939911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",1840,187,1.00 [0.87-1.14],0.947873539371316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",1801,185,1.01 [0.82-1.24],0.9321076159851116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFE2,Transcription factor NF-E2 45 kDa subunit,1562,150,1.10 [0.89-1.36],0.3738599864828339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFIC,Nuclear factor 1 C-type,1601,151,1.10 [0.84-1.44],0.4924325465390776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB1,Nuclear factor NF-kappa-B p105 subunit,1541,149,1.09 [0.88-1.36],0.4358143292734175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKB2,Nuclear factor NF-kappa-B p100 subunit,1574,146,1.03 [0.78-1.37],0.8097072639882646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFKBIE,NF-kappa-B inhibitor epsilon,1798,185,1.24 [0.95-1.60],0.108091756395247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",1581,150,1.08 [0.93-1.26],0.3025404431186103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFX1,Transcriptional repressor NF-X1,1541,149,1.16 [0.95-1.41],0.1452401813688116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NFYA,Nuclear transcription factor Y subunit alpha,1541,149,1.16 [0.78-1.73],0.4732320933009046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGF,Beta-nerve growth factor,1832,185,2.20 [0.72-6.68],0.1642944217411862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGFR,Tumor necrosis factor receptor superfamily member 16,1596,150,1.69 [1.05-2.73],0.030904103094696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NGRN,Neugrin,1592,150,1.83 [0.98-3.42],0.0566588768031614
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NHLRC3,NHL repeat-containing protein 3,1524,143,1.50 [0.90-2.50],0.1170100315520152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID1,Nidogen-1,1856,187,1.00 [0.73-1.38],0.9844130108016516
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NID2,Nidogen-2,1855,188,1.01 [0.85-1.20],0.8966209108075004
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NINJ1,Ninjurin-1,1798,185,1.08 [0.85-1.37],0.5224600952474403
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT1,Deaminated glutathione amidase,1562,150,1.04 [0.74-1.47],0.806999973311823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NIT2,Omega-amidase NIT2,1585,150,1.02 [0.82-1.26],0.8721266241397687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN1,Neuroligin-1,1557,147,1.00 [0.81-1.25],0.9779425967130908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NLGN2,Neuroligin-2,1537,150,1.08 [0.79-1.47],0.6196676171320041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME1,Nucleoside diphosphate kinase A,1548,150,0.56 [0.25-1.26],0.1592591163424714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NME3,Nucleoside diphosphate kinase 3,1845,187,1.18 [0.72-1.92],0.5170741306120181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMI,N-myc-interactor,1585,150,1.00 [0.80-1.25],0.9919863889167908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,1832,185,1.01 [0.86-1.19],0.9258016619555538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMRK2,Nicotinamide riboside kinase 2,1538,145,1.10 [0.79-1.53],0.566794691036394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,1601,151,1.22 [1.01-1.48],0.0367181045378116
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOMO1,Nodal modulator 1,1855,188,0.75 [0.45-1.26],0.2812164911706631
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOP56,Nucleolar protein 56,1541,149,1.15 [1.02-1.30],0.0226402899917606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS1,"Nitric oxide synthase, brain",1788,185,1.36 [1.07-1.73],0.0119440610000316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS2,"Nitric oxide synthase, inducible",1541,149,0.98 [0.64-1.50],0.9235805457010774
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOS3,"Nitric oxide synthase, endothelial",1788,185,1.23 [1.01-1.49],0.0443853104033181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH1,Neurogenic locus notch homolog protein 1,1869,190,2.62 [1.23-5.54],0.0120536196958846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH2,Neurogenic locus notch homolog protein 2,1604,153,2.34 [1.35-4.06],0.0024101503948179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NOTCH3,Neurogenic locus notch homolog protein 3,1869,190,0.98 [0.71-1.36],0.8954358142432076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPC2,NPC intracellular cholesterol transporter 2,1585,150,2.66 [1.75-4.05],4.743764993826642e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPDC1,Neural proliferation differentiation and control protein 1,1850,189,1.82 [1.38-2.39],1.9353608753079225e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS1,Nephrin,1548,150,0.62 [0.38-1.02],0.0580538943665771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPHS2,Podocin,1548,150,0.91 [0.77-1.08],0.2727597420431188
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPL,N-acetylneuraminate lyase,1596,150,1.11 [0.80-1.53],0.5274359811129621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPB,Natriuretic peptides B,1814,185,1.05 [0.96-1.15],0.305663547713254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPPC,C-type natriuretic peptide,1840,187,1.02 [0.80-1.29],0.887572729077519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPR1,Atrial natriuretic peptide receptor 1,1541,149,1.65 [1.17-2.31],0.0038249690950492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTN,Neuroplastin,1798,185,0.97 [0.82-1.16],0.7514856188407054
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX1,Neuronal pentraxin-1,1855,188,0.94 [0.68-1.31],0.7293685428829791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTX2,Neuronal pentraxin-2,1604,153,1.25 [0.80-1.93],0.3266792548613785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPTXR,Neuronal pentraxin receptor,1850,189,0.72 [0.51-1.02],0.0683190909126619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NPY,Pro-neuropeptide Y,1867,190,1.42 [1.18-1.72],0.0002587547879749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRCAM,Neuronal cell adhesion molecule,1850,189,1.71 [1.17-2.48],0.0050814605513603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRGN,Neurogranin,1606,152,1.12 [0.94-1.33],0.1947283790783095
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRN1,Neuritin,1601,151,0.82 [0.49-1.37],0.4580583523620485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP1,Neuropilin-1,1859,188,2.13 [1.42-3.20],0.0002532572447831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRP2,Neuropilin-2,1855,188,1.14 [0.74-1.76],0.5419913322319472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRTN,Neurturin,1801,185,1.06 [0.80-1.38],0.6953699932481604
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NRXN3,Neurexin-3,1557,147,1.19 [0.77-1.83],0.443589920286951
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NSFL1C,NSFL1 cofactor p47,1863,188,1.24 [1.03-1.50],0.0244201357078662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",1596,150,1.22 [0.98-1.51],0.070175481914059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1592,150,1.76 [1.24-2.51],0.0016627642095011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5C3A,Cytosolic 5'-nucleotidase 3A,1839,187,1.06 [0.91-1.23],0.4690555032423017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NT5E,5'-nucleotidase,1855,187,0.87 [0.69-1.09],0.2204423712435856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF3,Neurotrophin-3,1840,187,1.31 [0.95-1.80],0.0960854551132801
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTF4,Neurotrophin-4,1798,185,0.94 [0.67-1.32],0.7278354584643711
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK2,BDNF/NT-3 growth factors receptor,1850,189,1.38 [0.87-2.20],0.1744842628798729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTRK3,NT-3 growth factor receptor,1863,188,1.09 [0.63-1.88],0.7559117712399708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1850,189,1.17 [1.05-1.31],0.0033420907787859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUB1,NEDD8 ultimate buster 1,1840,187,1.06 [0.91-1.24],0.4328869944700574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,1593,150,0.99 [0.84-1.18],0.9237491404555448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUCB2,Nucleobindin-2,1866,190,1.53 [1.10-2.12],0.0109872814973378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDC,Nuclear migration protein nudC,1864,187,1.19 [0.96-1.47],0.1223650983580405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,1562,150,1.10 [0.70-1.72],0.6897813542200691
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,1541,149,1.05 [0.82-1.36],0.6853638887800595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT16,U8 snoRNA-decapping enzyme,1579,150,1.09 [0.91-1.30],0.3624899842382881
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],1849,189,0.97 [0.77-1.22],0.7761392269778176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUDT5,ADP-sugar pyrophosphatase,1855,188,1.40 [1.14-1.71],0.0011275166213375
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUMB,Protein numb homolog,1548,150,1.03 [0.85-1.25],0.7419046114381369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NUP50,Nuclear pore complex protein Nup50,1541,149,1.02 [0.68-1.53],0.923433152691159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPE4,NXPE family member 4,1541,149,1.08 [0.74-1.57],0.6892709519696143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH1,Neurexophilin-1,1788,185,1.26 [0.92-1.74],0.1544954826941488
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,NXPH3,Neurexophilin-3,1548,150,1.40 [0.84-2.34],0.1954891050389619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OBP2B,Odorant-binding protein 2b,1827,185,1.06 [0.88-1.28],0.5486669452462059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OCLN,Occludin,1601,151,1.44 [1.06-1.96],0.0188623457332084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ODAM,Odontogenic ameloblast-associated protein,1787,185,1.21 [0.99-1.49],0.0688901827749406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OFD1,Oral-facial-digital syndrome 1 protein,1574,146,1.10 [0.89-1.36],0.3996361265791701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGA,Protein O-GlcNAcase,1581,150,1.18 [0.94-1.48],0.1509163125658011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGFR,Opioid growth factor receptor,1849,189,1.40 [0.95-2.06],0.0879253255170709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGN,Mimecan,1855,188,2.00 [1.55-2.58],8.424867910570038e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,1574,146,0.94 [0.71-1.26],0.6949522313346532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLFM4,Olfactomedin-4,1507,138,1.13 [0.99-1.28],0.0803329819590459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OLR1,Oxidized low-density lipoprotein receptor 1,1841,188,1.08 [0.87-1.32],0.493792048787317
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMD,Osteomodulin,1853,187,0.80 [0.62-1.03],0.089234839630852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMG,Oligodendrocyte-myelin glycoprotein,1849,189,0.82 [0.68-0.98],0.0337818042570137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OMP,Olfactory marker protein,1537,150,1.25 [0.96-1.63],0.0995284014442374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPHN1,Oligophrenin-1,1592,150,1.07 [0.93-1.23],0.3660446791414283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPLAH,5-oxoprolinase,1562,150,1.10 [0.87-1.38],0.4302268358933981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OPTC,Opticin,1849,189,1.10 [0.82-1.48],0.5119200969395351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ORM1,Alpha-1-acid glycoprotein 1,1605,152,1.03 [0.49-2.19],0.935577452309427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSBPL2,Oxysterol-binding protein-related protein 2,1592,150,1.29 [0.95-1.76],0.1012075936193997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,1845,187,1.53 [1.06-2.20],0.0226778998650803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSM,Oncostatin-M,1834,187,1.06 [0.89-1.26],0.4880413423668678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSMR,Oncostatin-M-specific receptor subunit beta,1859,188,1.69 [0.94-3.03],0.0775246849581987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OSTN,Osteocrin,1557,147,1.16 [0.89-1.53],0.2752536900851869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTOA,Otoancorin,1537,150,1.14 [0.90-1.44],0.2775681410284854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD6B,Deubiquitinase OTUD6B,1581,150,1.24 [0.96-1.60],0.1016286755305826
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OTUD7B,OTU domain-containing protein 7B,1601,151,1.22 [0.95-1.56],0.1170863599115305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",1562,150,1.12 [0.89-1.40],0.3293123065912532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,OXT,Oxytocin-neurophysin 1,1863,188,0.97 [0.89-1.07],0.5835212249064989
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,P4HB,Protein disulfide-isomerase,1835,186,1.49 [1.07-2.08],0.0190215618673322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PACS2,Phosphofurin acidic cluster sorting protein 2,1541,149,1.08 [0.85-1.38],0.527571326654231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI2,Protein-arginine deiminase type-2,1801,185,1.13 [0.89-1.42],0.316944626940381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PADI4,Protein-arginine deiminase type-4,1787,185,0.95 [0.81-1.13],0.5758327158131544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAEP,Glycodelin,1832,185,0.99 [0.87-1.12],0.8550792216781754
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,1601,151,1.01 [0.88-1.16],0.9191165367787478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",1574,146,1.09 [0.79-1.49],0.6154725397024621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,1814,185,1.20 [0.95-1.51],0.1193600664186345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAGR1,PAXIP1-associated glutamate-rich protein 1,1562,150,1.19 [0.90-1.56],0.2248850850953987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,1535,145,1.12 [0.82-1.54],0.4694097572136148
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAK4,Serine/threonine-protein kinase PAK 4,1788,185,1.25 [1.02-1.52],0.0312946641700938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALLD,Palladin,1548,150,0.68 [0.42-1.11],0.126497261432551
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM,Paralemmin-1,1573,149,2.12 [1.43-3.13],0.0001771552563502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM2,Paralemmin-2,1592,150,1.89 [1.35-2.64],0.000195390750706
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PALM3,Paralemmin-3,1541,149,1.10 [0.89-1.35],0.3950496523943047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAM,Peptidyl-glycine alpha-amidating monooxygenase,1862,189,1.32 [0.85-2.04],0.2185766534942841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAMR1,Inactive serine protease PAMR1,1855,188,0.84 [0.53-1.33],0.4560284443708411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAPPA,Pappalysin-1,1801,185,0.93 [0.71-1.23],0.6200527414819171
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARD3,Partitioning defective 3 homolog,1574,146,1.01 [0.81-1.27],0.9027107072780932
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARK7,Parkinson disease protein 7,1855,188,1.28 [1.02-1.62],0.0360235027323962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PARP1,Poly [ADP-ribose] polymerase 1,1840,187,1.16 [0.94-1.42],0.1750373733603659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PAXX,Protein PAXX,1570,146,1.25 [0.90-1.73],0.1771110348889877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBK,Lymphokine-activated killer T-cell-originated protein kinase,1538,145,0.98 [0.58-1.66],0.9293704651820748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBLD,Phenazine biosynthesis-like domain-containing protein,1788,185,0.91 [0.71-1.15],0.4163721107482501
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,1581,150,1.65 [1.03-2.66],0.0375676854650186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCARE,Photoreceptor cilium actin regulator,1537,150,1.01 [0.86-1.20],0.871170135075181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,1568,145,0.88 [0.66-1.16],0.3525880169711722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCBP2,Poly(rC)-binding protein 2,1601,151,1.14 [0.92-1.40],0.2399108287346167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH1,Protocadherin-1,1858,187,1.51 [0.93-2.47],0.0988744143291929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH12,Protocadherin-12,1601,151,1.73 [0.96-3.12],0.0666952033808887
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH17,Protocadherin-17,1850,189,1.47 [1.08-1.98],0.0127816525809059
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH7,Protocadherin-7,1581,150,1.63 [1.22-2.19],0.0010443764892531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDH9,Protocadherin-9,1581,150,0.91 [0.60-1.37],0.6565190002922923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCDHB15,Protocadherin beta-15,1593,150,1.33 [0.96-1.83],0.0854466423144759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCNA,Proliferating cell nuclear antigen,1538,145,0.96 [0.75-1.24],0.7698160510379441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK7,Proprotein convertase subtilisin/kexin type 7,1593,150,0.74 [0.51-1.06],0.1024471010571118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,1869,190,1.23 [0.89-1.69],0.2104011156627675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PCYT2,Ethanolamine-phosphate cytidylyltransferase,1581,150,1.17 [0.95-1.43],0.1460712692592478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDAP1,28 kDa heat- and acid-stable phosphoprotein,1596,150,1.16 [0.98-1.36],0.0823310937681943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1,Programmed cell death protein 1,1864,188,1.40 [1.11-1.77],0.00530623841079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD1LG2,Programmed cell death 1 ligand 2,1849,189,2.41 [1.64-3.55],7.773897990806853e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD5,Programmed cell death protein 5,1863,188,1.41 [1.14-1.75],0.0016678815254474
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCD6,Programmed cell death protein 6,1850,189,1.31 [1.03-1.67],0.0268134184365271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDCL2,Phosducin-like protein 2,1538,145,0.88 [0.62-1.25],0.479930149683439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",1538,145,1.07 [0.81-1.42],0.6117690814782575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",1541,149,0.97 [0.74-1.27],0.80699018564582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",1570,146,1.04 [0.89-1.22],0.5900111175013458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFA,Platelet-derived growth factor subunit A,1869,190,0.91 [0.76-1.09],0.3079437361914455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFB,Platelet-derived growth factor subunit B,1853,187,1.00 [0.85-1.16],0.9521963124196596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFC,Platelet-derived growth factor C,1798,185,1.21 [0.83-1.79],0.3250609764440634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRA,Platelet-derived growth factor receptor alpha,1850,189,2.26 [1.53-3.33],3.9893589052731233e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDGFRB,Platelet-derived growth factor receptor beta,1869,190,1.16 [0.81-1.66],0.4237002833990071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA2,Protein disulfide-isomerase A2,1538,145,1.35 [0.87-2.11],0.1803551642143621
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA3,Protein disulfide-isomerase A3,1570,146,1.67 [0.94-2.95],0.0804640397895767
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA4,Protein disulfide-isomerase A4,1604,153,1.05 [0.82-1.35],0.6932991687012529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDIA5,Protein disulfide-isomerase A5,1538,145,0.94 [0.71-1.23],0.6337385066064207
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM5,PDZ and LIM domain protein 5,1601,151,1.09 [0.95-1.24],0.2117773381159038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDLIM7,PDZ and LIM domain protein 7,1853,187,1.09 [0.98-1.20],0.1067933404296872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",1798,185,1.15 [0.89-1.48],0.2920759289882746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDRG1,p53 and DNA damage-regulated protein 1,1557,147,1.12 [0.87-1.44],0.3691772978579893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,1538,145,0.95 [0.72-1.24],0.6856227207186348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZD2,PDZ domain-containing protein 2,1541,149,1.11 [0.89-1.40],0.3588218063487796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,1548,150,0.88 [0.64-1.20],0.4126323113754458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEAR1,Platelet endothelial aggregation receptor 1,1869,190,1.67 [0.97-2.85],0.0620699344789081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEBP1,Phosphatidylethanolamine-binding protein 1,1855,188,1.39 [1.14-1.70],0.0012030826641756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECAM1,Platelet endothelial cell adhesion molecule,1855,188,1.15 [0.76-1.73],0.5120566470720262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PECR,Peroxisomal trans-2-enoyl-CoA reductase,1562,150,2.01 [1.16-3.47],0.0125392708108075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PENK,Proenkephalin-A,1570,146,1.41 [0.91-2.18],0.1206963419715185
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PEPD,Xaa-Pro dipeptidase,1606,152,1.10 [0.61-1.96],0.7552669739219406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PER3,Period circadian protein homolog 3,1548,150,1.03 [0.90-1.16],0.6979897955578799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PF4,Platelet factor 4,1597,152,0.99 [0.84-1.16],0.8714676629009497
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN2,Prefoldin subunit 2,1788,185,1.05 [0.83-1.32],0.7134743771662645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN4,Prefoldin subunit 4,1538,145,1.29 [1.03-1.63],0.027860660932536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFDN6,Prefoldin subunit 6,1557,147,1.07 [0.84-1.35],0.5846891455701064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",1846,188,1.17 [1.00-1.37],0.0569719613596367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGA4,Pepsin A-4,1606,152,1.08 [0.91-1.29],0.3726830621858972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",1596,150,1.37 [1.06-1.78],0.0167905044903837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGF,Placenta growth factor,1864,187,2.20 [1.49-3.24],7.50487455127033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP1,Peptidoglycan recognition protein 1,1862,190,1.06 [0.79-1.42],0.6989504945224478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,1592,150,1.47 [0.87-2.49],0.1542483576266174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGLYRP4,Peptidoglycan recognition protein 4,1541,149,0.92 [0.69-1.23],0.5672665383019269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGM2,Phosphoglucomutase-2,1557,147,1.05 [0.79-1.40],0.7469593030416055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PGR,Progesterone receptor,1548,150,0.96 [0.81-1.14],0.6442788950239441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHACTR2,Phosphatase and actin regulator 2,1601,151,1.02 [0.89-1.16],0.819200370493453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB1,Pleckstrin homology-like domain family B member 1,1581,150,1.65 [1.24-2.20],0.0005710374695085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHLDB2,Pleckstrin homology-like domain family B member 2,1538,145,0.96 [0.81-1.14],0.65638104115408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1832,185,2.20 [1.43-3.38],0.000340622136209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,1570,146,0.87 [0.60-1.26],0.4679801424352312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI16,Peptidase inhibitor 16,1606,152,1.69 [0.95-3.02],0.0760333871654991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PI3,Elafin,1829,188,1.27 [1.04-1.55],0.0171709663373799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",1601,151,1.10 [0.90-1.34],0.3382133892192811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIGR,Polymeric immunoglobulin receptor,1831,185,2.04 [1.50-2.76],4.0527842952429865e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,1840,187,1.10 [0.91-1.33],0.3407526024524916
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1855,188,3.03 [2.19-4.20],2.628373095863836e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,1548,150,0.94 [0.69-1.27],0.6734112415934193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1855,188,1.71 [1.26-2.33],0.0006044847794852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1850,189,1.38 [1.09-1.74],0.0071203272692445
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,1570,146,0.80 [0.64-1.00],0.0452761713305547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PITHD1,PITH domain-containing protein 1,1535,145,0.93 [0.76-1.14],0.4990321747873346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD1,Polycystin-1,1596,150,2.91 [1.66-5.10],0.0001948304884305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKD2,Polycystin-2,1541,149,1.02 [0.78-1.34],0.8924482532424622
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKLR,Pyruvate kinase PKLR,1845,185,1.13 [0.95-1.35],0.1658202650951588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PKN3,Serine/threonine-protein kinase N3,1574,146,1.01 [0.82-1.24],0.9217882031383356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G10,Group 10 secretory phospholipase A2,1832,185,1.42 [1.16-1.73],0.0008097246425466
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G15,Phospholipase A2 group XV,1855,187,1.21 [0.78-1.86],0.3996604634574164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G1B,Phospholipase A2,1866,190,0.91 [0.71-1.16],0.454359687499458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G2A,"Phospholipase A2, membrane associated",1837,187,0.99 [0.80-1.23],0.9405327500534524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G4A,Cytosolic phospholipase A2,1853,187,1.08 [0.94-1.25],0.2818580726557732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLA2G7,Platelet-activating factor acetylhydrolase,1855,188,0.46 [0.33-0.63],1.3532698352550242e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAT,Tissue-type plasminogen activator,1864,190,0.73 [0.58-0.91],0.0051087848373333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAU,Urokinase-type plasminogen activator,1855,188,0.78 [0.51-1.19],0.2420940012761397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLAUR,Urokinase plasminogen activator surface receptor,1834,187,3.02 [2.03-4.50],5.0421239603014004e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLB1,"Phospholipase B1, membrane-associated",1592,150,0.72 [0.55-0.95],0.0179188347459199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",1548,150,1.00 [0.69-1.44],0.9832775099588216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",1592,150,1.07 [0.91-1.25],0.4253373990229996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLEKHO1,Pleckstrin homology domain-containing family O member 1,1592,150,1.08 [0.87-1.34],0.4658335174270064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLG,Plasminogen,1561,146,1.58 [0.75-3.34],0.2305995765732321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN1,Perilipin-1,1788,185,1.34 [0.97-1.84],0.0736696715752256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLIN3,Perilipin-3,1850,189,1.58 [1.21-2.08],0.0009198790266113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLPBP,Pyridoxal phosphate homeostasis protein,1850,189,1.18 [0.98-1.43],0.07590620509393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLSCR3,Phospholipid scramblase 3,1588,149,1.22 [0.93-1.60],0.1469356488157129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLTP,Phospholipid transfer protein,1863,190,1.04 [0.75-1.44],0.827471104379029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC1,Plexin domain-containing protein 1,1798,185,1.25 [0.85-1.84],0.2602313578234975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXDC2,Plexin domain-containing protein 2,1592,150,1.38 [0.86-2.21],0.1836604489322568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNA4,Plexin-A4,1840,187,0.98 [0.83-1.15],0.7870298527876743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB2,Plexin-B2,1857,190,3.77 [2.52-5.64],1.0342253144382015e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PLXNB3,Plexin-B3,1843,188,1.14 [0.87-1.49],0.3571782944116674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,1847,189,0.99 [0.92-1.06],0.7564014162548257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMCH,Pro-MCH,1541,149,1.07 [0.88-1.29],0.5078469865115218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMM2,Phosphomannomutase 2,1541,149,1.17 [0.90-1.52],0.2284594978833321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMS1,PMS1 protein homolog 1,1557,147,1.13 [0.88-1.45],0.3399965536911425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PMVK,Phosphomevalonate kinase,1784,184,1.04 [0.92-1.18],0.4834707853429097
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIP,Pancreatic triacylglycerol lipase,1606,152,1.05 [0.84-1.30],0.6941712831825873
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,1592,150,1.07 [0.89-1.27],0.4831355375066911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNLIPRP2,Pancreatic lipase-related protein 2,1841,187,1.04 [0.99-1.08],0.1461116486686723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA1,Paraneoplastic antigen Ma1,1562,150,1.08 [0.83-1.40],0.5764112048170582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNMA2,Paraneoplastic antigen Ma2,1537,150,1.00 [0.72-1.40],0.9998568630182082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",1801,185,1.00 [0.89-1.13],0.9776601907958667
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL,Podocalyxin,1849,189,0.96 [0.44-2.14],0.9290106248918442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PODXL2,Podocalyxin-like protein 2,1855,187,1.24 [0.83-1.87],0.2962587240949268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POF1B,Protein POF1B,1548,150,1.66 [1.33-2.07],8.422776092283385e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2A,DNA-directed RNA polymerase II subunit RPB1,1548,150,0.90 [0.52-1.57],0.7194266856553999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1849,189,1.75 [1.34-2.29],4.414270575038222e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POMC,Pro-opiomelanocortin,1562,150,0.73 [0.59-0.91],0.0046829589599086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON1,Serum paraoxonase/arylesterase 1,1606,152,0.72 [0.46-1.12],0.1400624281868918
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON2,Serum paraoxonase/arylesterase 2,1814,185,0.91 [0.64-1.30],0.5943390235962347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PON3,Serum paraoxonase/lactonase 3,1853,187,0.62 [0.44-0.87],0.0052363898334197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,POSTN,Periostin,1604,153,0.79 [0.53-1.17],0.2463702439758878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPBP,Platelet basic protein,1594,152,0.99 [0.82-1.19],0.9333460405437491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPCDC,Phosphopantothenoylcysteine decarboxylase,1863,188,1.19 [0.92-1.54],0.1958224805839166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIB,Peptidyl-prolyl cis-trans isomerase B,1849,190,1.08 [0.94-1.25],0.2692467067173051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIE,Peptidyl-prolyl cis-trans isomerase E,1574,146,1.00 [0.78-1.29],0.9848914888831812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",1604,153,1.01 [0.80-1.28],0.941634050880732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPL,Periplakin,1548,150,0.90 [0.57-1.42],0.6447022187188066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1A,Protein phosphatase 1A,1798,185,1.26 [0.89-1.79],0.1960635177210519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1B,Protein phosphatase 1B,1548,150,1.02 [0.78-1.33],0.8960083298026544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPM1F,Protein phosphatase 1F,1596,150,1.20 [0.90-1.61],0.2217728807317619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPME1,Protein phosphatase methylesterase 1,1849,189,1.28 [1.05-1.57],0.0168750786465576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,1593,150,1.01 [0.83-1.22],0.9443672843943098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,1855,187,1.11 [0.97-1.26],0.1379533027362144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,1574,146,1.14 [0.93-1.41],0.2008663305295914
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,1601,151,1.16 [0.96-1.41],0.1275740679139537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,1601,151,1.55 [1.16-2.08],0.003164985322727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R2,Protein phosphatase inhibitor 2,1850,189,1.13 [0.96-1.33],0.1493379202214818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP1R9B,Neurabin-2,1864,187,1.10 [0.96-1.26],0.1841791740070043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,1581,150,1.09 [0.96-1.24],0.1712334362534872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPP3R1,Calcineurin subunit B type 1,1832,185,1.41 [1.04-1.93],0.0287710618054416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPT1,Palmitoyl-protein thioesterase 1,1557,147,1.00 [0.82-1.21],0.9888117881142136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PPY,Pancreatic prohormone,1845,184,1.18 [1.05-1.33],0.0043726522083523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PQBP1,Polyglutamine-binding protein 1,1798,185,1.22 [1.01-1.48],0.0357362985846699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAME,Melanoma antigen preferentially expressed in tumors,1538,145,0.71 [0.38-1.32],0.2828071065793999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRAP1,Proline-rich acidic protein 1,1604,153,2.19 [1.51-3.17],3.813551505332942e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRC1,Protein regulator of cytokinesis 1,1593,150,0.97 [0.70-1.34],0.8585905778347355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRCP,Lysosomal Pro-X carboxypeptidase,1861,190,1.50 [1.07-2.12],0.0203726438509382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX1,Peroxiredoxin-1,1786,181,1.06 [0.91-1.23],0.4474336026043427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX2,Peroxiredoxin-2,1573,150,1.10 [0.88-1.38],0.4101461113765781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",1801,185,1.19 [0.99-1.43],0.0580300482660329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX5,"Peroxiredoxin-5, mitochondrial",1864,187,0.98 [0.81-1.19],0.8255610949089286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRDX6,Peroxiredoxin-6,1867,190,0.96 [0.78-1.18],0.6720432085351458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PREB,Prolactin regulatory element-binding protein,1801,185,1.50 [1.02-2.21],0.0373039354962811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRELP,Prolargin,1841,187,2.27 [1.38-3.74],0.0013262296667039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG2,Bone marrow proteoglycan,1604,153,1.41 [1.10-1.81],0.00767982860626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRG3,Proteoglycan 3,1604,153,0.97 [0.73-1.29],0.8336106701717073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,1801,185,1.23 [0.97-1.56],0.0944715455203803
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,1557,147,1.65 [1.11-2.43],0.0122125124285896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,1850,189,1.08 [0.92-1.27],0.3264589339201785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,1590,150,1.04 [0.86-1.26],0.6878150473459619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKCQ,Protein kinase C theta type,1801,185,0.86 [0.63-1.18],0.3516019205237495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKD2,Serine/threonine-protein kinase D2,1541,149,1.23 [0.86-1.75],0.2546350958218971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKG1,cGMP-dependent protein kinase 1,1570,146,0.98 [0.87-1.12],0.8057744728531531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,1798,185,1.15 [0.95-1.40],0.146825610599868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRL,Prolactin,1863,188,1.11 [0.96-1.29],0.1662099440188607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRND,Prion-like protein doppel,1592,150,0.97 [0.75-1.26],0.8395179040207247
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROC,Vitamin K-dependent protein C,1857,188,0.88 [0.55-1.43],0.6152460224267748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROCR,Endothelial protein C receptor,1541,149,1.11 [0.76-1.63],0.5828157557415408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROK1,Prokineticin-1,1840,187,1.03 [0.84-1.25],0.7926136302904032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PROS1,Vitamin K-dependent protein S,1608,152,0.85 [0.46-1.58],0.6093996061764853
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR4,Proline-rich protein 4,1555,144,0.97 [0.77-1.22],0.7682063936628306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRR5,Proline-rich protein 5,1548,150,0.93 [0.66-1.30],0.6557071345790535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRRT3,Proline-rich transmembrane protein 3,1562,150,1.45 [1.04-2.04],0.0300846018172565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS2,Trypsin-2,1858,188,1.04 [0.84-1.28],0.7270396455744165
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS22,Brain-specific serine protease 4,1548,150,1.39 [0.91-2.15],0.1316778584442156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS27,Serine protease 27,1846,189,1.48 [1.10-1.98],0.0087241628146549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS53,Serine protease 53,1592,150,0.73 [0.49-1.08],0.1152323233147615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRSS8,Prostasin,1841,185,1.69 [1.28-2.23],0.0001919364149791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,1788,185,1.03 [0.91-1.16],0.6112417394667194
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTG,Protogenin,1867,190,1.32 [0.83-2.10],0.233786473280168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRTN3,Myeloblastin,1805,188,1.14 [0.88-1.47],0.3100360480393447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PRUNE2,Protein prune homolog 2,1574,146,0.69 [0.38-1.26],0.2272425755670182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAP,Prosaposin,1594,152,3.16 [1.88-5.33],1.5423267657748112e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSAPL1,Proactivator polypeptide-like 1,1581,150,1.03 [0.77-1.36],0.8643096346803297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSCA,Prostate stem cell antigen,1581,150,1.06 [1.00-1.13],0.0681215659315705
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1832,185,1.42 [1.26-1.60],7.0901772900767075e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSIP1,PC4 and SFRS1-interacting protein,1840,187,1.06 [0.88-1.28],0.5420993230271178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMA1,Proteasome subunit alpha type-1,1798,185,0.89 [0.65-1.21],0.4571650196985161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMC3,26S proteasome regulatory subunit 6A,1538,145,0.94 [0.57-1.55],0.8141814642722389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD1,26S proteasome non-ATPase regulatory subunit 1,1601,151,1.13 [0.84-1.50],0.4174681189055113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD5,26S proteasome non-ATPase regulatory subunit 5,1557,147,1.09 [0.83-1.44],0.5302143187822702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMD9,26S proteasome non-ATPase regulatory subunit 9,1849,189,1.17 [0.96-1.43],0.118550414042499
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME1,Proteasome activator complex subunit 1,1831,185,1.23 [0.87-1.74],0.235802609056136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSME2,Proteasome activator complex subunit 2,1821,184,1.52 [1.06-2.18],0.0218324704400843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG3,Proteasome assembly chaperone 3,1840,187,1.33 [1.06-1.67],0.0148373924390325
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSMG4,Proteasome assembly chaperone 4,1548,150,1.16 [0.91-1.49],0.2335408015688233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSPN,Persephin,1840,187,1.02 [0.90-1.15],0.7601979627905656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSRC1,Proline/serine-rich coiled-coil protein 1,1798,185,1.26 [1.04-1.54],0.0200021815580676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,1517,135,1.05 [0.89-1.22],0.5726161196629751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",1788,185,1.74 [1.14-2.67],0.0106915022332565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGDS,Prostaglandin-H2 D-isomerase,1838,186,2.15 [1.57-2.94],1.6689867475818582e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGES2,Prostaglandin E synthase 2,1535,148,1.15 [0.86-1.54],0.3558064122499157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTGR1,Prostaglandin reductase 1,1596,150,0.99 [0.83-1.17],0.8959847636966634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH,Parathyroid hormone,1557,147,0.92 [0.77-1.10],0.3599029414150865
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,1840,187,1.36 [1.06-1.73],0.01369570273888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTK7,Inactive tyrosine-protein kinase 7,1788,185,1.99 [1.44-2.75],3.0850679477475605e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTN,Pleiotrophin,1814,185,1.06 [0.82-1.37],0.6750769203414422
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,1548,150,1.03 [0.74-1.43],0.8717312494645677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,1832,185,1.13 [0.96-1.33],0.1500944959585878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,1848,187,1.04 [0.90-1.21],0.6064377351419314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,1548,150,1.13 [0.77-1.66],0.5235998054720068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRB,Receptor-type tyrosine-protein phosphatase beta,1596,150,1.63 [0.98-2.70],0.0578022461571517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,1604,153,1.92 [0.99-3.71],0.052632163983639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,1869,190,1.08 [0.71-1.63],0.7265650058257476
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,1581,150,1.44 [1.06-1.95],0.0200448784346515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,1581,150,1.24 [0.70-2.19],0.4577261169546496
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,1837,187,1.11 [0.68-1.81],0.670383282615127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1827,185,1.81 [1.31-2.49],0.0002992168810822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRR,Receptor-type tyrosine-protein phosphatase R,1592,150,0.95 [0.63-1.42],0.7935728641725491
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRS,Receptor-type tyrosine-protein phosphatase S,1869,190,1.65 [1.02-2.67],0.0415029935251722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,1596,150,1.25 [0.78-2.02],0.3491123846876729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,1570,146,1.11 [0.86-1.44],0.4322682813192868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,1778,184,1.07 [0.89-1.28],0.4696050791005886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTTG1,Securin,1574,146,1.20 [0.86-1.69],0.283454621943386
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PTX3,Pentraxin-related protein PTX3,1840,187,1.57 [1.17-2.10],0.002391574278297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVALB,Parvalbumin alpha,1857,189,1.03 [0.92-1.15],0.6632759753397743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PVR,Poliovirus receptor,1863,188,0.93 [0.67-1.29],0.672262106040701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXDNL,Peroxidasin-like protein,1593,150,1.08 [0.85-1.38],0.529018439634333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PXN,Paxillin,1788,185,1.29 [1.02-1.62],0.0345960681832174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYDC1,Pyrin domain-containing protein 1,1562,150,1.11 [0.80-1.54],0.5386326410828941
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PYY,Peptide YY,1541,149,1.26 [1.11-1.43],0.0003047162709232
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,PZP,Pregnancy zone protein,1608,152,0.91 [0.71-1.16],0.4370250655866737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QDPR,Dihydropteridine reductase,1843,187,1.19 [0.88-1.60],0.2531723567825623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QPCT,Glutaminyl-peptide cyclotransferase,1854,190,1.62 [1.03-2.56],0.0381487553681905
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,QSOX1,Sulfhydryl oxidase 1,1571,146,1.22 [0.88-1.69],0.2375481999284586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB10,Ras-related protein Rab-10,1596,150,1.07 [0.81-1.41],0.6203661458622776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB11FIP3,Rab11 family-interacting protein 3,1596,150,1.03 [0.89-1.18],0.7301026246199405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB27B,Ras-related protein Rab-27B,1596,150,1.02 [0.84-1.24],0.8124076256450199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB2B,Ras-related protein Rab-2B,1593,150,0.98 [0.76-1.25],0.847520548768965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB33A,Ras-related protein Rab-33A,1541,149,1.07 [0.85-1.36],0.5594738607164611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB37,Ras-related protein Rab-37,1801,185,1.07 [0.92-1.24],0.3753975488386255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB39B,Ras-related protein Rab-39B,1541,149,1.00 [0.84-1.20],0.9920407343214762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,1537,150,1.03 [0.79-1.35],0.8051294453621052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB44,Ras-related protein Rab-44,1593,150,1.02 [0.76-1.36],0.9205610416838064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6A,Ras-related protein Rab-6A,1840,187,0.65 [0.50-0.86],0.0021082539509759
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAB6B,Ras-related protein Rab-6B,1788,185,0.95 [0.72-1.25],0.7107429176633069
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEP1,Rab GTPase-binding effector protein 1,1570,146,1.07 [0.87-1.30],0.521346517384911
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABEPK,Rab9 effector protein with kelch motifs,1798,185,1.11 [0.89-1.38],0.3463864898051755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RABGAP1L,Rab GTPase-activating protein 1-like,1801,185,1.28 [1.05-1.56],0.0137800705485582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAC3,Ras-related C3 botulinum toxin substrate 3,1557,147,1.13 [0.92-1.38],0.2529432017360791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD23B,UV excision repair protein RAD23 homolog B,1798,185,1.12 [0.85-1.48],0.4331992803025191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAD51,DNA repair protein RAD51 homolog 1,1574,146,1.19 [0.87-1.61],0.276740469218975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALB,Ras-related protein Ral-B,1548,150,1.08 [0.62-1.86],0.7944639752565278
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RALY,RNA-binding protein Raly,1593,150,1.05 [0.79-1.41],0.7288097789411532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP1,Ran-specific GTPase-activating protein,1562,150,1.30 [0.99-1.71],0.0621389983293329
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANBP2,E3 SUMO-protein ligase RanBP2,1537,150,1.58 [1.01-2.45],0.0432582289887518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RANGAP1,Ran GTPase-activating protein 1,1798,185,1.06 [0.81-1.39],0.6527780110187902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAP1A,Ras-related protein Rap-1A,1548,150,1.01 [0.81-1.26],0.9351901790349618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RAPGEF2,Rap guanine nucleotide exchange factor 2,1574,146,1.17 [0.87-1.58],0.300593592619417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES1,Retinoic acid receptor responder protein 1,1798,185,1.55 [1.17-2.05],0.0023848527891999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RARRES2,Retinoic acid receptor responder protein 2,1859,188,1.35 [1.04-1.76],0.0225808323227058
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASA1,Ras GTPase-activating protein 1,1788,185,0.82 [0.54-1.23],0.3272876077632197
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,1538,145,1.27 [0.94-1.72],0.1152878459778843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RASSF2,Ras association domain-containing protein 2,1798,185,1.17 [0.99-1.40],0.0711691338466985
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBFOX3,RNA binding protein fox-1 homolog 3,1601,151,1.51 [1.17-1.95],0.001594674831333
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBKS,Ribokinase,1806,184,0.89 [0.71-1.11],0.289044760456433
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM17,Splicing factor 45,1601,151,1.13 [0.93-1.38],0.2289424941181554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM19,Probable RNA-binding protein 19,1541,149,1.12 [0.78-1.60],0.5436721366664338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBM25,RNA-binding protein 25,1538,145,1.09 [0.80-1.48],0.6037593147431212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP1,Retinol-binding protein 1,1557,147,1.30 [1.10-1.54],0.0019674697860096
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP2,Retinol-binding protein 2,1849,189,1.28 [1.09-1.50],0.0022856294696439
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP5,Retinol-binding protein 5,1849,189,1.05 [0.87-1.27],0.6171759308610427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBP7,Retinoid-binding protein 7,1581,150,1.34 [1.09-1.64],0.0058060097471643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS,RNA-binding protein with multiple splicing,1548,150,1.15 [0.91-1.44],0.2368981529853974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RBPMS2,RNA-binding protein with multiple splicing 2,1562,150,1.08 [0.92-1.26],0.3423924744874632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCC1,Regulator of chromosome condensation,1593,150,1.11 [0.86-1.43],0.4254616718145595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RCOR1,REST corepressor 1,1814,185,1.33 [1.08-1.63],0.0065730554789204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,1562,150,0.85 [0.38-1.90],0.6929407598010446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REEP4,Receptor expression-enhancing protein 4,1601,151,1.21 [0.95-1.54],0.1282218723595891
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1A,Lithostathine-1-alpha,1843,185,2.03 [1.72-2.41],1.301260798037574e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG1B,Lithostathine-1-beta,1869,190,1.70 [1.45-1.99],3.3192723134477536e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3A,Regenerating islet-derived protein 3-alpha,1869,190,1.51 [1.28-1.77],5.610990281959294e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG3G,Regenerating islet-derived protein 3-gamma,1593,150,1.27 [0.91-1.76],0.1570707027767567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REG4,Regenerating islet-derived protein 4,1845,187,2.03 [1.69-2.45],7.733121610808772e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELB,Transcription factor RelB,1548,150,1.17 [0.91-1.52],0.2248020713311515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1855,188,2.30 [1.59-3.32],8.67201978597302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REN,Renin,1850,189,1.53 [1.37-1.72],5.0720094896442095e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REPS1,RalBP1-associated Eps domain-containing protein 1,1548,150,0.82 [0.53-1.26],0.3690881414619014
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REST,RE1-silencing transcription factor,1538,145,1.19 [0.77-1.84],0.4274165701174852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,1849,189,0.87 [0.64-1.16],0.3399194129258085
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RETN,Resistin,1848,190,1.27 [0.98-1.64],0.073667767186339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,REXO2,"Oligoribonuclease, mitochondrial",1541,149,0.99 [0.71-1.37],0.9504647309822482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RFC4,Replication factor C subunit 4,1593,150,1.02 [0.51-2.05],0.95151898669558
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGCC,Regulator of cell cycle RGCC,1601,151,1.03 [0.84-1.27],0.7544628918624436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,1574,146,1.00 [0.79-1.27],0.9883820866455556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMA,Repulsive guidance molecule A,1863,188,1.56 [1.07-2.29],0.0222416327543762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGMB,RGM domain family member B,1863,188,1.77 [1.17-2.68],0.0064678769931545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS10,Regulator of G-protein signaling 10,1601,151,1.19 [0.92-1.54],0.1829084764637248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RGS8,Regulator of G-protein signaling 8,1801,185,1.19 [1.02-1.38],0.023971393397377
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RHOC,Rho-related GTP-binding protein RhoC,1823,184,1.08 [0.96-1.21],0.2205648883406133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RICTOR,Rapamycin-insensitive companion of mTOR,1548,150,0.85 [0.62-1.17],0.3101612047326042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,1570,146,1.07 [0.82-1.40],0.611524780025154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILP,Rab-interacting lysosomal protein,1859,189,1.11 [0.91-1.37],0.3033852634829975
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RILPL2,RILP-like protein 2,1596,150,1.07 [0.91-1.25],0.4293669242061972
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1541,149,1.07 [0.86-1.34],0.546153687592392
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN1,Prorelaxin H1,1601,151,1.14 [0.95-1.38],0.1624037253722067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RLN2,Prorelaxin H2,1565,146,1.09 [0.94-1.26],0.2724976176486854
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE1,Ribonuclease pancreatic,1606,152,2.74 [1.68-4.46],5.50289210857944e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE10,Inactive ribonuclease-like protein 10,1562,150,1.20 [0.89-1.62],0.2351573092130573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE3,Eosinophil cationic protein,1843,189,0.99 [0.89-1.11],0.9150981682237912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE4,Ribonuclease 4,1548,149,2.38 [1.38-4.10],0.0017163155557953
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASE6,Ribonuclease K6,1591,150,2.28 [1.54-3.39],4.172827298087813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASEH2A,Ribonuclease H2 subunit A,1601,151,1.26 [0.96-1.66],0.1011832411790083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNASET2,Ribonuclease T2,1863,190,2.35 [1.83-3.01],1.5744656110066318e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF149,E3 ubiquitin-protein ligase RNF149,1562,150,2.29 [1.52-3.46],7.277410862282711e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF168,E3 ubiquitin-protein ligase RNF168,1548,150,0.68 [0.43-1.08],0.1054088142408381
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF31,E3 ubiquitin-protein ligase RNF31,1548,150,0.96 [0.64-1.42],0.8216289653079037
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF4,E3 ubiquitin-protein ligase RNF4,1574,146,1.10 [0.89-1.35],0.3971833788937712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF41,E3 ubiquitin-protein ligase NRDP1,1798,185,1.09 [0.90-1.32],0.3691705947934532
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF43,E3 ubiquitin-protein ligase RNF43,1574,146,1.10 [0.85-1.41],0.4793289983207729
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RNF5,E3 ubiquitin-protein ligase RNF5,1562,150,0.99 [0.79-1.24],0.9559527219164696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO1,Roundabout homolog 1,1845,187,1.56 [1.07-2.28],0.0218040022917592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO2,Roundabout homolog 2,1863,188,0.90 [0.53-1.52],0.6811345909262727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROBO4,Roundabout homolog 4,1562,150,1.84 [0.76-4.43],0.1758340705754099
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,1850,189,1.85 [1.29-2.65],0.0008487807390837
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RP2,Protein XRP2,1849,189,1.02 [0.76-1.37],0.8971479281637664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPA2,Replication protein A 32 kDa subunit,1548,150,1.33 [0.86-2.06],0.1930451485596489
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPE,Ribulose-phosphate 3-epimerase,1574,146,1.05 [0.83-1.31],0.6931897224440793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPGR,X-linked retinitis pigmentosa GTPase regulator,1557,147,1.19 [0.90-1.57],0.2292625402784512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPL14,60S ribosomal protein L14,1562,150,1.25 [0.89-1.77],0.2031823717176055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RPS10,40S ribosomal protein S10,1541,149,0.97 [0.67-1.42],0.8908084155739399
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRAS,Ras-related protein R-Ras,1557,147,1.08 [0.96-1.21],0.2124235557701297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2,Ribonucleoside-diphosphate reductase subunit M2,1798,185,1.07 [0.86-1.34],0.5510070878431983
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,1798,185,1.09 [0.90-1.32],0.3809487171033153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RRP15,RRP15-like protein,1537,150,1.01 [0.86-1.19],0.9036161195043072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO1,R-spondin-1,1832,185,1.07 [0.74-1.53],0.7215793815526963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RSPO3,R-spondin-3,1867,190,1.48 [1.02-2.16],0.038319464783545
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTBDN,Retbindin,1849,189,1.44 [1.00-2.09],0.0518554718206748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTKN2,Rhotekin-2,1541,149,0.98 [0.74-1.30],0.9070087109638784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",1601,151,1.07 [0.91-1.27],0.4057953888278642
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RTN4R,Reticulon-4 receptor,1867,190,1.83 [1.26-2.66],0.0015099081989958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RUVBL1,RuvB-like 1,1798,185,1.02 [0.90-1.15],0.8006472816953913
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RWDD1,RWD domain-containing protein 1,1863,188,1.22 [1.00-1.49],0.0531499959804455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,RYR1,Ryanodine receptor 1,1541,149,0.95 [0.59-1.54],0.830241394646547
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A11,Protein S100-A11,1836,188,1.19 [0.94-1.49],0.1405380332322518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A12,Protein S100-A12,1833,185,1.10 [0.93-1.31],0.2482933467619746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A13,Protein S100-A13,1548,150,1.12 [0.72-1.75],0.607916580301017
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A14,Protein S100-A14,1601,151,0.83 [0.63-1.09],0.1842379589603117
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A16,Protein S100-A16,1787,185,1.06 [0.86-1.31],0.5722513857770073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A3,Protein S100-A3,1593,150,0.79 [0.52-1.20],0.2659168209282521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100A4,Protein S100-A4,1855,187,1.20 [0.95-1.52],0.1216516831682563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100G,Protein S100-G,1601,151,0.63 [0.45-0.90],0.0103729384326256
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,S100P,Protein S100-P,1814,185,1.35 [1.12-1.63],0.0019298234352175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAA4,Serum amyloid A-4 protein,1608,152,0.92 [0.47-1.79],0.8120364838008599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAFB2,Scaffold attachment factor B2,1601,151,1.16 [0.63-2.13],0.6411411959672225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAG,S-arrestin,1537,150,0.87 [0.64-1.17],0.3556686441735942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAMD9L,Sterile alpha motif domain-containing protein 9-like,1840,187,1.12 [0.94-1.34],0.2089243309143973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAP18,Histone deacetylase complex subunit SAP18,1574,146,0.93 [0.74-1.17],0.5415675257179156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SARG,Specifically androgen-regulated gene protein,1592,149,1.07 [0.93-1.23],0.3618660555005073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SART1,U4/U6.U5 tri-snRNP-associated protein 1,1541,149,1.11 [0.75-1.65],0.5997429721917145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT1,Diamine acetyltransferase 1,1541,149,1.07 [0.81-1.41],0.6259408320997506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SAT2,Thialysine N-epsilon-acetyltransferase,1574,146,0.76 [0.58-0.99],0.0393954336559411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SATB1,DNA-binding protein SATB1,1601,151,1.13 [0.71-1.79],0.6166043785354636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SBSN,Suprabasin,1598,152,1.08 [0.71-1.64],0.7114779106737301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCAMP3,Secretory carrier-associated membrane protein 3,1849,189,1.09 [0.94-1.27],0.263771011017883
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARA5,Scavenger receptor class A member 5,1863,188,3.07 [2.21-4.27],2.0572494223440565e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB1,Scavenger receptor class B member 1,1788,185,0.92 [0.73-1.16],0.4884524417793583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARB2,Lysosome membrane protein 2,1791,181,2.39 [1.80-3.18],2.058862156479108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF1,Scavenger receptor class F member 1,1869,190,1.61 [1.21-2.16],0.0012376570782393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCARF2,Scavenger receptor class F member 2,1863,188,2.27 [1.54-3.36],3.6796987999981664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG2,Secretogranin-2,1858,189,1.98 [1.44-2.73],2.9048794954581245e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCG3,Secretogranin-3,1845,187,1.46 [1.01-2.09],0.0425226549968156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB1A1,Uteroglobin,1850,187,1.56 [1.23-1.97],0.0002356920380231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB2A2,Mammaglobin-A,1541,149,0.60 [0.33-1.10],0.0984126259759874
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A1,Secretoglobin family 3A member 1,1570,146,1.21 [0.66-2.25],0.5369399426697576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGB3A2,Secretoglobin family 3A member 2,1848,187,1.06 [0.94-1.19],0.3776500897628732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCGN,Secretagogin,1801,185,2.10 [1.66-2.65],8.008630351892414e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCIN,Adseverin,1537,150,1.03 [0.83-1.28],0.8045032746135605
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCLY,Selenocysteine lyase,1859,189,0.73 [0.58-0.93],0.0114065188392708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2A,Sodium channel protein type 2 subunit alpha,1537,150,1.02 [0.74-1.39],0.9235730753434684
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN2B,Sodium channel subunit beta-2,1557,147,1.52 [0.98-2.36],0.0609611995207299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3A,Sodium channel protein type 3 subunit alpha,1557,147,1.02 [0.67-1.55],0.9207171059097266
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN3B,Sodium channel subunit beta-3,1537,150,0.98 [0.71-1.36],0.9057665362219408
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCN4B,Sodium channel subunit beta-4,1562,150,1.09 [0.78-1.52],0.6179527014446287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCP2,Non-specific lipid-transfer protein,1798,185,1.00 [0.83-1.20],0.9968518897594224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCPEP1,Retinoid-inducible serine carboxypeptidase,1556,149,1.23 [0.90-1.68],0.1900781699530958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRG1,Scrapie-responsive protein 1,1596,150,1.52 [0.94-2.46],0.0864350996698814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRIB,Protein scribble homolog,1562,150,1.03 [0.87-1.21],0.740128145700681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCRN1,Secernin-1,1840,187,1.21 [0.97-1.50],0.0944543936093478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SCT,Secretin,1557,147,1.18 [0.85-1.62],0.3227566149213313
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC1,Syndecan-1,1850,189,1.27 [0.96-1.69],0.091805959155066
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDC4,Syndecan-4,1850,189,0.79 [0.60-1.04],0.0922344343639134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDCCAG8,Serologically defined colon cancer antigen 8,1593,150,1.00 [0.87-1.15],0.9583762319058048
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDHB,Succinate dehydrogenase,1581,150,0.87 [0.68-1.11],0.2698094325882286
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SDK2,Protein sidekick-2,1570,146,1.13 [0.75-1.72],0.5612658098956571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEC31A,Protein transport protein Sec31A,1562,150,1.07 [0.87-1.32],0.520414850705397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEL1L,Protein sel-1 homolog 1,1562,150,1.79 [1.44-2.23],2.360077518064988e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELE,E-selectin,1869,190,1.09 [0.87-1.37],0.4507272982304122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELENOP,Selenoprotein P,1608,152,0.84 [0.44-1.59],0.5902816457842681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELL,L-selectin,1608,152,0.72 [0.38-1.38],0.3264875441131897
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELP,P-selectin,1858,188,1.00 [0.80-1.26],0.9776492005913616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SELPLG,P-selectin glycoprotein ligand 1,1840,187,1.51 [0.99-2.30],0.0544089629723569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3F,Semaphorin-3F,1850,189,1.29 [0.83-2.00],0.2639657821822457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA3G,Semaphorin-3G,1570,146,1.47 [1.07-2.03],0.0185051868843644
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4C,Semaphorin-4C,1849,189,1.15 [0.80-1.67],0.4439308427068786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA4D,Semaphorin-4D,1863,188,1.48 [0.94-2.31],0.0876593287807978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA6C,Semaphorin-6C,1548,150,0.96 [0.52-1.77],0.8928965948873221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEMA7A,Semaphorin-7A,1864,190,2.00 [1.40-2.87],0.0001599459457569
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN3,Neuronal-specific septin-3,1601,151,0.82 [0.66-1.02],0.0797902485997027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN7,Septin-7,1574,146,1.04 [0.75-1.42],0.831199227857238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN8,Septin-8,1591,150,1.74 [1.27-2.39],0.0006304056085708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEPTIN9,Septin-9,1849,189,1.13 [0.76-1.70],0.5457333098722039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA1,Alpha-1-antitrypsin,1576,149,6.69 [1.13-39.51],0.0360387800235839
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA11,Serpin A11,1869,190,1.16 [0.86-1.58],0.3290036074464107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA12,Serpin A12,1805,184,0.89 [0.79-1.00],0.0486651034322513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA3,Alpha-1-antichymotrypsin,1600,150,1.99 [0.79-5.04],0.1458705505978943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA4,Kallistatin,1568,147,0.80 [0.43-1.48],0.4700757972721949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA5,Plasma serine protease inhibitor,1584,150,0.81 [0.50-1.31],0.3867970155754063
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA6,Corticosteroid-binding globulin,1608,152,1.78 [0.75-4.25],0.193999635316796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA7,Thyroxine-binding globulin,1608,152,1.70 [0.75-3.86],0.2053628605640639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINA9,Serpin A9,1837,189,1.08 [0.92-1.28],0.3533342446008271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB1,Leukocyte elastase inhibitor,1851,188,1.11 [0.96-1.27],0.1492939773681557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB5,Serpin B5,1814,185,0.98 [0.75-1.28],0.88816133569522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB6,Serpin B6,1858,187,1.21 [0.98-1.51],0.0806145562183043
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB8,Serpin B8,1864,187,1.16 [0.97-1.38],0.103566082244274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINB9,Serpin B9,1832,185,1.06 [0.69-1.61],0.8034025510287794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINC1,Antithrombin-III,1604,152,3.12 [1.25-7.76],0.014533219217265
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPIND1,Heparin cofactor 2,1604,152,1.11 [0.66-1.88],0.690239014057858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE1,Plasminogen activator inhibitor 1,1869,190,0.86 [0.70-1.04],0.1228934396468546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINE2,Glia-derived nexin,1596,150,0.94 [0.74-1.19],0.6173942779104376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF1,Pigment epithelium-derived factor,1576,150,1.60 [0.94-2.73],0.085858699289579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINF2,Alpha-2-antiplasmin,1570,148,2.02 [0.73-5.59],0.1772002002234452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPING1,Plasma protease C1 inhibitor,1604,152,1.66 [0.74-3.75],0.2198575276992415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINH1,Serpin H1,1574,146,1.13 [1.00-1.27],0.0512820971536242
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI1,Neuroserpin,1566,146,0.46 [0.27-0.78],0.004015895914156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SERPINI2,Serpin I2,1581,150,0.95 [0.73-1.24],0.7108574259259995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,1788,185,1.15 [0.95-1.39],0.1531534628506818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,1824,184,0.77 [0.48-1.22],0.2655976486783587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6,Seizure protein 6 homolog,1557,147,1.52 [1.04-2.24],0.0320100146720852
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L,Seizure 6-like protein,1855,187,1.87 [1.24-2.80],0.0025715787367177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SEZ6L2,Seizure 6-like protein 2,1849,189,1.07 [0.64-1.78],0.8101128932984506
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SF3B4,Splicing factor 3B subunit 4,1849,189,1.24 [1.05-1.47],0.0108772462125842
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP1,Secreted frizzled-related protein 1,1828,185,1.50 [1.15-1.96],0.0028575245206111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFRP4,Secreted frizzled-related protein 4,1570,146,1.00 [0.70-1.42],0.9951075511995868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA1,Pulmonary surfactant-associated protein A1,1798,185,0.96 [0.76-1.21],0.7243766147702908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPA2,Pulmonary surfactant-associated protein A2,1798,185,0.95 [0.74-1.22],0.681388626823331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SFTPD,Pulmonary surfactant-associated protein D,1850,189,1.06 [0.88-1.28],0.5494240190206947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SGSH,N-sulphoglucosamine sulphohydrolase,1573,150,0.98 [0.75-1.28],0.8797054726954137
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2B3,SH2B adapter protein 3,1798,185,1.08 [0.95-1.24],0.2506632835972398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH2D1A,SH2 domain-containing protein 1A,1840,187,1.14 [0.91-1.43],0.2594797082861737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,1537,150,1.09 [0.84-1.42],0.5218801462850967
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3BP1,SH3 domain-binding protein 1,1581,150,0.85 [0.61-1.20],0.3689490808883955
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GL3,Endophilin-A3,1561,145,0.90 [0.75-1.08],0.2721767598557082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SH3GLB2,Endophilin-B2,1592,150,1.28 [1.03-1.60],0.0292575366217687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHBG,Sex hormone-binding globulin,1606,152,1.33 [1.03-1.72],0.0291457939864159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHC1,SHC-transforming protein 1,1538,145,0.92 [0.80-1.07],0.274989345121003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHD,SH2 domain-containing adapter protein D,1536,148,1.06 [0.91-1.23],0.4535832441581398
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHH,Sonic hedgehog protein,1548,150,0.89 [0.61-1.31],0.5574737591059447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHISA5,Protein shisa-5,1604,153,2.57 [1.72-3.84],4.109888374875577e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHMT1,"Serine hydroxymethyltransferase, cytosolic",1848,187,0.98 [0.84-1.15],0.8325476072943615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SHPK,Sedoheptulokinase,1574,146,1.13 [0.79-1.61],0.5032921611859805
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIAE,Sialate O-acetylesterase,1854,187,1.25 [0.95-1.64],0.1085114806085685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC1,Sialoadhesin,1853,187,1.43 [1.09-1.88],0.0099327859378755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,1840,187,1.76 [1.25-2.49],0.0013750971612974
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC15,Sialic acid-binding Ig-like lectin 15,1788,185,1.03 [0.88-1.21],0.7001010364997664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,1855,188,1.10 [0.98-1.24],0.1128895989335845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,1867,190,2.08 [1.44-3.01],8.74678807395744e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,1850,189,1.31 [0.84-2.03],0.2349923920369844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,1562,150,1.38 [1.00-1.91],0.0503900144409825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIGLEC9,Sialic acid-binding Ig-like lectin 9,1864,189,0.72 [0.48-1.06],0.0988805282314902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIL1,Nucleotide exchange factor SIL1,1562,150,1.18 [0.79-1.77],0.4240449191145112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,1847,190,1.50 [1.17-1.92],0.0012727868280514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRPB1,Signal-regulatory protein beta-1,1838,185,1.80 [1.39-2.33],9.53340984385848e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT1,NAD-dependent protein deacetylase sirtuin-1,1548,150,0.95 [0.76-1.18],0.621568064153138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT2,NAD-dependent protein deacetylase sirtuin-2,1849,189,1.10 [0.95-1.27],0.1990366062971349
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",1788,185,0.80 [0.62-1.03],0.0892383315818311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,1801,185,1.14 [0.91-1.43],0.2632197028613084
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP1,Src kinase-associated phosphoprotein 1,1828,185,0.97 [0.81-1.16],0.7130370354797825
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKAP2,Src kinase-associated phosphoprotein 2,1853,187,1.02 [0.90-1.16],0.7255358791587112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SKIV2L,Helicase SKI2W,1541,149,1.21 [0.86-1.72],0.268533165889341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLA2,Src-like-adapter 2,1601,151,1.08 [0.93-1.26],0.2993305833540844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF1,Signaling lymphocytic activation molecule,1801,185,1.26 [1.02-1.57],0.0337850744443119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF6,SLAM family member 6,1798,185,1.32 [0.97-1.79],0.0728166308566686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF7,SLAM family member 7,1840,187,1.29 [1.04-1.60],0.0185128415391761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLAMF8,SLAM family member 8,1798,185,1.36 [1.07-1.73],0.0119272864979431
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC12A2,Solute carrier family 12 member 2,1541,149,0.68 [0.37-1.25],0.2173933357502212
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC13A1,Solute carrier family 13 member 1,1593,150,1.32 [1.08-1.61],0.0074660123339518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC16A1,Monocarboxylate transporter 1,1788,185,1.15 [0.95-1.38],0.1548685406788709
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC1A4,Neutral amino acid transporter A,1557,147,1.10 [0.82-1.47],0.5393978843255482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC27A4,Long-chain fatty acid transport protein 4,1788,185,1.03 [0.84-1.27],0.7620775921187574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC28A1,Sodium/nucleoside cotransporter 1,1538,145,1.06 [0.82-1.36],0.6699687780457761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC34A3,Sodium-dependent phosphate transport protein 2C,1538,145,0.93 [0.65-1.33],0.6928686520553565
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A14,Zinc transporter ZIP14,1788,185,1.54 [1.20-1.97],0.000627779528912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC39A5,Zinc transporter ZIP5,1840,187,1.25 [0.97-1.61],0.0822705328869683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC44A4,Choline transporter-like protein 4,1557,147,0.98 [0.79-1.22],0.8871715564134202
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC4A1,Band 3 anion transport protein,1604,153,1.45 [1.06-1.98],0.019752334342108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC51B,Organic solute transporter subunit beta,1541,149,0.92 [0.74-1.14],0.4538546413616851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,1570,146,1.07 [0.89-1.29],0.4750167807193606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,1581,150,1.17 [0.90-1.52],0.2397467800784343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",1538,145,1.00 [0.76-1.31],0.975787867416306
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLIT2,Slit homolog 2 protein,1788,185,1.03 [0.81-1.33],0.7890456259072292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK1,SLIT and NTRK-like protein 1,1548,150,0.76 [0.46-1.25],0.2744720091157199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK2,SLIT and NTRK-like protein 2,1867,190,1.58 [1.15-2.18],0.0049452594218698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLITRK6,SLIT and NTRK-like protein 6,1814,185,2.10 [1.49-2.95],2.374248908445484e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLK,STE20-like serine/threonine-protein kinase,1574,146,0.78 [0.60-1.02],0.0722484221219761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLMAP,Sarcolemmal membrane-associated protein,1581,150,1.18 [0.99-1.40],0.0638159950448519
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SLURP1,Secreted Ly-6/uPAR-related protein 1,1583,149,1.39 [0.99-1.96],0.057040716214538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD1,Mothers against decapentaplegic homolog 1,1798,185,1.12 [0.96-1.31],0.1371324850285122
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD2,Mothers against decapentaplegic homolog 2,1593,150,1.04 [0.84-1.28],0.7407188816972125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD3,Mothers against decapentaplegic homolog 3,1593,150,1.15 [0.86-1.55],0.3476836225351214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMAD5,Mothers against decapentaplegic homolog 5,1849,189,0.46 [0.24-0.87],0.0171780574620367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMARCA2,Probable global transcription activator SNF2L2,1788,185,1.09 [0.93-1.29],0.2930210414073187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMC3,Structural maintenance of chromosomes protein 3,1538,145,0.94 [0.69-1.27],0.6863353809059654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMNDC1,Survival of motor neuron-related-splicing factor 30,1581,150,1.11 [0.88-1.39],0.3902322407864675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC1,SPARC-related modular calcium-binding protein 1,1867,190,1.67 [1.16-2.39],0.0057832623280119
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMOC2,SPARC-related modular calcium-binding protein 2,1853,187,1.66 [1.27-2.17],0.0002242194857787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD1,Sphingomyelin phosphodiesterase,1849,185,1.01 [0.78-1.31],0.939169514851758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPD3,Sphingomyelin phosphodiesterase 3,1548,150,0.91 [0.65-1.27],0.5781189808338425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,1850,185,0.80 [0.67-0.97],0.0231977198154108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,1593,150,0.80 [0.62-1.03],0.0883200524395912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMS,Spermine synthase,1537,150,1.20 [0.97-1.48],0.0920351863715999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SMTN,Smoothelin,1589,150,1.07 [0.91-1.25],0.4065633889107958
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP23,Synaptosomal-associated protein 23,1850,189,1.03 [0.88-1.20],0.7135435542488233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP25,Synaptosomal-associated protein 25,1537,150,1.18 [0.87-1.61],0.2820261762982102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAP29,Synaptosomal-associated protein 29,1855,187,1.05 [0.91-1.21],0.5075699084571674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNAPIN,SNARE-associated protein Snapin,1601,151,0.83 [0.63-1.09],0.1825991279464737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCA,Alpha-synuclein,1570,146,1.13 [0.99-1.29],0.0782658286687876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNCG,Gamma-synuclein,1832,185,1.43 [1.20-1.71],7.686489338302243e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",1562,150,1.68 [1.19-2.39],0.0034835866675693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNRPB2,U2 small nuclear ribonucleoprotein B'',1592,150,1.16 [0.90-1.49],0.2587659725966125
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNU13,NHP2-like protein 1,1541,149,0.92 [0.68-1.24],0.594341484839479
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX15,Sorting nexin-15,1570,146,1.24 [0.94-1.63],0.1282373134894047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX18,Sorting nexin-18,1581,150,1.27 [0.95-1.70],0.1103104122283475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX2,Sorting nexin-2,1593,150,1.10 [0.91-1.33],0.337496972668079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX5,Sorting nexin-5,1562,150,1.68 [1.08-2.62],0.020925510662064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SNX9,Sorting nexin-9,1850,189,1.23 [1.03-1.48],0.0245190863963072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD1,Superoxide dismutase [Cu-Zn],1816,184,1.29 [1.00-1.66],0.0493029322001732
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD2,"Superoxide dismutase [Mn], mitochondrial",1855,188,0.93 [0.71-1.24],0.6319233294515747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOD3,Extracellular superoxide dismutase,1606,152,1.12 [0.91-1.37],0.2858317599212367
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORBS1,Sorbin and SH3 domain-containing protein 1,1601,151,1.11 [0.82-1.50],0.4880079083318669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORCS2,VPS10 domain-containing receptor SorCS2,1798,185,1.98 [1.45-2.70],1.713654962616669e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORD,Sorbitol dehydrogenase,1856,189,0.87 [0.74-1.03],0.1122669669695728
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SORT1,Sortilin,1850,189,1.04 [0.75-1.45],0.8037101082659338
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOST,Sclerostin,1850,189,1.06 [0.77-1.45],0.723899533230181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,1557,147,1.24 [0.98-1.57],0.0789892912263149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX2,Transcription factor SOX-2,1598,150,0.81 [0.42-1.56],0.5234395383226285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SOX9,Transcription factor SOX-9,1557,147,2.26 [1.25-4.10],0.0071482907704533
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,1601,151,1.35 [0.95-1.94],0.0974673331381612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPAG1,Sperm-associated antigen 1,1601,151,1.03 [0.80-1.33],0.8146614931743745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARC,SPARC,1855,187,0.93 [0.78-1.12],0.4643151629948221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPARCL1,SPARC-like protein 1,1847,188,1.12 [0.72-1.74],0.6258638485370149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPART,Spartin,1570,146,1.10 [0.89-1.35],0.367907487345538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPESP1,Sperm equatorial segment protein 1,1596,150,1.43 [0.85-2.38],0.17428548300351
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK1,Serine protease inhibitor Kazal-type 1,1855,188,1.95 [1.63-2.33],1.933507977224921e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK2,Serine protease inhibitor Kazal-type 2,1570,146,1.36 [0.98-1.89],0.0674045111756074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK4,Serine protease inhibitor Kazal-type 4,1840,187,1.73 [1.48-2.01],1.898937469894067e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK5,Serine protease inhibitor Kazal-type 5,1855,188,1.20 [0.82-1.75],0.3511213941471818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK6,Serine protease inhibitor Kazal-type 6,1867,190,0.97 [0.77-1.22],0.7949761358281145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINK8,Serine protease inhibitor Kazal-type 8,1541,149,0.65 [0.39-1.08],0.0997876107191006
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT1,Kunitz-type protease inhibitor 1,1851,188,1.71 [1.12-2.62],0.0129198372108552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT2,Kunitz-type protease inhibitor 2,1853,187,1.70 [1.25-2.31],0.0007599301097619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPINT3,Kunitz-type protease inhibitor 3,1581,150,0.86 [0.77-0.96],0.0065396376173661
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPOCK1,Testican-1,1832,185,0.41 [0.25-0.65],0.0001800704532166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON1,Spondin-1,1845,187,2.06 [1.50-2.83],8.094792842568046e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPON2,Spondin-2,1845,189,1.68 [1.24-2.29],0.0009045159096563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPP1,Osteopontin,1867,190,1.19 [0.93-1.53],0.1563052904600735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",1548,150,0.92 [0.63-1.36],0.6853685918284365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRING1,SREBP regulating gene protein,1538,145,1.08 [0.80-1.44],0.6217143643310727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR1B,Cornifin-B,1574,146,1.09 [0.92-1.30],0.3347926781299549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRR3,Small proline-rich protein 3,1592,150,1.05 [0.86-1.28],0.6306463940488221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPRY2,Protein sprouty homolog 2,1801,185,1.11 [0.97-1.28],0.1214896295589915
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",1537,150,1.22 [0.82-1.82],0.3205736739591459
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SPTLC1,Serine palmitoyltransferase 1,1592,150,1.15 [0.80-1.66],0.4536691944161798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRC,Proto-oncogene tyrosine-protein kinase Src,1851,187,1.05 [0.94-1.17],0.39247211461651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRP14,Signal recognition particle 14 kDa protein,1849,189,1.17 [0.95-1.44],0.1495414242934781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPK2,SRSF protein kinase 2,1840,187,1.09 [0.94-1.26],0.2476708299462981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SRPX,Sushi repeat-containing protein SRPX,1596,150,1.39 [0.92-2.12],0.1209652528578309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSB,Lupus La protein,1788,185,1.07 [0.86-1.32],0.5386826576463152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",1548,150,1.06 [0.70-1.62],0.7789971944117831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,1850,189,0.91 [0.82-1.01],0.0858172648542228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,1858,188,1.02 [0.76-1.38],0.8917253267990529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSH3,Protein phosphatase Slingshot homolog 3,1538,145,0.43 [0.23-0.82],0.0098579635018378
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SSNA1,Sjoegren syndrome nuclear autoantigen 1,1581,150,1.39 [1.07-1.82],0.0147361768686875
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST13,Hsc70-interacting protein,1570,146,1.12 [0.86-1.46],0.4021821168978093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1849,189,1.46 [1.11-1.94],0.0075851687060072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",1869,190,1.12 [0.72-1.74],0.6081437583622131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1548,150,0.61 [0.36-1.03],0.0620763888298528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAB2,Stabilin-2,1604,153,1.25 [0.72-2.18],0.4224756424839593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAM,Signal transducing adapter molecule 1,1593,150,0.96 [0.62-1.47],0.8365288364285152
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAMBP,STAM-binding protein,1828,185,1.17 [0.96-1.43],0.1260981810232564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT2,Signal transducer and activator of transcription 2,1548,150,1.13 [0.92-1.38],0.2521902175391786
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAT5B,Signal transducer and activator of transcription 5B,1849,189,1.06 [0.96-1.16],0.2279074694921681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,1538,145,1.04 [0.83-1.31],0.7279966032483929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC1,Stanniocalcin-1,1863,188,1.43 [1.09-1.86],0.0091096927572168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STC2,Stanniocalcin-2,1852,187,1.29 [0.78-2.11],0.3177117031767437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STEAP4,Metalloreductase STEAP4,1537,150,0.91 [0.71-1.16],0.4325944561635856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STIP1,Stress-induced-phosphoprotein 1,1852,188,1.18 [0.98-1.42],0.0862433906206523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK11,Serine/threonine-protein kinase STK11,1814,185,1.15 [0.96-1.36],0.1255363486750345
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK24,Serine/threonine-protein kinase 24,1788,185,1.22 [0.98-1.51],0.0698867305849541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STK4,Serine/threonine-protein kinase 4,1850,189,1.08 [0.93-1.26],0.3132667267518987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STOML2,"Stomatin-like protein 2, mitochondrial",1538,145,1.06 [0.89-1.26],0.5352477824795563
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX16,Syntaxin-16,1798,185,0.91 [0.73-1.13],0.3913833754535746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX1B,Syntaxin-1B,1557,147,1.11 [0.78-1.59],0.5601193010866308
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX3,Syntaxin-3,1592,150,0.97 [0.64-1.46],0.87973051034993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX4,Syntaxin-4,1849,189,1.16 [0.95-1.41],0.1473954405668894
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX5,Syntaxin-5,1548,150,1.08 [0.77-1.51],0.6463202018622659
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX6,Syntaxin-6,1798,185,1.08 [0.89-1.32],0.4436557793072807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX7,Syntaxin-7,1548,150,1.13 [0.81-1.57],0.4865968273687062
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STX8,Syntaxin-8,1840,187,1.17 [0.91-1.51],0.2272828739269003
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP1,Syntaxin-binding protein 1,1601,151,0.95 [0.78-1.17],0.6423990514579893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,STXBP3,Syntaxin-binding protein 3,1798,185,1.18 [0.86-1.60],0.3037192825026251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGP1,SURP and G-patch domain-containing protein 1,1581,150,1.01 [0.69-1.47],0.9720067961776522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUGT1,Protein SGT1 homolog,1798,185,1.13 [0.96-1.33],0.1295924596929892
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT1A1,Sulfotransferase 1A1,1863,188,1.04 [0.94-1.15],0.4237651908315799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SULT2A1,Bile salt sulfotransferase,1840,187,0.97 [0.80-1.17],0.7194742383030522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF1,Formylglycine-generating enzyme,1548,150,0.86 [0.64-1.15],0.3098584237118401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,1863,188,0.95 [0.75-1.20],0.6656901066025009
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUOX,"Sulfite oxidase, mitochondrial",1601,151,0.96 [0.76-1.20],0.6959753217124118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD1,Sushi domain-containing protein 1,1814,185,0.95 [0.72-1.25],0.7126602881439554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD2,Sushi domain-containing protein 2,1855,188,1.55 [1.05-2.29],0.0259426368444405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD4,Sushi domain-containing protein 4,1593,150,1.15 [0.84-1.58],0.3690255446939183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SUSD5,Sushi domain-containing protein 5,1561,145,1.57 [1.02-2.43],0.0425932966411715
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SV2A,Synaptic vesicle glycoprotein 2A,1557,147,1.17 [0.93-1.48],0.1816303669293274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SWAP70,Switch-associated protein 70,1581,150,1.19 [0.75-1.88],0.4518112191848269
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYAP1,Synapse-associated protein 1,1570,146,1.04 [0.79-1.36],0.8004485522799206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,1537,150,1.13 [0.88-1.45],0.3277030646241425
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYT1,Synaptotagmin-1,1592,150,1.02 [0.67-1.55],0.9233461050834156
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,SYTL4,Synaptotagmin-like protein 4,1596,150,1.08 [0.88-1.32],0.443101683588869
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,1574,146,1.08 [0.93-1.26],0.3289504648774606
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACC3,Transforming acidic coiled-coil-containing protein 3,1849,189,1.04 [0.93-1.16],0.5192633078488021
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TACSTD2,Tumor-associated calcium signal transducer 2,1652,168,1.77 [1.12-2.78],0.0136738680262858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TADA3,Transcriptional adapter 3,1593,150,1.23 [0.86-1.77],0.2600702889098341
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAFA5,Chemokine-like protein TAFA-5,1849,189,1.80 [1.37-2.36],2.444344264125364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAGLN3,Transgelin-3,1538,145,0.96 [0.74-1.25],0.7565000397813769
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TALDO1,Transaldolase,1602,153,1.22 [0.88-1.71],0.2388869663167238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TANK,TRAF family member-associated NF-kappa-B activator,1801,185,1.07 [0.89-1.30],0.4574439585111067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAP1,Antigen peptide transporter 1,1574,146,1.03 [0.81-1.31],0.8321171899504977
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARBP2,RISC-loading complex subunit TARBP2,1788,185,1.18 [0.99-1.39],0.0634599972959262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",1557,147,1.03 [0.83-1.27],0.8105839806647643
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",1593,150,0.96 [0.64-1.43],0.8242960105120302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TAX1BP1,Tax1-binding protein 1,1592,150,1.04 [0.82-1.33],0.7192393745836745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D17,TBC1 domain family member 17,1788,185,1.43 [1.14-1.79],0.0016981632249051
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D23,TBC1 domain family member 23,1849,189,1.06 [0.92-1.22],0.4388781014516222
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBC1D5,TBC1 domain family member 5,1840,187,1.02 [0.87-1.20],0.7983987961661347
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCA,Tubulin-specific chaperone A,1570,146,1.12 [0.94-1.34],0.2110772956299314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCB,Tubulin-folding cofactor B,1832,185,1.10 [0.97-1.26],0.1445443147643648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBCC,Tubulin-specific chaperone C,1832,185,1.12 [0.95-1.32],0.1644758242165649
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBL1X,F-box-like/WD repeat-containing protein TBL1X,1798,185,1.09 [0.93-1.27],0.2740243070165674
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TBR1,T-box brain protein 1,1557,147,1.13 [0.87-1.46],0.3517755667614022
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1A,T-cell leukemia/lymphoma protein 1A,1830,185,0.89 [0.78-1.01],0.0611953326122427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCL1B,T-cell leukemia/lymphoma protein 1B,1814,185,1.05 [0.89-1.22],0.578452675112049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN1,Transcobalamin-1,1566,147,0.77 [0.47-1.25],0.2910698092035522
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCN2,Transcobalamin-2,1867,190,1.97 [1.41-2.76],6.665330379242496e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCOF1,Treacle protein,1596,150,1.31 [0.80-2.15],0.2823962856732591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCP11,T-complex protein 11 homolog,1574,146,1.21 [1.01-1.45],0.0370690546266862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TCTN3,Tectonic-3,1596,150,0.71 [0.43-1.17],0.1737773244137713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDGF1,Teratocarcinoma-derived growth factor 1,1788,185,0.99 [0.91-1.09],0.8825752919430025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDO2,"Tryptophan 2,3-dioxygenase",1557,147,0.86 [0.55-1.35],0.5189400823810781
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDP1,Tyrosyl-DNA phosphodiesterase 1,1593,150,0.96 [0.76-1.21],0.717083828504234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TDRKH,Tudor and KH domain-containing protein,1788,185,1.10 [0.94-1.28],0.2400173228476795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEF,Thyrotroph embryonic factor,1541,149,1.12 [0.78-1.61],0.5285474765802933
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEK,Angiopoietin-1 receptor,1855,187,1.46 [0.84-2.54],0.1789977487848365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TERF1,Telomeric repeat-binding factor 1,1548,150,0.74 [0.42-1.30],0.293444700807132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TET2,Methylcytosine dioxygenase TET2,1570,146,1.00 [0.86-1.16],0.980544584780524
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX101,Testis-expressed protein 101,1557,147,1.07 [0.71-1.62],0.7425028502700215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TEX33,Testis-expressed protein 33,1574,146,0.85 [0.53-1.39],0.5250464277167879
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TF,Serotransferrin,1608,152,1.59 [0.81-3.11],0.1752373826878016
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFAP2A,Transcription factor AP-2-alpha,1537,150,1.04 [0.81-1.32],0.7737314687623297
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF1,Trefoil factor 1,1847,188,1.43 [1.27-1.62],1.572372517796002e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF2,Trefoil factor 2,1848,187,1.78 [1.50-2.12],5.30006175517745e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFF3,Trefoil factor 3,1840,188,1.81 [1.51-2.17],1.2883549092976128e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI,Tissue factor pathway inhibitor,1851,187,0.82 [0.55-1.23],0.3403611887902339
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFPI2,Tissue factor pathway inhibitor 2,1850,187,1.26 [0.93-1.71],0.1369612603016145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TFRC,Transferrin receptor protein 1,1856,186,1.24 [0.91-1.69],0.1776493717239415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TG,Thyroglobulin,1593,150,1.10 [0.97-1.24],0.1255343995199583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFA,Protransforming growth factor alpha,1840,187,1.58 [1.26-1.99],7.959034573082427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB1,Transforming growth factor beta-1 proprotein,1862,187,1.24 [0.90-1.73],0.1930637251739296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFB2,Transforming growth factor beta-2 proprotein,1593,150,1.12 [0.87-1.44],0.3999816076512942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1842,185,0.44 [0.29-0.68],0.0002209659715296
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR1,TGF-beta receptor type-1,1548,150,1.05 [0.49-2.28],0.8927068115885259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR2,TGF-beta receptor type-2,1855,187,2.00 [1.56-2.56],4.7062187595660374e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGFBR3,Transforming growth factor beta receptor type 3,1869,190,1.39 [0.97-2.01],0.0731078931608588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGM2,Protein-glutamine gamma-glutamyltransferase 2,1846,189,1.09 [0.93-1.28],0.3002525110808745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TGOLN2,Trans-Golgi network integral membrane protein 2,1606,152,2.07 [1.26-3.41],0.0040712307080159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THAP12,52 kDa repressor of the inhibitor of the protein kinase,1535,145,0.89 [0.73-1.09],0.2706563803271822
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBD,Thrombomodulin,1850,189,1.86 [1.28-2.72],0.0012794998644103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS2,Thrombospondin-2,1855,188,1.24 [0.97-1.58],0.0868889283664795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THBS4,Thrombospondin-4,1856,187,0.92 [0.71-1.19],0.5116000833525993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THOP1,Thimet oligopeptidase,1843,188,0.85 [0.58-1.24],0.3982142252733405
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THPO,Thrombopoietin,1814,185,1.19 [0.87-1.64],0.281206303706727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THRAP3,Thyroid hormone receptor-associated protein 3,1541,149,0.96 [0.82-1.11],0.5617232410251394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THSD1,Thrombospondin type-1 domain-containing protein 1,1534,147,1.03 [0.68-1.56],0.9007752223367996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THTPA,Thiamine-triphosphatase,1590,150,1.10 [0.92-1.32],0.2879495650025908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,THY1,Thy-1 membrane glycoprotein,1863,188,1.33 [0.90-1.95],0.1501260349517798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIA1,Nucleolysin TIA-1 isoform p40,1790,182,1.10 [0.99-1.23],0.0700747774134764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIE1,Tyrosine-protein kinase receptor Tie-1,1869,190,1.00 [0.74-1.34],0.9792803982318272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",1784,185,1.07 [0.80-1.42],0.6398750144810841
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,1574,146,1.47 [1.05-2.04],0.0230008070846648
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,1858,188,0.82 [0.63-1.07],0.1484293459458074
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,1596,150,1.34 [0.93-1.94],0.1148441158540372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,1592,150,1.01 [0.84-1.22],0.8832066344754748
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP1,Metalloproteinase inhibitor 1,1828,187,1.19 [0.81-1.76],0.3766090118552719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP2,Metalloproteinase inhibitor 2,1596,150,1.58 [0.95-2.64],0.0786154129776423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP3,Metalloproteinase inhibitor 3,1853,187,0.98 [0.89-1.07],0.6004305767276485
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TIMP4,Metalloproteinase inhibitor 4,1855,188,1.26 [0.95-1.66],0.1130173458875596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TINAGL1,Tubulointerstitial nephritis antigen-like,1848,189,1.60 [0.94-2.74],0.0821449874819811
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJAP1,Tight junction-associated protein 1,1855,187,1.09 [0.93-1.27],0.2890190235474996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TJP3,Tight junction protein ZO-3,1537,150,1.20 [0.86-1.67],0.2757330278297288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TK1,"Thymidine kinase, cytosolic",1574,146,1.10 [0.76-1.57],0.6190102499079218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR1,Toll-like receptor 1,1548,150,1.74 [1.00-3.03],0.0517269500979928
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR2,Toll-like receptor 2,1574,146,1.17 [0.59-2.31],0.6554413310376215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR3,Toll-like receptor 3,1864,187,1.14 [0.92-1.40],0.2264477473259429
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TLR4,Toll-like receptor 4,1548,150,0.66 [0.36-1.19],0.1680525684397722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,1557,147,1.27 [0.96-1.69],0.0935534865011502
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED1,Transmembrane emp24 domain-containing protein 1,1574,146,0.93 [0.69-1.26],0.6325926050263988
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED10,Transmembrane emp24 domain-containing protein 10,1541,149,1.07 [0.76-1.52],0.6874155834899529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED4,Transmembrane emp24 domain-containing protein 4,1541,149,0.86 [0.64-1.15],0.3126779224419586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMED8,Protein TMED8,1581,150,1.07 [0.92-1.24],0.3870659121948758
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM106A,Transmembrane protein 106A,1593,150,1.02 [0.82-1.28],0.8501640952540923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM132A,Transmembrane protein 132A,1562,150,1.16 [0.91-1.48],0.242780069298292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMEM25,Transmembrane protein 25,1601,151,1.10 [0.78-1.55],0.5785970428876093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMOD4,Tropomodulin-4,1538,145,1.10 [0.78-1.55],0.6007371002281414
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11B,Transmembrane protease serine 11B,1537,150,1.03 [0.84-1.25],0.7822314666111886
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS11D,Transmembrane protease serine 11D,1591,150,1.23 [0.87-1.74],0.2324438820341457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS15,Enteropeptidase,1849,189,1.31 [1.13-1.50],0.0002276812604792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMPRSS5,Transmembrane protease serine 5,1823,184,1.18 [0.84-1.66],0.3369146402581703
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TMSB10,Thymosin beta-10,1855,188,1.36 [1.14-1.62],0.0008174446225527
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNC,Tenascin,1858,188,1.29 [1.01-1.65],0.0413493242888092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNF,Tumor necrosis factor,1812,184,1.40 [1.11-1.78],0.0053320658139086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,1581,150,1.22 [0.93-1.60],0.159748234142067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,1801,185,1.08 [0.75-1.54],0.6812655365375571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,1570,146,1.15 [0.91-1.47],0.2366814948524163
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1832,185,3.33 [2.35-4.72],1.578137547970129e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1832,185,1.43 [1.25-1.65],2.60018739560098e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,1853,189,1.15 [0.87-1.50],0.3259155481197157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1864,187,2.23 [1.76-2.82],3.2502609114471985e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1841,187,1.53 [1.08-2.18],0.0169990176249348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1855,187,2.15 [1.63-2.83],4.604269363285465e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,1845,187,1.84 [1.33-2.54],0.0002300517504484
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,1801,185,1.34 [1.00-1.81],0.0519160044967587
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1845,187,2.84 [2.14-3.77],3.822751805550757e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,1570,146,1.63 [1.13-2.35],0.0089694977857726
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1867,190,2.07 [1.57-2.71],1.7753284372906385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1855,188,2.99 [2.18-4.11],1.2148553316226188e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1855,188,1.57 [1.31-1.87],7.14389130544151e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1863,188,1.75 [1.15-2.67],0.0087750919138435
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1862,187,2.10 [1.61-2.74],3.760265065068416e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1832,185,1.48 [1.19-1.85],0.0004900891205561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1863,188,1.52 [1.19-1.93],0.0006602311299495
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1832,185,2.16 [1.67-2.78],3.376609914046825e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,1864,187,0.66 [0.41-1.06],0.0869185178178999
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,1840,187,0.85 [0.68-1.05],0.1249739013248813
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,1864,187,0.66 [0.43-1.02],0.0602763650563612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1853,187,3.14 [2.08-4.74],5.517835899524077e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,1866,190,1.02 [0.67-1.56],0.9149498668957669
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF14,Tumor necrosis factor ligand superfamily member 14,1832,185,1.05 [0.84-1.33],0.6540450065449799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1604,153,1.68 [1.15-2.45],0.0075822001003366
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNIP1,TNFAIP3-interacting protein 1,1592,150,1.01 [0.85-1.20],0.9214192430069564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNN,Tenascin-N,1604,153,0.85 [0.60-1.19],0.3361688983615513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNNI3,"Troponin I, cardiac muscle",1814,185,1.11 [0.94-1.31],0.210181043897208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNPO1,Transportin-1,1574,146,1.42 [0.92-2.19],0.1167049130783734
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNR,Tenascin-R,1832,185,1.31 [0.97-1.77],0.082268952290718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TNXB,Tenascin-X,1855,188,0.88 [0.55-1.40],0.5848073753128002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,1596,150,1.20 [0.99-1.45],0.0579430623148139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1,DNA topoisomerase 1,1581,150,1.00 [0.87-1.15],0.9794637229247404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP1MT,"DNA topoisomerase I, mitochondrial",1538,145,0.94 [0.65-1.34],0.7258151913269812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOP2B,DNA topoisomerase 2-beta,1548,150,1.04 [0.85-1.27],0.7149302536338007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TOR1AIP1,Torsin-1A-interacting protein 1,1562,150,1.18 [0.92-1.50],0.191225248666945
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53,Cellular tumor antigen p53,1798,185,1.38 [1.03-1.86],0.0332765271254219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53BP1,TP53-binding protein 1,1548,150,1.06 [0.89-1.27],0.5104001960232203
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53I3,Quinone oxidoreductase PIG3,1527,141,1.27 [0.96-1.67],0.0952927969938098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP53INP1,Tumor protein p53-inducible nuclear protein 1,1814,185,0.86 [0.55-1.36],0.5284075916308191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TP73,Tumor protein p73,1557,147,1.08 [0.70-1.67],0.7369957807466172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPBGL,Trophoblast glycoprotein-like,1557,147,1.19 [0.86-1.65],0.3026713102061619
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPD52L2,Tumor protein D54,1570,146,1.04 [0.90-1.21],0.5920640695697867
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPK1,Thiamin pyrophosphokinase 1,1596,150,1.02 [0.58-1.78],0.9560924663415808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPM3,Tropomyosin alpha-3 chain,1541,149,0.99 [0.71-1.37],0.9506828745676024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPMT,Thiopurine S-methyltransferase,1798,185,0.99 [0.83-1.19],0.9400099783807376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPP1,Tripeptidyl-peptidase 1,1832,186,1.05 [0.82-1.36],0.6848310702231843
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP2,Tubulin polymerization-promoting protein family member 2,1574,146,0.98 [0.80-1.18],0.7989294895595135
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPPP3,Tubulin polymerization-promoting protein family member 3,1788,185,0.85 [0.59-1.21],0.3577427684906348
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPR,Nucleoprotein TPR,1541,149,0.99 [0.73-1.34],0.9284604330361322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPRKB,EKC/KEOPS complex subunit TPRKB,1538,145,1.08 [0.85-1.36],0.5322153433320617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSAB1,Tryptase alpha/beta-1,1860,187,1.07 [0.82-1.39],0.6291529397202336
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSD1,Tryptase delta,1601,151,1.15 [0.76-1.74],0.5125829444753611
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPSG1,Tryptase gamma,1548,150,1.04 [0.61-1.79],0.8791223469988129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TPT1,Translationally-controlled tumor protein,1801,185,1.05 [0.85-1.31],0.6291305750340075
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF2,TNF receptor-associated factor 2,1840,187,1.11 [0.92-1.32],0.2697523573985566
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3,"TNF receptor-associated factor 3, Isoform 2",1548,150,1.04 [0.70-1.54],0.8638051467626082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,1541,149,0.98 [0.70-1.39],0.9245049607567172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,1574,146,1.01 [0.84-1.21],0.8953352662368701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREH,Trehalase,1604,153,1.05 [0.85-1.28],0.6569585453044453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREM2,Triggering receptor expressed on myeloid cells 2,1841,187,1.06 [0.85-1.31],0.6198890217966482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML1,Trem-like transcript 1 protein,1606,152,1.12 [0.84-1.50],0.4223285960266039
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TREML2,Trem-like transcript 2 protein,1855,188,1.01 [0.69-1.49],0.9437692503052162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIAP1,TP53-regulated inhibitor of apoptosis 1,1867,190,1.20 [0.98-1.47],0.0755732386271787
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM21,E3 ubiquitin-protein ligase TRIM21,1840,187,1.13 [0.96-1.32],0.136473418133179
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM24,Transcription intermediary factor 1-alpha,1569,146,1.25 [1.00-1.55],0.0489286428538543
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,1581,150,1.08 [0.93-1.24],0.3250557761016446
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM26,Tripartite motif-containing protein 26,1538,145,0.88 [0.66-1.15],0.3442836558979372
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM40,E3 ubiquitin ligase TRIM40,1557,147,1.14 [0.92-1.41],0.226485218932175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM5,Tripartite motif-containing protein 5,1840,187,0.99 [0.85-1.15],0.9080572063784124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRIM58,E3 ubiquitin-protein ligase TRIM58,1593,150,1.15 [0.97-1.38],0.1140751026953254
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TRPV3,Transient receptor potential cation channel subfamily V member 3,1541,149,1.02 [0.76-1.38],0.8934353569679213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC1,Hamartin,1548,150,0.92 [0.72-1.18],0.5293098422333906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSC22D1,TSC22 domain family protein 1,1601,151,1.21 [0.98-1.50],0.0773814479955316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSHB,Thyrotropin subunit beta,1850,189,0.85 [0.74-0.98],0.0221401619697493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSLP,Thymic stromal lymphopoietin,1814,185,1.06 [0.87-1.29],0.5567848569290132
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSNAX,Translin-associated protein X,1541,149,1.33 [0.92-1.91],0.1251301360107183
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN1,Tetraspanin-1,1814,185,2.04 [1.53-2.71],9.541508634182008e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN15,Tetraspanin-15,1541,149,0.77 [0.53-1.11],0.1543175339437259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN7,Tetraspanin-7,1537,150,1.16 [0.99-1.37],0.063538270888305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPAN8,Tetraspanin-8,1581,150,0.97 [0.85-1.12],0.6740371173597213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TSPYL1,Testis-specific Y-encoded-like protein 1,1548,150,1.24 [0.87-1.76],0.2367069540903404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TST,Thiosulfate sulfurtransferase,1788,185,1.14 [0.95-1.35],0.151058784120149
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTF2,Transcription termination factor 2,1557,147,1.42 [1.06-1.91],0.018581238924355
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTN,Titin,1541,149,1.30 [1.09-1.56],0.0044313746445088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TTR,Transthyretin,1596,152,0.86 [0.49-1.49],0.5890574016554593
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TUBB3,Tubulin beta-3 chain,1537,150,2.22 [1.28-3.83],0.0044030557594552
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TWF2,Twinfilin-2,1604,153,1.10 [0.92-1.32],0.277192411065592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXK,Tyrosine-protein kinase TXK,1574,146,0.94 [0.74-1.18],0.5735527449447626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXLNA,Alpha-taxilin,1832,185,1.09 [0.94-1.26],0.2667684274993736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXN,Thioredoxin,1577,150,1.24 [0.91-1.69],0.1727280121055749
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC15,Thioredoxin domain-containing protein 15,1855,187,1.04 [0.68-1.60],0.8549650776908144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC5,Thioredoxin domain-containing protein 5,1863,188,1.29 [1.08-1.56],0.0059940968096271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNDC9,Thioredoxin domain-containing protein 9,1592,150,1.22 [0.93-1.60],0.1555240529119783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNL1,Thioredoxin-like protein 1,1535,150,1.07 [0.91-1.25],0.410018027728792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",1855,188,1.10 [0.84-1.43],0.4808850309019995
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYMP,Thymidine phosphorylase,1835,187,1.08 [0.89-1.33],0.4300092022619315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRO3,Tyrosine-protein kinase receptor TYRO3,1850,189,1.08 [0.70-1.67],0.7219257973185138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1548,150,1.14 [0.89-1.45],0.3067974495177528
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBAC1,Ubiquitin-associated domain-containing protein 1,1849,189,1.41 [1.00-2.00],0.0493715502771328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2B,Ubiquitin-conjugating enzyme E2 B,1593,150,1.26 [0.76-2.07],0.3692798943909665
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,1596,150,1.16 [0.90-1.50],0.2457038423408187
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,1548,150,1.05 [0.80-1.38],0.7283252983826562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBQLN3,Ubiquilin-3,1541,149,1.08 [0.83-1.41],0.5454466890612334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UBXN1,UBX domain-containing protein 1,1570,146,1.15 [0.92-1.42],0.2174116036435575
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,1581,150,1.07 [0.95-1.19],0.2510966259748585
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UGDH,UDP-glucose 6-dehydrogenase,1541,149,1.06 [0.91-1.23],0.4765696694980208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UHRF2,E3 ubiquitin-protein ligase UHRF2,1541,149,0.94 [0.58-1.52],0.7978519895922246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ULBP2,UL16-binding protein 2,1832,185,1.86 [1.40-2.47],1.853123107623915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UMOD,Uromodulin,1860,187,0.57 [0.47-0.70],3.882764437113211e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC5D,Netrin receptor UNC5D,1548,150,0.94 [0.50-1.78],0.851278068450525
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNC79,Protein unc-79 homolog,1538,145,1.26 [0.97-1.65],0.088189279021607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UNG,Uracil-DNA glycosylase,1593,150,1.19 [0.77-1.84],0.4313366248738312
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPB1,Beta-ureidopropionase,1596,150,0.81 [0.70-0.95],0.0087634725191357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3A,Uroplakin-3a,1537,150,1.05 [0.77-1.43],0.7645507169093322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UPK3BL1,Uroplakin-3b-like protein 1,1571,145,0.92 [0.65-1.30],0.6464519967525856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROD,Uroporphyrinogen decarboxylase,1570,146,1.06 [0.85-1.32],0.6117404817626542
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UROS,Uroporphyrinogen-III synthase,1557,147,1.38 [1.12-1.71],0.0023294531809948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USO1,General vesicular transport factor p115,1849,189,1.12 [0.97-1.29],0.109435944768393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP25,Ubiquitin carboxyl-terminal hydrolase 25,1593,150,1.15 [0.93-1.43],0.2058757165447919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,1592,150,1.55 [1.15-2.10],0.0041481956602595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP47,Ubiquitin carboxyl-terminal hydrolase 47,1541,149,1.15 [0.96-1.38],0.1253866752787301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,USP8,Ubiquitin carboxyl-terminal hydrolase 8,1814,185,1.16 [1.02-1.33],0.0249267739151613
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,UXS1,UDP-glucuronic acid decarboxylase 1,1798,185,1.10 [0.88-1.37],0.3838552916177568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP5,Vesicle-associated membrane protein 5,1814,185,0.95 [0.75-1.22],0.7026201023284712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAMP8,Vesicle-associated membrane protein 8,1548,150,1.03 [0.85-1.24],0.7713943183782274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASH1,Tubulinyl-Tyr carboxypeptidase 1,1840,187,1.09 [0.93-1.27],0.2700129159686151
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASN,Vasorin,1819,181,2.07 [1.36-3.15],0.0007158527058441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VASP,Vasodilator-stimulated phosphoprotein,1606,152,1.06 [0.87-1.31],0.5520043812776206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,1849,189,1.44 [0.76-2.75],0.2632936029489214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VAV3,Guanine nucleotide exchange factor VAV3,1537,150,1.06 [0.90-1.24],0.4925727629224282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAM1,Vascular cell adhesion protein 1,1857,188,1.87 [1.26-2.78],0.0019425559018877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCAN,Versican core protein,1863,188,1.33 [0.90-1.98],0.1536010128379663
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VCPKMT,Protein-lysine methyltransferase METTL21D,1538,145,1.00 [0.83-1.19],0.9698458605917568
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFA,Vascular endothelial growth factor A,1860,187,1.19 [0.97-1.46],0.1008862208397578
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFB,Vascular endothelial growth factor B,1548,150,1.46 [0.89-2.38],0.1359589434950415
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFC,Vascular endothelial growth factor C,1855,187,0.94 [0.75-1.18],0.6213453417023073
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VEGFD,Vascular endothelial growth factor D,1862,187,1.96 [1.40-2.75],9.406716966709888e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VGF,Neurosecretory protein VGF,1601,151,1.09 [0.70-1.70],0.701788643849144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIM,Vimentin,1814,185,0.95 [0.86-1.06],0.3825537547598788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIPR1,Vasoactive intestinal polypeptide receptor 1,1562,150,0.99 [0.55-1.78],0.9773694056030564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VIT,Vitrin,1596,150,1.08 [0.74-1.58],0.6811497582317112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1849,189,1.19 [0.97-1.45],0.0907769075391208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN1,Pantetheinase,1606,152,0.85 [0.70-1.02],0.0839666078303373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VNN2,Vascular non-inflammatory molecule 2,1849,189,1.06 [0.80-1.41],0.67518597412662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS28,Vacuolar protein sorting-associated protein 28 homolog,1574,146,1.05 [0.83-1.33],0.6623990992224997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS37A,Vacuolar protein sorting-associated protein 37A,1849,189,1.20 [1.03-1.40],0.022909133181895
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS4B,Vacuolar protein sorting-associated protein 4B,1593,150,1.02 [0.87-1.20],0.8321489669802735
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VPS53,Vacuolar protein sorting-associated protein 53 homolog,1849,189,1.08 [0.92-1.27],0.3425224742887252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10,V-set and immunoglobulin domain-containing protein 10,1593,150,0.73 [0.46-1.18],0.2011730090497635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,1541,149,1.37 [0.93-2.04],0.1137531854046483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1593,150,1.49 [1.24-1.80],2.476104444682133e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1852,187,2.09 [1.65-2.65],1.2590465583818332e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,1847,189,1.19 [0.98-1.43],0.0748028628090858
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSNL1,Visinin-like protein 1,1592,150,0.57 [0.40-0.81],0.0019255598634521
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM1,V-set and transmembrane domain-containing protein 1,1788,185,1.43 [1.11-1.83],0.0049090394604354
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2B,V-set and transmembrane domain-containing protein 2B,1574,146,0.75 [0.48-1.16],0.1929636494438792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,1814,185,1.15 [0.95-1.39],0.154863586345623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,1863,188,1.13 [0.94-1.34],0.187574296007042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,1798,185,1.32 [0.89-1.95],0.1651555124794315
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,1570,146,1.12 [0.86-1.46],0.4138609176939301
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA1,von Willebrand factor A domain-containing protein 1,1862,190,0.95 [0.70-1.30],0.7529137438265331
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWA5A,von Willebrand factor A domain-containing protein 5A,1538,145,1.02 [0.84-1.23],0.8466977813023806
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2,Brorin,1825,185,1.69 [1.25-2.29],0.0007208507403178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWC2L,von Willebrand factor C domain-containing protein 2-like,1601,151,1.12 [0.87-1.43],0.3885633643674391
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,VWF,von Willebrand factor,1869,190,1.12 [0.94-1.33],0.2097066252039126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WARS,"Tryptophan--tRNA ligase, cytoplasmic",1855,188,1.06 [0.76-1.48],0.7262417298887365
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WAS,Wiskott-Aldrich syndrome protein,1801,185,0.98 [0.81-1.18],0.8113988887375556
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF1,Wiskott-Aldrich syndrome protein family member 1,1814,185,1.09 [0.95-1.26],0.2231875709408083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASF3,Wiskott-Aldrich syndrome protein family member 3,1788,185,1.07 [0.91-1.26],0.4234734546783628
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASHC3,WASH complex subunit 3,1592,150,1.04 [0.85-1.27],0.6836315230506574
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WASL,Neural Wiskott-Aldrich syndrome protein,1548,150,1.03 [0.81-1.30],0.8061354361714111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WDR46,WD repeat-containing protein 46,1593,150,0.75 [0.46-1.20],0.2278770615744239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC1,WAP four-disulfide core domain protein 1,1560,149,1.04 [0.81-1.35],0.7437623826547244
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC12,WAP four-disulfide core domain protein 12,1865,190,1.24 [1.04-1.48],0.0189322209307259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFDC2,WAP four-disulfide core domain protein 2,1761,176,2.08 [1.67-2.58],3.7885826625352846e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1824,184,0.65 [0.48-0.89],0.0063924149493092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",1845,187,1.16 [0.83-1.62],0.3810696053723639
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WIF1,Wnt inhibitory factor 1,1867,190,0.69 [0.48-1.00],0.0484362765438494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WNT9A,Protein Wnt-9a,1801,185,1.82 [1.40-2.36],7.834322467961716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,1832,185,1.02 [0.80-1.29],0.8903774571056936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XCL1,Lymphotactin,1867,190,1.27 [1.05-1.53],0.0148752512656047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XG,Glycoprotein Xg,1859,189,2.09 [1.56-2.81],7.684417141797724e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XIAP,E3 ubiquitin-protein ligase XIAP,1548,150,1.13 [0.86-1.47],0.3884269676471634
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XPNPEP2,Xaa-Pro aminopeptidase 2,1855,187,0.83 [0.72-0.95],0.0067632167953157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,XRCC4,DNA repair protein XRCC4,1788,185,1.20 [0.85-1.69],0.3010467731369809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YAP1,Transcriptional coactivator YAP1,1592,150,2.67 [1.73-4.12],9.901445094450922e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",1581,150,1.06 [0.95-1.19],0.2732841740511812
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YES1,Tyrosine-protein kinase Yes,1849,189,1.06 [0.95-1.19],0.2890624415175818
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YJU2,Splicing factor YJU2,1593,150,1.64 [1.02-2.65],0.0419579019022326
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YOD1,Ubiquitin thioesterase OTU1,1541,149,1.09 [0.87-1.38],0.4515723504120161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YTHDF3,YTH domain-containing family protein 3,1801,185,1.07 [0.92-1.25],0.4016732853558291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YWHAQ,14-3-3 protein theta,1570,146,1.08 [0.88-1.33],0.4547672845810033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,YY1,Transcriptional repressor protein YY1,1548,150,0.70 [0.38-1.28],0.2448821973986571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBP1,Z-DNA-binding protein 1,1548,150,1.08 [0.71-1.64],0.730595795458064
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB16,Zinc finger and BTB domain-containing protein 16,1798,185,1.12 [0.93-1.34],0.2286502094831448
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,1814,185,1.30 [1.00-1.71],0.0524648869925291
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZCCHC8,Zinc finger CCHC domain-containing protein 8,1541,149,1.01 [0.79-1.30],0.930957497547694
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZFYVE19,Abscission/NoCut checkpoint regulator,1581,150,1.11 [0.93-1.31],0.2474368584502174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZHX2,Zinc fingers and homeoboxes protein 2,1592,150,1.09 [0.72-1.65],0.6734889606828218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF174,Zinc finger protein 174,1548,150,1.08 [0.73-1.61],0.7002370598070033
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF75D,Zinc finger protein 75D,1574,146,0.75 [0.56-1.02],0.0675439961532681
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNF830,Zinc finger protein 830,1593,150,0.88 [0.71-1.11],0.2815536670319961
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRD2,Protein ZNRD2,1581,150,1.13 [0.92-1.38],0.2583017811070768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,1593,150,0.93 [0.69-1.25],0.6225522949703738
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP3,Zona pellucida sperm-binding protein 3,1562,150,1.05 [0.99-1.11],0.1155172215224946
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZP4,Zona pellucida sperm-binding protein 4,1538,145,1.29 [0.89-1.87],0.1743878839130462
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,ZPR1,Zinc finger protein ZPR1,1537,150,0.94 [0.80-1.11],0.4940490738086037
